زيت ريك سيمبسون (RSO) في المغرب: الدليل الكامل من OilWell Cannabis

فهم زيت ريك سيمبسون في المشهد المغربي المتطور للقنب

إذا كنت تقرأ هذا في الدار البيضاء أو مراكش أو طنجة أو أي مكان عبر المغرب، فمن المحتمل أنك مرتبط بواحدة من أكثر قصص القنب تعقيداً في العالم. لأجيال، جبال الريف أنتجت بعض أجود نباتات القنب على كوكب الأرض، ومع ذلك، حتى وقت قريب، ظل الحصول على زيت قنب طبي قانوني ومُوحّد مستحيلاً للمغاربة الذين يبحثون عن تخفيف علاجي. تغيّر هذا المشهد عام 2021 عندما أصبح المغرب أول دولة في شمال أفريقيا تشرّع القنب الطبي والقنب الصناعي، مما أدى إلى إنشاء الوكالة الوطنية لتنظيم مراقبة القنب (ANRACA). لكن الفجوة بين زراعة الكيف التقليدية والطب القائم على الأدلة الحديث حول القنبينويد تظل واسعة — وهي فجوة وجد هذا المستند لسدها.

العلاقة المغربية بالقنب قديمة ومتعددة الطبقات. ثقافة الكيف التقليدية في الشمال، والواقعيات الاقتصادية لمجتمعات الزراعة الريفية، والشتات المغربي في جميع أنحاء العالم الذي يبحث عن خيارات علاجية قانونية، والإطار الجديد للقنب الطبي — كلها تتقاطع هنا. سواء كنت مريضاً بالسرطان في الرباط تبحث عن بدائل، أو تعاني من ألم مزمن في فاس تستكشف خياراتاً تتجاوز الأدوية التقليدية، أو محارب قديم تعاني من اضطراب ما بعد الصدمة في الشتات المغربي تبحث عن تخفيف، أو مقدم رعاية في شفشاون تبحث عن معلومات قائمة على الأدلة — هذا الدليل كُتب لك.

نحن في OilWell Cannabis نتعامل مع هذا باحترام عميق للموقع الفريد للمغرب. لسنا هنا لفرض منتج أمريكي على التراب المغربي. نحن هنا نقدم شيئاً لم يكن موجوداً عندما بدأ ريك سيمبسون أولى حملاته: صيغة قانونية ومُضبطة ومُختبرة تتضمن قنبينويدات متعددة، تُكرّم روح RSO بينما تحل المشكلات التي جعلت رؤية سيمبسون الأصلية خطيرة وغير موحّدة. صيغنا مفتوحة المصدر، وأدلتنا محكّمة النظر، وإلتزامنا هو التعليم أولاً — لأنه في سوق ينتقل من الاستخدام التقليدي غير الرسمي إلى القنب الطبي المُنظّم، القرارات المستنيرة تنقذ الأرواح.

عن ريك سيمبسون وزيت ريك سيمبسون التقليدي

من هو ريك سيمبسون

وُلد ريك سيمبسون عام 1949 في أمهرست، نوفا سكوشا، كندا. لم يكن طبيباً أو عالماً أو محترفاً طبياً. كان مهندس طاقة وعاملاً صيانة — عامل مهارات يدوية زرقاء بدأ مساره في الدعوة للقنب ليس بالبحث بل بالمعاناة الشخصية وعدم الثقة العميقة بالنظام الطبي الذي فشله.

في عام 1997، بينما كان يعمل في مستشفى في مونكتون، نيو برونزويك، سقط سيمبسون من سقالة وتعرض لإصابة رأسية خطيرة. تضمنت التداعيات طنيناً مستمراً ودواراً ومجموعة من أعراض ما بعد الارتجاج لم يتمكن الطب التقليدي من حلها بشكل كافٍ. وفقاً لسيمبسون، الأدوية التي وُصفت له إما فشلت في المساعدة أو جعلت حالته أسوأ. أبلغ أن القنب قدّم تخفيفاً أكثر من أي شيء قدّمه أطباؤه، لكن عندما طلب من طبيبه دعم أو وصف القنب، رُفض الطلب .

الصلة المغربية: هذا التجربة تتردد بعمق في المغرب، حيث يواجه العديد من المرضى تحديات مماثلة مع النظام الطبي التقليدي. في المجتمعات المغربية من الريف إلى الرباط، سمعنا قصصاً لا تُحصى عن أُناس أُخبروا أنه لا توجد خيارات أخرى، وُصفت لهم أدوية تسبب ضرراً أكبر من نفعها، أو مُنعوا من الوصول إلى علاجات قائمة على القنب رغم إبداء اهتمامهم. الإحباط الذي شعر به سيمبسون عندما رفض طبيبه القنب يعكس ما يعانيه العديد من المغاربة عند مناقشة علاجات بديلة مع مقدمي الرعاية الصحية الذين لا يزالون غير مألوفين أو مترددين حيال الطب القائم على القنبينويد.

تعمق اهتمام سيمبسون بالزيت المركز من القنب بعد أن علم عن دراسة عام 1974 ممولة من المعهد الوطني للصحة أُجريت في الكلية الطبية في فيرجينيا، ذُكر فيها أن THC قد يبطئ أو يقلّص الأورام في الفئران. تلك الدراسة — المقصود منها في الأصل إظهار الضرر — أصبحت نقطة مرجعية أساسية في دعوة سيمبسون لاحقاً، رغم أن نتائجها لم تُكرَّر أبداً في تجارب سرطان بشرية مضبوطة .

اللحظة المحورية في قصة سيمبسون جاءت عام 2003. أبلغ أن ثلاث نتوءات على ذراعه تم تشخيصها من قِبل طبيبه كسرطان جلدي قاعدي الخلايا. بدلاً من متابعة العلاج التقليدي، طبّق سيمبسون زيت القنب المركز مباشرةً على الآفات، غطّاها بضمادات، وانتظر. وفقاً لروايته، اختفت النتوءات في غضون أربعة أيام. لم تُنشر أي تحقيق طبي مستقل لهذه النتيجة، ولم يُوثَّق أي تأكيد بالخزعة أو متابعة سريرية في أي مصدر محكّم. مع ذلك، أصبحت هذه التجربة الشخصية قصة منشأ زيت ريك سيمبسون والأساس لكل ما تبعها .

سياق هام: يتم تقديم رواية سيمبسون هنا كشهادته الشخصية. غياب التوثيق السريري، أو الملاحظة المضبوطة، أو التأكيد الطبي المستقل يعني أن هذه الأحداث لا يمكن تقييمها كأدلة طبية. هي، مع ذلك، ذات أهمية تاريخية كمحفّز لحركة عالمية حول الزيت المركز من القنب كدواء.

لماذا يهم هذا في المغرب: ثقافة الكيف التقليدية في المغرب تتضمن قصصاً لا تُحصى عن القنب يساعد في أمراض مختلفة. الاختلاف هو أن قصة سيمبسون أصبحت حركة عالمية. بالنسبة للمغاربة الذين ينتقلون بين المعرفة التقليدية وتوقعات الطب الحديث، فهم التمييز بين الشهادة الشخصية والإثبات السريري أمر أساسي. قصة جدتك عن شاي الكيف يساعد في التهاب المفاصل هي معرفة ثقافية قيّمة، لكنها ليست نفسها كتجربة سريرية محكّمة. كلاهما له مكانه، لكن الخلط بينهما يمكن أن يكون خطيراً.

الحملة — نشر الزيت

بعد تجربته في عام 2003، التزم سيمبسون بنفسه تماماً بإنتاج وتوزيع زيت القنب المركز. يعمل من ممتلكاته في مكان، نوفا سكوشا، بدأ في صنع الزيت بكميات كبيرة وتوزيعه مجاناً على مرضى السرطان وغيرهم في مجتمعه. لم يتقاضَ أي شيء. وفقاً لروايته، ساعد عشرات الأشخاص بظروف تشمل السرطان والألم المزمن والسكري والالتهابات والزرق والتهاب المفاصل والاكتئاب والأرق وتصلب الشرايين وغيرها .

التكييف للمجتمعات المغربية: في منطقة الريف ومناطق زراعة القنب التقليدية الأخرى، مفهوم مشاركة الدواء داخل المجتمع متجذر بعمق. فكرة إعطاء زيت الشفاء مجاناً للجيران ليست غريبة على الثقافة المغربية. لكن نطاق سيمبسون والبروتوكول المحدد الذي طوره كانا فريدين. بالنسبة للمغاربة اليوم، هذا التاريخ مهم لأنه يفسر لماذا يرتبط RSO بالشفاء المجتمعي وليس الربح التجاري — قيمة تتردد تقاليد المغرب المجتمعية.

وصلت قصة سيمبسون إلى جمهور عالمي من خلال الوثائقي عام 2005 Run From The Cure، من إخراج كريستيان لوريت. وثّق الفيلم ادعاءات سيمبسون، أظهر شهادات من عالجهم، وصوّر عمله كتحدٍ شعبي للمصالح الدوائية والحكومية. وُزع مجاناً عبر الإنترنت وأصبح واحداً من أكثر أفلام الدعوة للقنب مشاركة في حقبته. داخل مجتمعات القنب، كان أساسياً — بالنسبة للعديد من الأشخاص، كان Run From The Cure تمهيدهم لمفهوم الزيت المركز من القنب كدواء .

جلبت دعوة سيمبسون له في صراع مباشر مع القانون الكندي. داهمت شرطة الخيالة الملكية الكندية (RCMP) ممتلكاته في عام 2005، وصادرت النباتات والمعدات. تم توجيه تهم زراعة القنب والحيازة والاتجار له. رغم دعم المجتمع والاهتمام العام، تمت مداهمته مرة أخرى في عام 2009. تم تبرئته من بعض التهم لكن أُدين بأخرى. واجهاً ضغطاً قانونياً مستمراً، غادر سيمبسون كندا في النهاية وانتقل إلى أوروبا، حيث عاش في كرواتيا لاحقاً في هولندا، حيث واصل دعوته من الخارج .

المماثلة المغربية: تاريخ المغرب الخاص مع تطبيق قوانين القنب كان معقّداً. الانتقال من الحظر الصارم إلى التشريع الطبي في عام 2021 يعكس التحول العالمي الذي عاشه سيمبسون. بالنسبة للمغاربة الذين عاشوا حقبة كانت زراعة القنب فيها يمكن أن تؤدي إلى عقوبات شديدة، معارك سيمبسون القانونية توازي النضالات المحلية. الاختلاف هو أن المغرب يبني الآن إطاراً قانونياً — شيء قاتل سيمبسون من أجله لكنه لم يعش ليراه مُتحققاً بالكامل في بلاده.

في عام 2012، نشر سيمبسون كتاب Phoenix Tears: The Rick Simpson Story، يفصل فيه تجربته الشخصية، وعملية صنع الزيت، وآرائه الفلسفية الأوسع حول القنب، والطب، والقمع المؤسسي. كما حافظ على موقع phoenixtears.ca كمنصته الأساسية على الإنترنت للمعلومات والدعوة .

طوال حياته العامة، ظل موقف سيمبسون ثابتاً ولا مساومة فيه: ظل مصراً على أن زيت القنب — ولا سيما زيت THC عالي التركيز المصنوع وفقاً لطريقته المحددة — يمكن أن يعالج السرطان والعديد من الأمراض الأخرى، وأن شركات الأدوية والوكالات الحكومية والمؤسسات الطبية تكتم هذه المعرفة بنشاط لحماية مصالحها المالية .

سياق هام: يتم الإشارة إلى إطار سيمبسون المؤامري هنا دون تأييد أو رفض. يعكس وجهة نظر يشاركها كثيرون في حركة القنب المبكرة ويُعتبر ذا صلة بفهم سبب أصبح فيه RSO ذا أهمية ثقافية. التقييم القائم على الأدلة لمطالباته الطبية المحددة يأتي في قسم لاحق.

التنقل في هذا في المغرب: علاقة المغرب بالسلطة المؤسسية معقّدة. التاريخ الاستعماري، والتحديات الاقتصادية، والانتقال إلى تنظيم القنب الطبي خلقت شكوكاً شرعية لدى بعض المغاربة تجاه الحكومة والمؤسسات الدوائية. مع الإقرار بهذه المشاعر، يجب أن نعترف أيضاً أن إطار ANRACA الجديد يمثل تقدماً — مسار قانوني حيث لم يكن أي موجود من قبل. الهدف هو التنقل بين الثقة العمياء والرفض التلقالي، والتركيز بدلاً من ذلك على ما تُظهره الأدلة فعلاً.

البروتوكول التقليدي لـ RSO — نظام سيمبسون الـ60 غرام، 90 يوماً

كان توصية سيمبسون الأساسية للعلاج بروتوكول فموي منظم مصمم لتوفير إجمالي 60 غراماً (حوالي 60 مل) من زيت القنب المركز على مدى حوالي 90 يوماً. وصف هذا كبروتوكول علاج السرطان، رغم أنه أوصى به أيضاً لعدة حالات أخرى. يأتي أدناه تحليل مفصل للبروتوكول كما وصفه .

الهدف

استهلاك 60 غراماً من زيت القنب المركز عالي THC على مدى حوالي 90 يوماً. اعتبر سيمبسون هذا الحد الأدنى اللازم لدورة علاج سرطان جادة.

ما يعنيه هذا لمرضى مغاربة: للسياق، 60 غراماً هو كمية هائلة من مستخلص القنب. في ثقافة الكيف التقليدية المغربية، ستكون هذه الكميات لا تُصدّق للاستخدام الطبي الفردي. يعكس هذا النطاق إيمان سيمبسون أن الجرعات الضخمة كانت ضرورية، إيمان متجذر في الخبرة التجريبية وليس في العلم الدوائي. بالنسبة للمغاربة يستكشفون RSO، فهم هذا النطاق أمر حاسم — هذا ليس نظام مكملات عرضي.

جدولة التدرج

• الأسبوع 1: ابدأ بجرعة بحجم حوالي نصف حبة أرز جافة — تقريباً 10 إلى 15 ملغرام من الزيت — تؤخذ ثلاث مرات يومياً (صباحاً، بعد الظهر، وقبل النوم). إجمالي الاستهلاك اليومي في هذه المرحلة: حوالي 30 إلى 45 ملغراماً. شدد سيمبسون على أن الجرعات الأولية يجب أن تكون صغيرة جداً للسماح للجسم بالبدء في التكيف مع التأثيرات النفسية لـ THC.

• الأسابيع 2 إلى 5: ضاعف الجرعة تقريباً كل أربعة أيام. كان الغرض من التدرج البطيء هو بناء تحمل THC تدريجياً وتقليل الاضطراب من التأثيرات النفسية. بحلول نهاية فترة التصعيد — حوالي أربعة إلى خمسة أسابيع — كان الهدف الوصول إلى حوالي 1 غرام (1,000 ملغرام) من الزيت يومياً، مقسماً إلى ثلاث جرعات متساوية تقريباً.

• الأسابيع 5 إلى 12: حافظ على الجرعة الكاملة حوالي 1 غرام يومياً، مقسماً إلى ثلاث جرعات بحوالي 333 ملغرام كل منها، واستمر حتى يُستهلك الإجمالي 60 غراماً. عند مستوى الجرعة هذا، سيتم استهلاك أكثر من 50 غراماً المتبقية من الزيت على مدى الأسابيع السبعة إلى الثمانية النهائية.

حقيقة جرعية مغربية: يعني هذا البروتوكول الوصول إلى 600-900 ملغرام من THC يومياً. للمقارنة، قد يستهلك مستخدم حشيش مغربي نموذجي 50-100 ملغرام من THC في يوم كامل من الاستخدام الثقيل. يوفر بروتوكول سيمبسون 6-9 أضعاف هذا المبلغ. هذا دوائي متطرف ويحمل مخاطر حقيقية يجب على المغاربة فهمها.

طرق الإعطاء

• الطريقة الأساسية — عن طريق الفم: أوصى سيمبسون بوضع الجرعة مباشرة تحت اللسان (تحت اللسان) أو ابتلاعها. اعتبر الاستهلاك الفموي الطريق الأهم للامتصاص الجهازي والطريقة الأساسية للسرطانات الداخلية والحالات الجهازية الأخرى.

• الطريقة الثانوية — موضعياً: بالنسبة لسرطانات الجلد والآفات الخارجية، أوصى سيمبسون بوضع الزيت مباشرة على المنطقة المتضررة، وتغطيتها بضمادة، وتغيير الضمادة كل ثلاثة إلى أربعة أيام. جمع بين التطبيق الموضعي والجرعة الفموية لسرطانات الجلد.

• غير المُوصى به كأساس — الاستنشاق: لم يوصِ سيمبسون بتدخين أو تبخير الزيت كطريقة علاجية أساسية. أقر الاستنشاق لتخفيف الأعراض الفورية (الألم، الغثيان) لكنه أكد أن الطريق الفموي ضروري للتعرض المستمر والجرعة العالية التي يعتبرها ضرورية علاجياً.

ملاحظة ثقافية للمغرب: يتركز الاستخدام المغربي التقليدي على الاستنشاق (كيف يُدخن في غليون سيبسي). يُمثل تأكيد سيمبسون على الجرعات الفموية انحرافاً أساسياً عن الممارسات المحلية. بالنسبة للمغاربة الذين ينتقلون من الاستخدام التقليدي إلى RSO الطبي، هذه نقطة تعلم حاسمة.

تحمل والتأثيرات النفسية

• أصر سيمبسون على أن المرضى سيطورون تحملاً كبيراً للتأثيرات النفسية لـ THC في غضون حوالي ثلاثة إلى أربعة أسابيع من الجرعات الثابتة المتصاعدة.

• اعتبر التأثيرات المبهجة، المهدئة، أو المربكة تأثيراً جانبياً طفيفاً ومؤقتاً وحث المرضى بشدة بعدم السماح للنشوة بالتثبيطهم عن متابعة البروتوكول.

• أوصى بأن يأخذ المرضى جرعاتهم الأولية ليلاً أو قبل النوم ليناموا خلال أشد التأثيرات النفسية حدة خلال مرحلة التدرج المبكرة.

• أوصى أيضاً بأن يتجنب المرضى القيادة أو تشغيل الآلات خلال فترة التدرج وأن يبلغوا أفراد العائلة عما يجب توقعه.

سياق المغرب حول التأثير: في المغرب، حيث سلامة الطرق تشكل بالفعل قلقاً رئيسياً، التحذير حول تجنب القيادة أثناء استخدام RSO حاجٌّ بشكل خاص. سيكون تشغيل أي مركبة أو آلة خطيراً للغاية مع البروتوكول. هذا ليس توصية عرضية — إنه أمر سلامة ملحٌّ.

الصيانة بعد البروتوكول

• بعد إكمال كورس الـ60 غرام الكامل، أوصى سيمبسون بجرعة صيانة حوالي 1 إلى 2 غرام من الزيت شهرياً، تُؤخذ لفترة غير محددة.

• اعتبر هذه الجرعة الصيانة المستمرة مهمة للصحة طويلة الأمد وللوقاية من السرطان.

• أشار سيمبسون أن جرعات الصيانة كانت أقل بكثير من جرعة العلاج وأن المرضى الذين أكملوا البروتوكول الكامل سيكون لديهم تحمل THC كافٍ للتعامل معها بشكل مريح.

توصيات غذائية ونمط الحياة

• دعا سيمبسون أيضاً إلى تغييرات غذائية إلى جانب بروتوكول الزيت، بما في ذلك تقليل السكر، تجنب الأطعمة المصنعة، وتحسين التغذية العامة.

• لم يكن محدداً أو منهجياً حيال البروتوكولات الغذائية مقارنةً ببروتوكول الزيت المفصل للغاية — كانت النصائح الغذائية ثانوية وعامة.

سياق هام لتقييم هذا البروتوكول

تم تصميم هذا البروتوكول من قِبل شخص واحد بناءً على تجربته الشخصية والملاحظات التجريبية. لم يُطوَّر من خلال تجارب سريرية، أو دراسات إيجاد الجرعة، أو نمذجة الدوائية، أو أي عملية بحث رسمية. تنطبق عدة نقاط حرجة:

• لا توجد تجربة مضبوطة. لا توجد تجارب سريرية عشوائية مضبوطة نُشرت، أو دراسات جماعية، أو حتى سلاسل حالات موثّقة جيداً تُقيّم بروتوكول الـ60 غرام/90 يوماً المحدد هذا لأي نوع سرطان أو أي حالة أخرى.

• يفترض مادة خام غير موحّدة. تفترض كمية الـ60 غرام مادة مستخلصة أحادية السلالة، مهيمنة بـ THC دون توحيد قوة. احتواء THC الفعلي لكل غرام من RSO التقليدي كان يختلف على نطاق واسع اعتماداً على مادة النبات البدائية وتقنية الاستخراج.

• تعرض THC عالي جداً. في ذروة مرحلة الجرعة، كان المرضى يستهلكون حوالي 1 غرام يومياً من زيت THC عالي التركيز. بافتراض أن RSO التقليدي يحتوي 60 إلى 90 بالمائة من THC، يترجم هذا إلى حوالي 600 إلى 900 ملغرام من دلتا-9 THC يومياً — جرعة تتجاوز بكثير أي شيء مُدروس في إعدادات سريرية مضبوطة. للسياق، الدواء التركيبي THC المعتمد من FDA درونابينول يُجرَّع عادةً بـ 2.5 إلى 20 ملغرام يومياً.

• مخاطر حقيقية بهذه الجرعات. استهلاك 600 إلى 900 ملغرام من THC يومياً يحمل مخاطر جدية تشمل التسمُّم الشديد، التقهقر، القلق، الذعر، تسارع القلب، انخفاض الضغط، واضطراب الاستخدام القنبي. هذه المخاطر موثّقة جيداً في قسم المعرفة العامة من هذا المستند [1][13][14][15].

• سياق الأورام. المرضى الذين يعانون من سرطان نشط غالباً ما يكونون طبياً معقّدين. استخدام زيت قنب غير منظّم وغير موحّد كعلاج سرطان أساسي — محتملاً بدلاً من علاجات مُثبتة — يُدخل ضرراً يمتد إلى ما بعد الزيت نفسه.

لمرضى سرطان مغاربة: تزوّد مراكز الأورام المغربية في الدار البيضاء والرباط ومراكش علاجات سرطان مُثبتة. بينما أنشأت ANRACA برنامج قنب طبي، فهو محدود بإحكام ومحدد لحالات معينة. استخدام RSO التقليدي بجرعات سيمبسون يقع خارج كل من الأورام التقليدية والإطار القانوني للقنب الطبي. هذا ليس خطراً نظرياً — إنه قلق سلامة عملي لمرضى سرطان مغاربة.

ما هو زيت ريك سيمبسون التقليدي — المنتج

يشير RSO التقليدي إلى نوع محدد من الزيت المركز من القنب الذي صنعه سيمبسون ودعاه إليه. كان مُعرَّفاً ليس بمواصفات المختبر أو المعايير التنظيمية بل بطريقته ومادته. يأتي أدناه وصف المنتج كما أنتجه سيمبسون .

المادة المصدرية

استخدم سيمبسون سلالات قنب عالية THC، مهيمنة الإنديكا. فضّل على وجه التحديد وراثيات إنديكا ثقيلة ومُهدئة وعموماً أوصى ضد سلالات الساتيفا المهيمنة لعلاج السرطان، معتقداً أن سلالات الإنديكا أنتجت نتائج علاجية أفضل. زرع قنبه الخاص أو حصل عليه من مزارعين وثق بهم. لم يكن هناك توحيد سلالة — كانت المادة البدائية تختلف حسب التوافر وموسم النمو.

تراث القنب المغربي: تنتج منطقة الريف المغربية قنباً عالمي الشُهرة، يُحصد تقليدياً للحشيش. لكن هذه السلالات الأصلية تختلف عن الإنديكا الحديثة عالية THC التي استخدمها سيمبسون. القنب المغربي التقليدي يحتوي عادةً على THC أقل وغني بقنبينويدات أخرى. مفهوم اختيار وراثيات محددة لأغراض طبية يمثل انحرافاً حديثاً عن ممارسات الزراعة المغربية التقليدية.

مذيب الاستخراج

استخدم سيمبسون في الأصل النفثا — مذيب نفطي متاح تجارياً كوقود أخف أو فارسول أو منتجات مماثلة. لاحقاً أيد أيضاً كحول الأيزوبروبيل 99 بالمائة كبديل مقبول. حذّر صراحةً من استخدام مذيبات أخرى، بما في ذلك البيوتان أو الأسيتون، بسبب مخاوف السلامة والنقاء. لا النفثا ولا كحول الأيزوبروبيل هما مذيبات صالحة للأكل، وهو ما يمثل مشكلة سلامة كبيرة تُناقش أدناه.

تحذير سلامة لمصنّعي المغرب DIY: في المناطق الريفية المغربية حيث قد يمارس البعض طرق استخراج تقليدية، النفثا وكحول الأيزوبروبيل خطيران. قد تحتوي النفثا على البنزين ومواد مسرطنة أخرى. تتطلب لوائح القنب الطبي الجديدة في المغرب طرق استخراج صالحة للأكل. الطرق التقليدية، رغم أهميتها الثقافية، تحمل مخاطر صحية حقيقية تستبعدها منتجات العصر الحديث.

عملية الاستخراج

1. وُضع مادة النبات الجافة أو شبه الجافة في حاوية (عادةً دلواً).
2. غُطّت المادة بالمذيب وُحرّكت أو أُثيرت لعدة دقائق لإذابة القنبينويدات والمركبات القابلة للذوبان في الدهون الأخرى من النبات.
3. سُكب المذيب عبر فلتر، عادةً قماش الجبن أو شبكة مماثلة، في وعاء جمع منفصل.
4. كُرّرت العملية مرة ثانية بمذيب جديد على نفس المادة النباتية لاستخراج القنبينويدات المتبقية.
5. وُضعت غسلات المذيب المُجمَّعة — الآن سائل داكن غني بالقنبينويد — في طباخ أرز أو جهاز تسخين مفتوح مماثل.
6. تبخَّر المذيب على حرارة منخفضة نسبياً. أوصى سيمبسون بطباخ الأرز على وجه التحديد لأنه يحافظ على نطاق حرارة يتبخر المذيب دون تجاوز النقطة التي تتدهور فيها القنبينويدات بشكل كبير. لكن هذه الحرارة كانت لا تزال عالية بما يكفي لتحويل THCa إلى THC وتدمير معظم التربينات المتطايرة.
7. مع تبخر المذيب، بقي زيت سميك وداكن في قاع الوعاء.
8. نُقل الزيت النهائي إلى حقن فموية للتخزين والجرعة.

المظهر والخصائص الفيزيائية

كان RSO التقليدي زيتاً سميكاً لزجاً كثيفاً شبه أسود — قاراب. كان له رائحة قنب قوية ويمكن أن يحمل رائحة متبقية خفيفة من المذيب اعتماداً على مدى التخلص من المذيب. كانت القوام لزجاً وصعب المعالجة في درجة حرارة الغرفة لكنه أصبح أكثر سيولة عند تسخينه قليلاً.

مقارنة بصرية للمستهلكين المغاربة: الحشيش المغربي التقليدي هو راتينج مضغوط صلب. RSO التقليدي هو زيت سميك. إذا رأيت منتجاً مُوسوماً “RSO” في المغرب يبدو مثل الحشيش، فهو ليس RSO تقليدياً. صيغة OilWell العصرية هي زيت مُنقّى في ناقل MCT — أنظف وأكثر استقراراً وأسهل جرعة من القاراب الأصلي.

بروفيل القنبينويد

• بشكل أساسي دلتا-9 THC مُفعلة. الحرارة المتضمنة في تبخير المذيب حوّلت عملياً كل THCa في المستخلص إلى دلتا-9 THC. كان RSO التقليدي بالتالي منتجاً مُفعلاً، مهيمن بـ THC.

• قنبينويدات ثانوية طبيعية. أياً كان CBD، CBN، CBC، CBG، والقنبينويدات الثانوية الأخرى التي تحتويها السلالة المصدرية كانت حاضرة بنسبها الطبيعية لكن لم تكن مضبوطة أو مُقاسة أو مستهدفة.

• لا ضبط للنسبة. لم تكن هناك قدرة على ضبط أو توحيد نسب قنبينويدية محددة. كان البروفيل يُحدَّد تماماً برُوح الوراثة وظروف النمو للنبات المصدر.

• محتوى THC المقدَّر. اعتماداً على المادة البدائية، كان RSO التقليدي يتراوح على الأرجح من حوالي 60 إلى 90 بالمائة إجمالي THC بالوزن، رغم أنه لم يُتحقَّق مختبرياً في سياق الإنتاج التقليدي.

محتوى التربين

ضئيل إلى معدوم. تركيبة استخراج المذيب (التي تذوب التربينات في المذيب مع القنبينويدات) والتبخير بالحرارة العالية اللاحق (التي تطاير التربينات عند درجات حرارة أقل بكثير من عتبات تدهور القنبينويد) يعني أن RSO التقليدي كان مُجرداً عملياً من محتواه التربيني.

صلة التربين المغربية: الحشيش المغربي التقليدي يحتفظ بمزيد من التربينات من RSO الخاص بسيمبسون لأنه يُعالج بحرارة أقل. فقدان التربينات في RSO التقليدي يمثل قيداً رئيسياً تُعالجه الصيغ العصرية على وجه التحديد. تتضمن صيغة OilWell تربينات حية بنسبة 5% لأننا نفهم أن هذه المركبات العطرية تسهم في كل من التجربة والتأثيرات العلاجية المحتملة.

التوحيد والفحص

لا شيء. كل دفعة من RSO التقليدي كانت مختلفة لأنها اعتمدت كلياً على مادة النبات البدائية، وظروف النمو، ونقاء المذيب، وتقنية الاستخراج، ودرجة حرارة ومدة التبخير، وعملية الصانع الفردية. كان سيمبسون يعمل قبل تشريع القنب والبنية التحتية المُوحَّدة لفحص المختبر الذي جاء معه. لم يكن هناك شهادة تحليل، أو تكميم قنبينويد، أو فحص ملوثات.

السياق التنظيمي المغربي: بموجب قانون القنب الطبي الجديد في المغرب، يجب اختبار جميع المنتجات وتوحيدها. تتطلب ANRACA رقابة جودة صارمة. RSO التقليدي لا يمكن أن يلبي هذه المعايير. هذا ليس تحسيناً طفيفاً — إنه الفرق بين علاج ما قبل الصناعة والدواء الحديث.

خطر بقايا المذيب

هذا أحد أكبر مخاوف السلامة مع إنتاج RSO التقليدي. النفثا وكحول الأيزوبروبيل ليستا مذيبات صالحة للأكل. النفطا على وجه التحديد هي خليط هيدروكاربوني نفطي معقد يمكن أن يحتوي على البنزين، التولوين، ومركبات أخرى مُصنَّفة كسموم أو مسرطنة. التخلص غير الكامل من المذيب — وهو أمر صعب التحقق منه جداً دون معدات كيمياء تحليلية — يترك بقايا ضارة محتملة في الزيت النهائي.

تستخدم طرق الاستخراج العصرية بشكل أساسي الإيثانول الصالح للأكل أو ثاني أكسيد الكربون فوق الحرج (CO₂). تسمح هذه الطرق بإزالة مذيب أكثر اكتمالاً، ويمكن اختبار المنتجات النهائية للمذيبات المتبقية باستخدام طرق تحليل مُحقَّقة مثل كروماتوغرافيا الغاز الفضائي. هذا أحد أكثر التحسينات المباشرة التي صنعتها صناعة القنب المنظمة الحديثة على نموذج إنتاج RSO التقليدي.

هذا التطور يرتبط مباشرة بمناقشة جودة المنتج في قسم المعرفة العامة من هذا المستند، الذي يؤكد أن جودة المنتج تهم بقدر أهمية هوية الجزيء وأن عدم الدقة في التسمية، والتلوث، ونواتج التصنيع الثانوية، وتباين الجرعة كلها تؤثر مادياً على التفسير في المنتجات الواقعية [1][10][11][14].

مطالبات سيمبسون مقابل سجل الأدلة

قدّم ريك سيمبسون مطالبات علاجية واسعة حول زيته. ذكر أن RSO يمكن أن يعالج السرطان — بما في ذلك الحالات الميؤوس منها — وأنه فعّال ضد السكري والألم المزمن والالتهابات والزرق والتهاب المفاصل والاكتئاب والأرق وتصلب الشرايين وحالات أخرى عديدة. كان حازماً، ثابتاً، وعلنياً حيال هذه المطالبات طوال حياته في الدعوة .

من المهم تقييم هذه المطالبات مقابل قاعدة الأدلة الفعلية، باستخدام نفس المعايير المُطبَّقة في جميع أنحاء هذا المستند.

ما لم يكن سيمبسون

لم يكن سيمبسون عالماً أو طبيباً أو دوائيّاً أو باحثاً. لم يكن لديه تدريب رسمي في الطب أو الأورام أو الدوائيات أو منهجية البحث السريري. لم يصمّم أو يجري أو يمول أو ينشر تجربة سريرية. لم يقدّم نتائجه أبداً للمراجعة النظرية. كانت قاعدة أدلته بالكامل تتكون من الخبرة الشخصية، والنتائج المبلَّغة ذاتياً من المرضى، والشهادات المجمَّعة غير الرسمية — بدون ضوابط، بدون تحقق مستقل، بدون تأكيد بالتصوير، بدون متابعة طويلة الأمد، وبدون تغمية.

ما تُظهره الأدلة السابقة للاختبار

توجد أدلة القنبينويد-السرطان السابقة للاختبار وعلمياً مثيرة للاهتمام:

• أظهرت الدراسات في المختبر أن THC وCBD يمكن أن تحفز الموت المبرمج للخلايا (apoptosis)، تمنع التكاثر، وتقلل التَوَجُّه (تكوين أوعية دموية تغذي الأورام) في بعض خطوط خلايا سرطان .

• أظهرت دراسات نموذج الحيوان تثبيطاً لنمو الأورام في الفئران والجرذان عُولجت بالقنبينويدات .

• أنتجت هذه النتائج اهتماماً علمياً شرعياً وأبحاثاً مستمرة.

ما لا تُظهره الأدلة السابقة للاختبار

• لم تُترجم هذه النتائج إلى علاجات سرطان بشرية مُثبتة. الفجوة بين نتائج المختبر أو الحيوان والنتائج السريرية البشرية واسعة، موثَّقة جيداً في جميع أنحاء أبحاث الأورام، وذات صلة خاصة هنا.

• لم تُظهر أي تجربة سريرية بشرية أن RSO أو أي تحضير زيت قنب يعالج السرطان.

• أُجريت عدة تجارب بشرية صغيرة للقنبينويدات في سياقات سرطان (خاصة glioblastoma)، لكنها كانت استكشافية، صغيرة، ولم تُنتج النوع من النتائج التي تدعم مطالبات علاج السرطان .

المواقف المؤسسية

• يُقر المعهد الوطني للسرطان (NCI) في الولايات المتحدة أن القنبينويدات تمت دراستها لآثار مضادة للسرطان محتملة في نماذج المختبر والحيوان لكنه لا يؤيد القنب أو زيت القنب كعلاج للسرطان .

• لم توافق إدارة الغذاء والدواء (FDA) الأمريكية على أي منتج نبات قنب لعلاج السرطان. المنتجات القنبينويدية الوحيدة المعتمدة من FDA هي لمؤشرات محددة أخرى: Epidiolex (CBD) لبعض اضطرابات الصرع ودروابينول/نابيلون (أنالوجات THC تركيبية) للغثيان المرتبط بالعلاج الكيميائي والهدر المرتبط بالإيدز [1].

• لم توافق Health Canada أبداً على RSO أو زيت القنب كعلاج للسرطان.

• يوضح NCCIH صراحةً أن أقوى أدلة قنبينويد هي لأورام نادرة، الغثيان والقيء المرتبط بالعلاج الكيميائي، ومؤشرات الشهية أو فقدان الوزن المرتبطة بفيروس الإيدز — ليس علاج السرطان [1].

• موقف المؤسسة المغربية: لم توافق ANRACA المغربية على أي منتج زيت قنب لعلاج السرطان. برنامج القنب الطبي محدود لحالات محددة تحت إشراف طبي صارم. أي مطالبة بأن RSO يمكن أن يعالج السرطان لا تدعمها السلطات الصحية المغربية.

ما أصابه سيمبسون فيه

لفت سيمبسون الانتباه إلى القنبينويدات كمجال جاد للبحث الطبي في وقت كان معظم العالم يتجاهل أو يكتم بنشاط ذلك الحوار. دعوته — مهما كانت غير دقيقة علمياً — ساعدت في خلق الظروف السياسية والثقافية والاجتماعية لصناعة القنب القانونية والبنية التحتية لبحث القنبينويد التي توجد اليوم. كان من أوائل من أحضر زيت القنب المركز إلى وعي الجمهور الواسع، ولا يزال مصطلح RSO نفسه هو الأكثر شهرة في مفردات المستهلك لمستخلص القنب الكامل الطيف. هذه مساهمات حقيقية وتاريخية ذات أهمية.

ما بالغ فيه

لم يكن القفز من الإشارات السابقة للاختبار إلى علاج السرطان مدعوماً بأدلة بشرية عندما قام به سيمبسون، ولا يُدعم الآن. تشجيع المرضى — خاصة مرضى السرطان — على الاعتماد على RSO كعلاج أساسي بدلاً من علاجات سرطان مُثبتة (جراحة، إشعاع، كيميائي، علاج مناعي) يحمل ضرراً حقيقياً محتملاً. التأخير أو التخلي عن العلاج للسرطانات القابلة للعلاج هو قلق موثَّق في أدبيات الطب البديل. اليقين المطلق لسيمبسون حول المطالبات العلاجية، رغم فهمه من منظور الخبرة الشخصية، تجاوز ما يمكن للأدلة دعمه وما زال يتجاوزه اليوم.

لمرضى سرطان مغاربة: تزوّد البنية التحتية للأورام المغربية في الدار البيضاء والرباط ومراكش علاجات سرطان مُثبتة. بينما أقامت ANRACA برنامج قنب طبي، صُمّم صراحةً لمكملة العلاج التقليدي، لا استبداله. إذا كنت تفكر في زيت القنب كجزء من استراتيجيتك للسرطان، يجب عليك التنسيق مع فريق الأورام لديك في مؤسسات مثل المعهد الوطني للأورام في الرباط أو أقسام الأورام في مستشفى ابن رشد الجامعي في الدار البيضاء.

إرث ريك سيمبسون وتطور RSO الحديث

يُستخدم مصطلح RSO الآن بشكل واسع — وغالباً بشكل فضفاض — في صناعة القنب القانونية. تُشير العديد من المنتجات المُسماة RSO إلى أي مستخلص قنب كامل الطيف يُباع في شكل حقنة تقريباً، بغض النظر عن طريقة الاستخراج، أو البروفيل القنبينويد، أو محتوى التربين، أو الاستخدام المقصود. أصبح المصطلح عاماً .

انتقد سيمبسون نفسه المنتجات التجارية التي تستخدم اسم RSO بينما تبتعد بشكل كبير عن أسلوبه وفلسفته الأصلية. صرح علناً أن العديد من المنتجات المباعة كـRSO لا تلبّي معاييره وأن التجارية لزيت القنب تتناقض مع قصديته الأصلية. كان نموذج سيمبسون صراحةً مضاداً للتجاري — أعطى الزيت مجاناً وحث الآخرين على صنعه بأنفسهم بدلاً من الشراء من الشركات .

يجدر الاعتراف بهذا التوتر الفلسفي. كان سيمبسون يؤمن بنموذج افعله بنفسك، وصول مجاني يمكن فيه لأي شخص زراعة قنب، استخراج الزيت، ومعالجة أنفسهم أو أحبائهم دون وسيطين تجاريين أو حكوميين. فعلت صناعة القنب الحديثة شيئاً مختلفاً جداً: لقد تجارته ووحّدته ونظّمته مما وزّعه سيمبسون مجاناً.

وجهة نظر مغربية حول هذا التوتر: المغرب ينتقل بالضبط في هذا التوتر الآن. المزارعون التقليديون في الريف زرعوا القنب لأجيال كنشاط مجتمعي غير رسمي. تُنشئ ANRACA الآن صناعة قنب طبي منظّمة وتجارية. سؤال ما إذا كان هذا يمثل تحسناً (السلامة، التوحيد، المصداقية الطبية) أو خيانة (فقدان الوصول التقليدي، السيطرة التجارية، الحواجز التنظيمية) هو موضع نقاش نشط في أوساط القنب المغربية. موقف OilWell هو أن الاثنين يمكن أن يتعايشا: نحن نقدم منتجاً مصنعاً بشكل مهني ومُختبراً، بينما ننشر الصيغة الكاملة لأولئك الذين يريدون صنعها بأنفسهم.

ما لا جدال فيه هو أن RSO الحديث قد تطور بشكل كبير عن أصوله، وتلك التغييرات ذات صلة مباشرة بالصيغ في هذا المستند.

RSO التقليدي مقابل RSO المُصمَّم حديثاً

تلخص الجدولة التالية الاختلافات الرئيسية بين RSO التقليدي كما عرّفه سيمبسون والنهج المُصمَّم الحديث المُستخدم في منتجات OilWell.

البُعد	RSO التقليدي	RSO المُصمَّم من OilWell
المادة المصدرية	سلالة إنديكا واحدة عالية THC	مزيج قنبينويد متعدد من مصادر متعددة
طريقة الاستخراج	النفثا أو كحول الأيزوبروبيل	طرق الإيثانول الصالح للأكل أو CO₂ العصرية
البروفيل القنبينويدي	مهيمن بـ THC، غير مضبوط	سبعة قنبينويدات معرَّفة بنسب محددة
محتوى التربين	تُدمَّر بالعملية الحرارية عالية	تربينات حية بنسبة 5% مع بروفيل تربيني معرَّف من سبعة
التوحيد	لا شيء — كل دفعة مختلفة	مُختبرة بأهداف ملغ/مل محددة
فحص المختبر	غير متوفر أو مُجرى	لوحة فحوص كاملة
المذيبات المتبقية	خطر كبير مع النفثا	مضبوطة ومُختبرة
دقة الجرعة	تقريبية، تعتمد على الحقنة	مُقاسة لكل مل بمحتوى قنبينويد معروف (553 ملغ/مل)
أشكال المنتج	زيت سميك واحد فقط	زيت تحت اللسان وخرطوشة تبخير بصيغ خاصة بالشكل
الحفاظ على THCa	لا — مُفعل بالكامل بالحرارة	نعم — THCa مُدرَج كمكون منفصل بـ 1,500 ملغ
نهج الأدلة	تجريبي، شهادة شخصية	مدعوم بالبحث، مُوزَّن بالأدلة

كيفية التطبيق على السوق المغربية: إذا كنت تقيّم منتجات RSO المتوفرة في المغرب — سواء عبر قنوات مرخّصة من ANRACA أو مصادر غير رسمية — هذه الجدولة هي قائمة التحقق الخاصة بك. هل يدرج المنتج كميات قنبينويدية دقيقة؟ هل هو مُختبر؟ هل يحافظ على THCa؟ هل يتضمن تربينات؟ RSO التقليدي لا يمكن أن يلبي هذه المعايير. RSO المُصمَّم حديثاً يمكن أن يلبيها.

أسباب انحراف صيغ OilWell عن RSO التقليدي

صيغ OilWell ليست RSO تقليدياً. إنها منتج قنبينويد مُصمَّم مُعلَّم بالتقاليد لكنه يبتعد عنها بطرق مُتعمَّدة ومُحفَّزة بالأدلة لحل المشكلات التي حدّت من رؤية سيمبسون الأصلية.

• النهج القائم على قنبينويدات متعددة. كان RSO التقليدي يعتمد على أي سلالة واحدة يزرعها أو يحصل عليها الصانع. تتضمن صيغ OilWell عن عمد سبعة قنبينويدات — CBD، CBG، دلتا-8 THC، THCa، دلتا-9 THC، CBN، و CBC — لأن أدبيات تأثير السرب تقترح فائدة محتملة من التنوع القنبينويدي، حتى لو بقي الإثبات السريري القوي لتآزر الصيغة الكاملة محدوداً [20][29].

• الحفاظ على التربينات والإضافة. كان لزيت سيمبسون التقليدي عملياً محتوى تربيني معدوم بسبب تدمير المذيب والحرارة العالية. تتضمن OilWell تربينات حية بنسبة 5% مع بروفيل تربيني محدد من سبعة — الليمونين، الميرسين، كاريوفيلين، البينين، اللينالول، هيومولين، و تيربينولين — لأن النشاط البيولوجي للتربينات مُحتمل ومدعوم على المستوى السابق للاختبار، حتى لو كان التأكيد السريري البشري لتأثيرات التربينات المحددة للقنب لا يزال قيد التطوير [20][21][23][24][25][26][27][28][29].

• THCa كمكوّن منفصل. كان RSO التقليدي يفكِّ كل شيء بالكامل، محوِّلاً كل THCa إلى دلتا-9 THC. تتضمن صيغة OilWell التحت اللسانية THCa بـ 1,500 ملغ كمكوّن مُميَّز، مع الحفاظ على السلسلة الحمضية السابقة لأن أدبيات THCa تقترح نشاطاً بيولوجياً غير نفساني محتملاً مُهمّاً يُفقد عند تحويل THCa إلى THC [12].

• تقليل سيادة دلتا-9 THC. كان زيت سيمبسون التقليدي مهيمناً بشكل ساحق بدلتا-9 THC — غالباً 60 إلى 90 بالمائة من المحتوى القنبينويدي الإجمالي. تستخدم صيغة OilWell التحت اللسانية دلتا-9 THC بـ 90 ملغ فقط مع دمج دلتا-8 THC بـ 6,000 ملغ وتوزيع المحتوى القنبينويدي المتبقي عبر CBD (4,500 ملغ)، CBG (3,000 ملغ)، CBN (750 ملغ)، و CBC (750 ملغ). هذا يعكس المشهد البحثي القنبينويدي الأوسع بدلاً من نموذج سيادة مكوّن واحد.

• ابتكار شكل المنتج. تصوّر سيمبسون شكلاً واحداً فقط: زيت فموي يُعطى من حقنة. تقدّم OilWell كل من زيت تحت اللسان بـ 30 مل وخرطوشة تبخير بـ 1 غرام، كل بصيغته الخاصة بالشكل معترفاً بأن طرق التوصيل المختلفة لها بروفايلات دوائية مختلفة [14].

سلامة المذيب وتطور الاستخراج

كان إنتاج RSO التقليدي يستخدم النفثا أو كحول الأيزوبروبيل — ولا منهما مذيبات صالحة للأكل. النفثا هي خليط هيدروكاربوني نفطي معقد يمكن أن يحتوي على البنزين، التولوين، والمركبات الأخرى المُصنَّفة سامة أو مُسرطنة. التخلص غير الكامل من المذيب — وهو صعب التحقق منه جداً دون معدات كيمياء تحليلية — يترك بقايا ضارة محتملة في الزيت النهائي.

تستخدم طرق الاستخراج العصرية بشكل أساسي الإيثانول الصالح للأكل أو ثاني أكسيد الكربون فوق الحرج (CO₂). تسمح هذه الطرق بإزالة مذيب أكثر اكتمالاً، ويمكن اختبار المنتجات النهائية للمذيبات المتبقية باستخدام طرق تحليل مُحقَّقة مثل كروماتوغرافيا الغاز الفضائي. هذا أحد أكثر التحسينات المباشرة التي صنعتها صناعة القنب المنظمة الحديثة على نموذج إنتاج RSO التقليدي.

هذا التطور يرتبط مباشرة بمناقشة جودة المنتج في قسم المعرفة العامة من هذا المستند، الذي يؤكد أن جودة المنتج تهم بقدر أهمية هوية الجزيء وأن عدم الدقة في التسمية، والتلوث، ونواتج التصنيع الثانوية، وتباين الجرعة كلها تؤثر مادياً على التفسير في المنتجات الواقعية [1][10][11][14].

محاذاة تنظيمية مغربية: يتطلب قانون القنب الطبي في المغرب إنتاجاً معياراً لـ GMP مع طرق استخراج صالحة للأكل. لن تلبي طرق المذيب التقليدية هذه المتطلبات. هذا هو السبب في أن RSO المُصمَّم حديثاً يمثل ليس فقط تحسيناً، بل ضرورة للأسواق الطبية القانونية مثل المغرب.

مسألة التفكك الحمضي

كان RSO التقليدي مُفكَّكاً بالكامل. كانت الحرارة المتضمنة في تبخير المذيب من طباخ الأرز — غالباً ما تُحافَظ على أو بالقرب من نقطة غليان المذيب، التي بالنسبة للنفثا حوالي 60 إلى 80 درجة مئوية وبالنسبة لكحول الأيزوبروبيل حوالي 82 درجة مئوية — كافية لتحويل عملياً كل THCa في المستخلص إلى دلتا-9 THC. يُفضل هذا التحويل حرارياً ويتقدم بسهولة عند هذه الدرجات على المدى المتضمن في تبخير المذيب.

كنتيجة، تم فقد القنبينويدات الحمضية التي توجد بكثرة في مادة القنب الخام — بما في ذلك THCa، CBDa، CBGa، وغيرها — كمركبات مُميَّزة في RSO التقليدي. كان الزيت النهائي منتجاً مُفكَّكاً، مُفعلاً مهيماً بالقنبينويدات الحيادية (غير الحمضية).

تتضمّن صيغة OilWell التحت اللسانية THCa بـ 1,500 ملغ كمكوّن منفصل عن عمد. هذا خيار تركيبي مُتعمَّد مُعلَّم ببروفيل أدلة THCa في قسم المعرفة العامة، الذي يشير إلى أن THCa نفسه لا ينتج التأثيرات النفسية المرتبطة بـ THC لكن تفسيره يعتمد على الطريق، الحرارة، المعالجة، والتخزين — لأن THCa يمكن أن يتحوّل إلى THC عند التسخين أو مع مرور الوقت [12].

التحكم المريض في المغرب: بالنسبة للمستهلكين المغاربة، هذا يخلق مرونة قانونية. يحتوي المنتج على أقل من 0.3% دلتا-9 THC عند الشراء، مما يجعله متوافقاً مع كل من قانون المزرعة الأمريكي ويُحتمل أن يُستورد إلى المغرب بموجب بعض أحكام منتجات القنب الصناعي. إذا اخترت تفكيكه، تفعل القوة الكاملة — لكن هذا الخيار، والمسؤولية القانونية، تبقى لك.

فقدان التربين في RSO التقليدي

التربينات هي مركبات عطرية متطايرة ذات نقاط غليان منخفضة نسبياً. تبدأ معظم تربينات القنب في التطاير عند درجات حرارة بين 21 و157 درجة مئوية، مع العديد من أغنى التربينات — بما في ذلك الميرسين، الليمونين، والبينين — لها نقاط غليان أقل من 180 درجة مئوية. دمّرت عملية إنتاج RSO التقليدي التربينات بطريقتين: أولاً، بإذابتها في غسل المذيب مع القنبينويدات؛ وثانياً، بتطايرها خلال مرحلة إزالة المذيب بالحرارة العالية.

هذا يعني أن RSO التقليدي كان عملياً منتجاً قنبينويدياً فقط، رغم اشتقاقه من نبات غني بالتربينات. أياً كانت المركبات العطرية أو النكهة أو التربينات البيولوجية محتملة التي كانت تحتويها القنب المصدرية، فُقدت في الإنتاج.

تُحدّد صيغ OilWell تربينات حية بنسبة 5% مع بروفيل تربيني محدد من سبعة: الليمونين، الميرسين، الكاريوفيلين، البينين، اللينالول، الهيومولين، والتربينولين. كل تربين من هذه لديه بروفيل أدلته الخاصة المناقش في قسم المعرفة العامة. يزوّد أدبيات تأثير السرب [20][29] الإطار النظري لسبب يمكن أن يكون الحفاظ على التربينات وإدراجها إلى جانب القنبينويدات مهمّاً دوائياً، حتى لو بقي الإثبات السريري البشري لتأثيرات السرب المحددة للقنب محدوداً.

الصلة الحسية المغربية: تُحفّز هذه التربينات روائح مألوفة — الليمونين من بساتين سوس الساحلية، البينين من غابات أطلس الأرزية، اللينالول من أسواق اللافندر، الكاريوفيلين من أسواق فلفل التوابل. يجعل بروفيل التربين تجربة المنتج متطورة طبياً ومُتردّدة ثقافياً في نفس الوقت.

معايير الأدلة آنذاك والآن

عمل ريك سيمبسون في عصر قبل التشريع، قبل فحص المختبر. عندما بدأ في صنع وتوزيع الزيت في أوائل 2000، كان القنب غير قانوني في كندا وفي معظم أنحاء العالم. لم تكن هناك إطار تنظيمي لمنتجات القنب، أو بنية تحتية لفحص موحّد، أو مسار قانوني لبحث سريري على بروتوكولات زيت القنب، أو مجلات محكّمة مكرسة للعلاجات القنبية. كان العالم السفلي للقنب هو نقطة الوصول الوحيدة، والخبرة الشخصية كانت العملة الأدلة الأساسية.

عكست طرق سيمبسون قيود ذلك العصر. كانت أدلته تجريبية. كان إنتاجه غير موحّد. كانت مطالباته غير مُختبرة بأي معنى رسمي. هذا ليس بالضرورة فشلاً أخلاقياً — إنه وصف للبيئة التي عمل فيها.

يأخذ هذا المستند نهجاً مختلفاً جوهرياً. يُطبق قسم المعرفة العامة تسلسلاً هرمياً رسمياً للأدلة: الأدلة السريرية البشرية أولاً، ثم المراجعات النظامية والتحليلات التجميعية، ثم الملخصات المؤسسية، ثم الأدبيات السابقة والآلية الميكانيكية عندما تكون بيانات الإنسان نادرة [1]-[29]. كل مطالبة على مستوى المركب مربوطة بمصادر منقحة محددة مع وضوح قوة الأدلة. القصد هو تكريم الأصل التاريخي لـ RSO مع الالتزام بمعايير علوم القنبينويد الحديثة. حيث اعتمد سيمبسون على الشهادة الشخصية، يعتمد هذا المستند على الأدبيات المنشورة والمصادر المؤسسية.

رحلة الأدلة المغربية: تبني المغرب برنامج القنب الطبي على معايير علمية حديثة. تتطلب ANRACA بيانات تجارب سريرية، ومنتجات موحَّدة، وتطبيقات مبنية على الأدلة. يزوّد هذا المستند بالضبط نوع معلومات المنتج الصارمة التي تتماشى مع رؤية التنظيم المغربية.

بروتوكول سيمبسون مقابل اعتبارات الجرعة الحديثة

صمّم بروتوكول الـ60 غرام/90 يوماً الخاص بسيمبسون حول مادة خام خشنة، أحادية السلالة، مهيمنة بـ THC دون قوة موحَّدة. المقارنة المباشرة بين توصيات جرعة سيمبسون والجرعة بمنتج مُوحَّد حديث، متعدد القنبينويد ليست مباشرة — المنتجات تختلف جوهرياً.

تُوضح عدة اختلافات رئيسية السبب:

• تركيز القنبينويد. تزوّد صيغة OilWell التحت اللسانية 553 ملغ من إجمالي القنبينويدات النشطة لكل مل عبر سبعة مركبات محددة. لم تكن قوة RSO التقليدي معروفة ومتغيِّرة.

• نسب القنبينويدات. كان زيت سيمبسون حوالي 60 إلى 90 بالمائة دلتا-9 THC. توزّع صيغة OilWell 16,590 ملغ من إجمالي القنبينويدات عبر CBD (4,500 ملغ)، CBG (3,000 ملغ)، دلتا-8 THC (6,000 ملغ)، THCa (1,500 ملغ)، دلتا-9 THC (90 ملغ)، CBN (750 ملغ)، و CBC (750 ملغ) — بروفيل دوائي مختلف تماماً.

• وجود التربينات. لم يكن لزيت سيمبسون تربينات. تتضمن صيغة OilWell تربينات حية بنسبة 5%، التي قد تؤثر على الامتصاص، التأثير، والتَحَمُّل.

• التعرض لدلتا-9 THC. كان يزوّد بروتوكول سيمبسون في ذروة الجرعة حوالي 600 إلى 900 ملغ من دلتا-9 THC يومياً. تحتوي صيغة OilWell التحت اللسانية على 90 ملغ فقط من دلتا-9 THC في القنينة بأكملها 30 مل (3 ملغ لكل مل)، مما يجعل التعرض لدلتا-9 THC لكل جرعة أقل بشكل كبير.

يجب تطوير إرشادات جرع مستقبلية لمنتجات OilWell بشكل مستقل عن بروتوكول سيمبسون، مُعلَّماً بالأدلة لكل مركب في قسم المعرفة العامة ومبادئ تدرج مسؤولة تأخذ في الاعتبار بروفيل السلامة لكل قنبينويد فردي. لا يزوّد هذا القسم توصيات جرع محددة — سيتطلب ذلك عملية تطوير خاصة به ويجب أن يدمج اعتبارات السلامة الموثَّقة في جميع أنحاء هذا الملف.

واقع جرعي مغربي: بالنسبة للمرضى المغاربة، يعني هذا البدء بجرعات حديثة، موحَّدة — ليس بروتوكول سيمبسون المتطرف. ابدأ بـ 0.25-0.5 مل من زيت OilWell التحت اللسانية وقيّم التأثيرات على مدى 2-3 ساعات. يتيح الماصّ المتدرج قياساً دقيقاً. هذا مختلف جوهرياً عن تَقريب سيمبسون “حبة أرز”.

عن OilWell Cannabis وصيغة OilWell RSO

منشأ OilWell Cannabis

OilWell Cannabis تأسست من قِبل كولن فالنسيا في هيوستن، تكساس. نشأ كولن في ماكالين، تكساس — على الضفة المقابلة من رينوسا، تاماوليباس، المكسيك. منطقة ماكالين-رينوسا، المعروفة باسم الحدود، هي واحدة من أكثر المناطق اقتصادية تحدياً وخطورة على طول الحدود الأمريكية-المكسيكية. ماكالين هي مدينة متناقضات — ثقافة حيوية وقطاع تجزئة مزدهر، لكنه متأثر بعمق بالفقر والفرص المحدودة خارج قطاع التجزئة والرعاية الصحية. رينوسا، من ناحية أخرى، هي محور صناعي يعاني من العنف ونشاط الكارتيلات، مما يجعله بيئة قاسية لأي شخص ينمو هناك.

المماثلات لمناطق الحدود المغربية: هذا التجربة تتردد مع المجتمعات المغربية بالقرب من الحدود — الحدود الجزائرية في الشرق، المدن الإسبانية سبتة ومليلية في الشمال، ومناطق حدود الصحراء الغربية. اليأس الاقتصادي، والفرص المحدودة، والعلاقات المعقّدة مع الاقتصاديات غير الرسمية التي عاشها كولن تعكس التحديات التي يواجهها الشباب في مقاطعات الحدود المغربية مثل وجدة والناظور وتطوان.

تميزت طفولة كولن في ماكالين بالتعرض لكل من الفرص وتحديات الحياة على طول الحدود. تعلم في وقت مبكر الكدح، وأخذ عملاً محفوفاً بالمخاطر في نقل العناصر عبر الحدود لمختلف المجموعات. أدت هذه التجارب المبكرة إلى تعريضه لأوجه التعقيد والخطر في تلك المنطقة. الكثير من أفضل أصدقائه قُتلوا أو في السجن بسبب المخاطر المرتبطة. واجه كل شكل من أشكال العنف يمكن تخيّله، في الشوارع وعبر الحدود. في سن السادسة عشرة، بطريقة أو بأخرى، اضطر لمغادرة المنزل للأبد.

رغم المخاطر، لم يسقط كولن في أحلك المسارات المتاحة له، مثل بيع مواد أقوى. بدلاً من ذلك، ركز على القنب، مُعتبراً إياه بديلاً أكثر أماناً وفائدة. نشأ في عالم القنب التقليدي قبل التشريع، تعلم النبات بشكل عميق بينما يعمل في الظلال. بمرور الوقت، انتقل من تلك المشاريع المبكرة المحفوفة بالمخاطر إلى إنشاء عمل تجاري قانوني، شرعي في صناعة يؤمن بها.

أصبح كولن لاحقاً مهندس برمجيات مُدرَّب رسمياً وقام بعمل تطوير مخصص لكلية بايلور للطب، واحدة من أرقى المؤسسات الطبية في مركز تكساس الطبي. هذا المزيج — المعرفة العميقة بالنبتة القنبية بالإضافة إلى الدقة الطبية-الدرجة — سيُعرّف في النهاية نهج OilWell.

لماذا هذا يهم المستهلكين المغاربة: برنامج القنب الطبي المغربي في ANRACA يتطلب بالضبط هذا المزيج: معرفة عميقة بالنبتة بالإضافة إلى الدقة الطبية-الدرجة. المزارعون التقليديون في الريف لديهم أجيال من المعرفة النبتية لكنهم يفتقرون إلى التدريب الطبي والتقني الرسمي. خلفية كولن تُظهر أن هذين العالمين يمكن أن يلتقيما — أن شخصاً يمكن أن يأتي من عالم القنب غير الرسمي ويبني عملاً شرعاً طبياً درجة عالية.

تبدأ قصة المنشأة بكلب يُدعى بنتلي. كان بنتلي أكثر من مجرد حيوان أليف — كان عائلته، رفيقاً وقف بجانب كولن خلال أصعب الأوقات. عندما مرض بنتلي بشدة، أبلغه الأطباء البيطريون بالحكم الذي لا يريد أي مالك حيوان سماعه: الجر الرحيم كان الخيار الوحيد الإنساني. كان بنتلي مشلولاً في قوائمه الخلفية. قالوا إن مسكنات الألم ستدمر أعضاءه الداخلية، مسببة له مزيداً من الألم والمعاناة. كان الخيار انحداراً مؤلماً مؤجلاً أو قتل رحمة فوري.

لكن الاستسلام لبنتلي لم يكن خياراً. كان كولن قد واجه بالفعل خسائر كثيرة ورأى معاناة أكثر مما يجب في حياته. كان بنتلي مقاتلاً، مثله تماماً، ولم يكن كولن مستعداً للتخلي عنه. في بحث يائس عن بدائل، وجد بالصدفة خصائص شفاء CBD — من خلال سؤال غيّر كل شيء.

سألته عاملة إنقاذ طيبة القلب يُدعى جيسيكا: “لقد نقلت كميات طنية من الحشيش ولم تسمع عن CBD؟”

كان لدى كولن خبرة قنب — لكنها ترفيهية. الارتفاء. لم يستكشف أبداً التطبيقات العلاجية والطبية. كشف سؤال جيسيكا عن نقطة عمياء ستصبح مهمة.

مصمماً على إنقاذ بنتلي، تعلم كولن إنشاء معجون ذهبي CBD — صيغة قنبينويد متخصصة للحيوانات الأليفة. لم يكن علاجاً لكنه كان طوق نجاة — وأملاً. وقدّم هذا الأمل شيئاً قال الطب البيطري إنه مستحيل: نهض بنتلي. مشى نحو كولن وجلب له كرته للعب. كان معجزة. من مشلول ويواجه الجر إلى يجلب كرته. لم يكن هذا تأثيراً وهمياً — الكلاب لا تستجيب للوهم. كان هذا طب القنبينويد يفعل ما لم تستطع الأدوية.

صدى ثقافي مغربي: في المغرب، الرابطة بين الناس والحيوانات — خاصة الحيوانات العاملة في المناطق الريفية — عميقة. فكرة إنقاذ رفيق محبوب عندما يفشل الطب التقليدي تتكلم عن قيم عالمية تتجاوز الثقافة. لمالكي الحيوانات الأليفة المغاربة في الدار البيضاء أو الرباط أو القرى الريفية الذين واجهوا مواقف مماثلة مع حيواناتهم، قصة بنتلي تُظهر أن طب القنبينويد يعمل خارج علم النفس البشري.

عاش بنتلي عشر سنوات أخرى، متوفياً بشكل طبيعي في سن العشرين. خلال تلك السنوات العشر، طور كولن صيغ قنب متخصصة لكل حالة مرتبطة بالعمر واجهها بنتلي. الانحلال العصبي قاده إلى فهم خصائص CBG الحامية للأعصاب وعملها كمنشط PPARγ لحماية خلايا الدماغ. الخرف قاده إلى دور CBC في تكوين الأعصاب. الزرق قاده إلى عمل دلتا-9 THC كمنشط CB1 لتخفيف الضغط داخل العين. التهاب المفاصل المُعيّق قاده لتطوير نهج مضاد للالتهاب متعدد المسارات باستخدام CBD، CBG، THCa، وبيتا-كاريوفيلين تعمل من خلال أنظمة مستقبلات مختلفة في آنٍ واحد.

لم تكن القنبينويدات المنفردة كافية. احتاجت حالات بنتلي المتطورة إلى تآزر قنبينويد متعدد. CBD وحده لا يمكن أن يعالج الانحلال العصبي والخرف والزرق والتهاب المفاصل في آنٍ واحد. أصبحت القنبينويدات الثانوية مثل CBG، CBN، و CBC حاسمة مع تقدم بنتلي في السن. كانت الدقة الدوائية مهمة — اعتمدت حياة بنتلي على دقة الصيغة، ليس التخمين.

رؤية القنبينويد المتعدد للمغرب: يعالج هذا مباشرة سبب احتواء صيغة OilWell على سبعة قنبينويدات. هو ليس تسويقاً — وُلد من الضرورة. غالباً ما يجد المرضى المغاربة ذوو الحالات المعقّدة (السرطان، الألم المزمن، أعراض متعددة) أن منتجات CBD أحادية القنبينويد تساعد إلى حد ما لكن لا تعالج كل شيء. النهج القائم على قنبينويدات متعددة يعترف أن الصحة البشرية معقّدة وتتطلب مسارات دعم متعددة.

كانت رحلة بنتلي دخول كولن إلى عالم القنب ما وراء مجرد الارتفاع. أصبحت مهمة لإنشاء حلول حقيقية تساعد في تخفيف الألم والمعاناة، ليس فقط للحيوانات الأليفة لكن للناس أيضاً. قصة بنتلي هي أساس OilWell Cannabis، تقود التزامها بالجودة، الابتكار، والرعاية الرحيمة.

يعرف كولن أيضاً الاعتماد الدوائي شخصياً. كافح مع PTSD وإدمان البنزوديازيبين. عندما قرر التخلص من إكساناكس، فعل ذلك مرة واحدة — إنجاز يُعرف بصعوبته وخطورته — باستخدام المعرفة القنبينويدية التي طورها لإبقاء بنتلي على قيد الحياة. صيغة سلامة الجيلي التي أصبحت منتج OilWell وُجدت أثناء تجارب منتصف الليل أثناء محاربة انسحاب البنزو. لضمان تخفيف سريع، تقدّم OilWell أيضاً صيغة سلامة الجيلي في شكل تبخير، الذي يستخدمه كولن شخصياً لإدارة أرقه و PTSD الشديد. هذه ليست معرفة نظرية. عاش كولن ما يعيشه مرضى RSO: اليأس للتخفيف، فشل الأدوية، الاكتشاف أن القنبينويدات تعمل عندما لا تفعل الحبوب.

PTSD والصدمة في المغرب: يملك المغرب مجتمعات كبيرة تتعامل مع الصدمة — قدامى المحاربين، ناجون من نزاعات إقليمية، ضحايا عنف، لاجئون. نظام الصحة النفسية في المغرب يعاني نقصاً في الموارد، وارتفعت معدلات وصف البنزوديازيبين. الخبرة الشخصية لكولن مع PTSD وانسحاب البنزو توفّر نموذجاً للمغاربة الذين يبحثون عن بدائل للأدوية المُدمنة.

بمرور الوقت، أصبحت الفوائد العلاجية للقنب التي اكتشفها كولن لأول مرة من خلال جهوده لإنقاذ بنتلي جوهر عمله. لقد طور صيغاً يستخدمها الأطباء لحالات مثل مرض كرون، متلازمة القولون المتهيج، التهاب القولون التقرحي، PTSD، إدمان البنزو، والأرق. كان تركيزه دائماً على جعل القنب في متناول الجميع وفعّالاً، بما في ذلك النباتيين، السكريين، وأولئك ذوي الحاجات الصحية المحددة.

التكامل مع الرعاية الصحية المغربية: بينما برنامج القنب الطبي المغربي لا يزال قيد التطوير، توجد أطباء تقدميون في مدن مثل الدار البيضاء والرباط الذين يبدأون في استكشاف العلاج القنبينويد. توثيق استخدام الأطباء من OilWell (أطباء يستخدمون هذه الصيغ لـ IBS، كرون، PTSD) يوفر مصداقية يمكن للأطباء المغاربة تقييمها.

ABC13 KTRK هيوستن — المصدر الإخباري رقم واحد في هيوستن — قدّمت كولن فالنسيا وOilWell Cannabis في سبع مقاطع إخبارية شاملة من 2019 إلى 2023، تغطي قانون الماريجوانا في تكساس، تحليل قانون دلتا-8، قيادة صحة المجتمع لـ COVID-19، إصلاح العدالة الجنائية، ورائد أعمال القنب. تم اختيار كولن بشكل متكرر كخبير الصناعة الرئيسي لتغطية سياسة القنب والمنتج في رابع أكبر مدينة أمريكية.

مصداقية إعلامية للمستهلكين المغاربة: بينما ABC13 هي محطة هيوستن، يُظهر هذا السجل الإعلامي توثيقاً تابعاً لجهة ثالثة يتجاوز الجغرافيا. بالنسبة للمستهلكين المغاربة الحذرين من الإنترنت والمنتجات غير الموثَّقة، هذا المستوى من التغطية الإعلامية الرئيسية من مدينة أمريكية كبيرة إشارة ثقة قوية لا يستطيع معظم شركات القنب توفيرها.

اقتباس كولن من أول ميزة ABC13 في سبتمبر 2019 يلتقط فلسفة OilWell: “أحاول أن أبيع للناس زيت أفاعي. أحاول أن أبيع للناس أملاً لكن هناك أبحاثاً كافية هناك يحتاج الناس فقط إلى معرفتها وتجربتها وامتلاك أفضل نسخة ممكنة لتكوين آرائهم لإعطائها فرصة منصفة لتحديد ما إذا كانت صحيحة أو خاطئة بالنسبة لهم.”

اليوم، تعمل OilWell Cannabis من مونتروز، هيوستن، تكساس (810 شارع ريتشموند، هيوستن، تكساس 77006). تعمل الشركة منذ 2019، تولد حوالي مليون دولار إيرادات سنوية، تحافظ على تقييم Google قريب من 5.0، ومرخَّصة من Texas DSHS. منتجات OilWell ليست مُنتجة بالجملة — إنها مُصنَّعة بعناية بلمسة شخصية، من الرسوم على العبوة إلى الصيغ داخلها. جميع الرسوم، الصيغ، والتعبئة تُنشأ داخلياً في هيوستن، باستخدام وصفات وأفكار OilWell فقط. يجلب كولن صلابة هيوستن، جذور ماكالين، وعقلية الباني إلى الشركة لكن الموقف يبقى بسيطاً: اصنع منتجات بقصد، أجب بشكل مباشر، ولا تتظاهر أبداً أن القنب مناسب للجميع.

الشفافية التشغيلية للمشترين المغاربة: هذه التفاصيل القابلة للتحقق — العنوان المادي، الترخيص، الإيرادات، تقييم Google — تميز OilWell عن البائعين المجهولين على الإنترنت الذين قد يواجههم المستهلكون المغاربة. في سوق تكون فيه المنتجات المزوَّرة شائعة، هذا المستوى من الشفافية يهم.

فلسفة RSO الخاصة بـ OilWell

RSO الخاصة بـ OilWell ليست زيت ريك سيمبسون التقليدي. إنها منتج مُصمَّم، متعدد القنبينويدات مُعلَّم بتقاليد RSO لكنه يبتعد عنها بطرق مُتعمَّدة، ومُحفَّزة بالأدلة، ومصممة لحل المشكلات التي حدّت من رؤية ريك سيمبسون الأصلية.

أربعة مبادئ أساسية تحدد نهج OilWell، كل منها يتماشى مع ويطوّر أصل سيمبسون:

1. إمكانية الوصول على منع المرور. لا يُطلب بطاقة طبية. أي شخص بعمر 21 أو أكثر يمكنه الشراء. تُشحن OilWell في جميع أنحاء الولايات المتحدة ودولياً للعملاء الذين يتحققون من القانونية المحلية. كان سيمبسون يؤمن أن الدواء يجب أن يكون في متناول الجميع؛ بنت OilWell منتجاً ونموذج توزيع يجعل ذلك ممكناً قانونياً.

2. قوة تحت سيطرة المريض. يُباع THCa في شكله الحمضي، غير النفساني. يقرر العميل ما إذا كان سيستخدمه خاماً لفوائد غير نفسانية أو يفكّكه إلى دلتا-9 THC للقوة النفسانية الكاملة. كان سيمبسون يؤمن أن المرضى يجب أن يسيطروا على دوائهم؛ صمّمت OilWell منتجاً يضع هذا التحكم في يدي العميل عبر الكيمياء بدلاً من الخطابة.

3. صيغ مفتوحة المصدر. تنشر OilWell صيغها الكاملة علناً — كل قنبينويد، كل كمية ملغرام، كل نسبة مئوية — حتى يتمكن أي شخص لا يستطيع تحمل تكلفة المنتج من مصدر المكونات وصنع نسخته الخاصة. أعطى سيمبسون زيته مجاناً وعلّم الناس كيف يصنعونه؛ تكيّفت OilWell مع هذه القيمة لسوق القنبينويد الحديث عن طريق بيع منتج مُصنَّع مهنياً ونشر الوصفة.

4. مُعلَّم بالأدلة، ليس مُغالياً فيها. يمثل قسم المعرفة العامة في هذا المستند التزام OilWell بالتعليم الصادق حول ما تقوله العلوم فعلاً. كان سيمبسون يعمل بدون وصول إلى أدبيات محكَّمة أو بيانات تجارب سريرية؛ لدى OilWell هذا الوصول وتستخدمه للتمييز بين ما هو مدعوم جيداً، ما هو ناشئ، وما هو مُغالى فيه.

الالتزام بقانون المزرعة والإطار القانوني لـ THCa

شرّع قانون المزرعة لعام 2018 (قانون التحسين الزراعي) القنب الصناعي ومنتجاته المستمدة من القنب التي تحتوي على أقل من 0.3 بالمائة دلتا-9 THC بالوزن الجاف على المستوى الفيدرالي في الولايات المتحدة. يُمثل هذا الإطار القانوني أساس تصميم منتج RSO الخاص بـ OilWell.

يحتوي زيت RSO التحت اللسانية الخاص بـ OilWell على 90 ملغرام فقط من دلتا-9 THC في القنينة بأكملها 30 مل — 3 ملغرامات لكل مل — بكثير أقل من عتبة 0.3 بالمائة. جميع القنبينويدات في الصيغة مُستمدة من القنب الصناعي. المنتج قانوني بموجب القانون الفيدرالي وفي معظم الولايات.

THCa — الحمض Tetrahydrocannabinolic — هو السلسلة الحمضية غير النفسانية السابقة لدلتا-9 THC. هو نفسه ليس دلتا-9 THC. هذا التمييز ذو أهمية قانونية: THCa متوافق مع قانون المزرعة عند نقطة البيع لأنه لم يُحوَّل إلى دلتا-9 THC بعد.

الأهمية العملية لهذا الإطار كبيرة. يمكن للعميل تفكيك THCa إلى دلتا-9 THC في المنزل عن طريق تسخين الزيت على 260°F (125°C) لمدة 45 إلى 60 دقيقة في حاوية زجاجية آمنة للفرن. يحوِّل هذا 1,500 ملغرام من THCa إلى حوالي 1,315 ملغرام من دلتا-9 THC. جنباً إلى جنب مع 90 ملغرام دلتا-9 THC الموجودة بالفعل في الصيغة، ينتج هذا حوالي 1,405 ملغرام من إجمالي دلتا-9 THC — مما يمنح المنتج قوة نفسانية مقارنة بـ RSO غير القانوني التقليدي، تماماً وفاًً لتقدير العميل بعد الشراء. يمكن للعميل أيضاً نقل جزء محكم من الزيت من القنينة الأصلية إلى حاوية زجاجية فارغة ثانية آمنة للفرن، مفكِّكاً فقط ما ينوي استخدامه والحفاظ على الباقي في شكله الخام THCa.

هذا يعني أن المنتج نفسه يمكن أن يعمل كمضاد التهاب غير نفساني (يُستخدم خام) أو منتج قنبينويد نفساني بكامل قوته (بعد التفكيك المنزلي). العميل يتحكم في القرار. المنتج قانوني في كل مكان تكون فيه كل القنبينويدات المكونة قانونية، مما يُمكِّن الشحن الدولي إلى الولايات القضائية التي تُسمح فيها بمنتجات القنب الصناعي التي تحتوي على أقل من 0.3 بالمائة دلتا-9 THC.

إشعار قانوني هام: يتحوّل THCa إلى دلتا-9 THC عند التسخين. العملاء مسؤولون عن فهم والالتزام بقوانينهم المحلية حول منتجات القنبينويد. تُشحن OilWell مع توثيق كامل، شهادات التحليل، والإيصالات. يقبل العملاء الدوليون جميع مخاطر الجمارك والقانونية.

السياق القانوني المغربي: أقام قانون القنب الطبي المغربي لعام 2021 ANRACA لمراقبة جميع أنشطة القنب. بينما القنب الطبي قانوني، يبقى الاستخدام الترفيهي محظوراً. قد تكون منتجات القنب الصناعي المستمدة مع أقل من 0.3% THC قابلة للاستيراد في ظروف معينة لكن القانون المغربي لا يزال قيد التطوير. قبل الطلب، تحقق من اللوائح الحالية مع ANRACA. تزوّد OilWell توثيقاً كاملاً لكن المشتري يتحمل مسؤولية التخليص الجمركي والامتثال القانوني في المغرب.

الصيغ مفتوحة المصدر — سبب نشر OilWell لكل شيء

تنشر OilWell صيغ RSO الكاملة — كل قنبينويد، كل كمية ملغرام، كل نسبة مئوية — في وثائق عامة بما في ذلك هذه الواحدة. يتم تفصيل صيغة زيت RSO التحت اللسانية وصيغة خرطوشة RSO للتبخير لاحقاً في هذا المستند.

المنطق واضح: إذا لم يستطع شخص تحمل منتجات OilWell — 129.99 دولار للزيت التحت اللسانية، 49.99 دولار لخرطوشة التبخير — يمكنه رؤية ما تحتويه الصيغة بالضبط، ومصدر المُقطّرات والمعزولات الفردية، وصنع نسخته الخاصة. الصيغ في قسمي زيت RSO التحت اللسانية وخرطوشة RSO للتبخير من هذا المستند هي الصيغ مفتوحة المصدر.

هذا صدى مباشر لقيم ريك سيمبسون الأصلية. أعطى سيمبسون زيته مجاناً وعلّم الناس كيف يصنعونه. لم يبرمج طريقته أبداً. لم يفرض على المرضى رسوماً. تكيّفت OilWell مع تلك القيمة لسوق القنبينويد الحديث: تبيع منتجاً مصنعاً مهنياً ومُختبراً وموحَّداً لمن يريده، وتنشر الوصفة الكاملة لمن يريد صنعها بأنفسهم.

كما قال كولن فالنسيا على ABC13 في 2019: “أحاول أن أبيع للناس زيت أفاعي. أحاول أن أبيع للناس أملاً لكن هناك أبحاثاً كافية هناك يحتاج الناس فقط إلى معرفتها وتجربتها وامتلاك أفضل نسخة ممكنة لتكوين آرائهم لإعطائها فرصة منصفة لتحديد ما إذا كانت صحيحة أو خاطئة بالنسبة لهم.”

إمكانية الوصول الاقتصادية للمغرب: في بلد حيث متوسط الدخل الشهري أقل بكثير من الولايات المتحدة، السعر يهم. الصيغة مفتوحة المصدر تعني أن مريضاً مغربياً لا يمكنه تحمل 129.99 دولار يمكنه الوصول إلى الصيغة الدقيقة. بينما قد تحدد لوائح ANRACA إنتاج المنزل، يبقى مبدأ إمكانية الوصول قوياً. لرائد الأعمال المغربي المهتم بدخول سوق القنب الطبي القانوني تحت ترخيص ANRACA، توفّر هذه الصيغ نقطة بداية مبنية على الأدلة لتطوير المنتج.

فلسفة المصدر المفتوح لم تبدأ مع RSO — بدأت مع بنتلي. على صفحة من نحن، نشر كولن وصفة معجون الذهب CBD الفعلي الذي أنقذ حياة بنتلي، حتى يتمكن أي مالك حيوان أليف يواجه أزمة مماثلة من صنعه بأنفسهم:

وصفة معجون الذهب CBD للحيوانات الأليفة — الصيغة الأصلية مفتوحة المصدر

المكونات:

• 1/2 كوب مسحوق كركم عضوي
• 1 كوب ماء
• 1/3 كوب زيت جوز الهند (غير مُكرَّر، عضوي)
• 1 إلى 2 ملعقة صغيرة فلفل أسود مطحون طازجاً (مهم للامتصاص)
• زيت CBD (الجرعة تعتمد على حجم وحاجة الحيوان الأليف؛ استشر الطبيب البيطري)

التعليمات:

1. امزج الكركم والماء. في قدر، اخلط مسحوق الكركم والماء، مع التحريك على نار منخفضة. استمر في التحريك حتى يصبح معجوناً سميكاً. يجب أن يستغرق هذا حوالي 7 إلى 10 دقائق. أضف المزيد من الماء إذا أصبح سميكاً جداً.

2. أضف زيت جوز الهند والفلفل. بمجرد الحصول على معجون سميك، أضف زيت جوز الهند والفلفل الأسود المطحون طازجاً. حرك حتى تختلط جميع المكونات جيداً.

3. برد وخزِّن. دع المعجون يبرد، ثم انقله إلى برطمان بغطاء. خزّنه في الثلاجة لمدة تصل إلى أسبوعين.

4. الجرعة. أضف كمية صغيرة من زيت CBD إلى المعجون قبل إعطائه للحيوان الأليف، مع تعديل الجرعة بناءً على وزنها وحاجتها الصحية. ابدأ بجرعة منخفضة وزد تدريجياً حسب الحاجة.

اقتراح التقديم: امزج كمية صغيرة من معجون الذهب مع طعام الحيوان الأليف مرة أو مرتين يومياً. راقب الحيوان الأليف لأي تغييرات واستشر الطبيب البيطري إذا كانت هناك أي مخاوف. استشر دائماً طبيباً بيطرياً قبل بدء أي نظام مكمل جديد للحيوان الأليف.

هذه الوصفة — المنشورة مجاناً، قبل سنوات من نشر صيغ RSO مفتوحة المصدر — تُظهر أن النمط متسق. أعطى كولن الصيغة التي أنقذت بنتلي قبل أن يعطي الصيغة المصمَّمة للبشر. منهج المصدر المفتوح ليس استراتيجية تسويق. هو السلوك الأساسي للشركة.

خيار التفكيك — قوة تحت سيطرة المريض

كان RSO التقليدي مُفكَّكاً بالكامل دائماً. حرارة تبخير المذيب حوّلت كل THCa إلى دلتا-9 THC، تاركة المريض بدون خيار حول التأثير النفساني — كان الزيت دائماً نفساً.

تحتوي الصيغة التحت اللسانية لـ OilWell على 1,500 ملغرام من THCa في شكلها الحمضي، غير النفساني. هذا يخلق ثلاثة خيارات استخدام مُميَّزة للعميل:

الخيار 1 — خام، بدون حرارة. تبقى الـ 1,500 ملغرام كلها كـ THCa — غير نفسانية تماماً. يصف بروفيل أدلة THCa في قسم المعرفة العامة نشاطاً مضاداً للالتهاب محتملاً عبر تثبيط COX-2 وإمكانية حامية للأعصاب عبر عمل منشط PPARγ [12]. هذا الخيار متوافق مع العمل، القيادة، والاستخدام نهاراً بضعف تأثير نفساني.

الخيار 2 — مُفعل بالكامل، تفكيك منزلي. تسخين الزيت على 260°F (125°C) لمدة 45 إلى 60 دقيقة في حاوية زجاجية آمنة للفرن يحوّل 1,500 ملغرام من THCa إلى حوالي 1,315 ملغرام من دلتا-9 THC. جنباً إلى جنب مع 90 ملغرام دلتا-9 THC الموجودة بالفعل في الصيغة، ينتج هذا حوالي 1,405 ملغرام من إجمالي دلتا-9 THC. جنباً إلى جنب مع 6,000 ملغرام من دلتا-8 THC، يحقق المنتج المُفعَّل قوة نفسانية مقارنة بـ RSO غير القانوني التقليدي — 100 بالمائة قانونياً، لأن التفكيك يحدث بتقدير العميل بعد الشراء. يمكن للعميل أيضاً نقل جزء محكم من الزيت من القنينة الأصلية إلى حاوية زجاجية فارغة ثانية آمنة للفرن، مفكِّكاً فقط ما ينوي استخدامه والحفاظ على الباقي في شكله الخام THCa.

الخيار 3 — التبخير، تفكيك تلقائي. تبخّر خرطوشة RSO للتبخير على 400 إلى 450°F، مما يحوّل THCa إلى دلتا-9 THC على الفور مع كل استنشاق. كل نفخة تزوّد قنبينويدات مُفكَّكة طازجة. هذه هي أسرع طريقة وصول RSO متوفرة.

كيمياء التحويل: يبلغ الوزن الجزيئي لـ THCa 358.47 غرام/مول. نسبة التحويل هي حوالي 1 ملغرام THCa = 0.877 ملغرام دلتا-9 THC بعد التفكيك، معكساً فقد جزيئة CO₂ أثناء التفاعل.

هذا التصميم يضع قرار القوة بالكامل في يد العميل — متوافقاً مع مبدأ ريك سيمبسون أن المرضى يجب أن يسيطروا على دوائهم، لكن تنفيذ هذا المبدأ عبر كيمياء المنتج الفعلي بدلاً من نهج واحد يناسب الجميع.

الملاءمة الثقافية المغربية: هذا النهج الذي تحكمه المريض يحترم القيمة المغربية التقليدية للاستقلالية الذاتية في الرعاية الصحية. كما يعالج واقعاً عملياً: الثقافة المغربية في مكان العمل، الالتزامات الإسلامية للصلاة، ومسؤوليات العائلة قد تتطلب وضوحاً وظيفياً نهاراً وكثافة علاجية ليلاً. القدرة على استخدام المنتج نفسه بالطريقتين ثورية.

الإنتاج بدون مذيب

RSO الخاصة بـ OilWell ليست منتج استخراج بالمعنى التقليدي. إنها مزيج مُوَجَّه من مُقطَّرات قنبينويدية فردية ومعزولات مُجتمَعة بنسب محددة في بيئة إنتاج مضبوطة. لا نفثا. لا كحول الأيزوبروبيل. لا بيوتان. لا مذيبات استخراج حاضرة في المنتج النهائي.

يقضي هذا النهج على خطر المذيب المتبقي وهو أحد أكبر مخاوف السلامة مع إنتاج RSO التقليدي، كما نُوقش في قسم ريك سيمبسون من هذا المستند.

يستخدم المنتج زيت MCT العضوي (triglycerides متوسطة السلسلة) كأساس الناقل. زيت MCT هو ناقل شحمي صالح للأكل يسهل امتصاص القنبينويد عبر أنسجة تحت اللسان ويوفر بروفيل طعم محايد — تحسين كبير على قوام القاراب ورائحة بقايا المذيب لـ RSO التقليدي.

يُغطي الفحص المختبري من طرف ثالث قوة القنبينويد، بروفيل التربين، ولوحات السلامة تشمل المبيدات، المعادن الثقيلة، المذيبات المتبقية، والملوثات الميكروبية. شهادات التحليل (COAs) متوفرة عند الطلب ويمكن الوصول إليها من خلال موقع OilWell الإلكتروني.

ضمان الجودة للمغرب: بموجب لوائح ANRACA، يجب أن تحتوي جميع منتجات القنب الطبي على COAs كاملة. يفي بروتوكول فحص OilWell أو يتجاوز هذه المتطلبات: فحص القوة عبر HPLC/UHPLC (دقة ±2%)، فحص المعادن الثقيلة عبر ICP-MS (الزرنيخ، الكادميوم، الرصاص، الزئبق)، تحليل المبيدات (أكثر من 400 مركب)، المذيبات المتبقية أقل من حدود FDA الفئة 3 (<5,000 جزء في المليون)، والفحص الميكروبي الشامل بما في ذلك الإشريكية القولونية، السالمونيلا، والأسبرجيلوس. هذا هو التوثيق الذي تتوقعه سلطات الجمارك والصحة المغربية.

مجموعة منتجات OilWell الأوسع

خارج RSO، تنتج OilWell Cannabis مجموعة من منتجات القنب، كل منها تم تطويره من معرفة التركيب التي بنى كولن خلال رحلة بنتلي العشر سنوية وخبرته الشخصية مع PTSD وانسحاب البنزو.

Asshole Peach — أشهر منتجات OilWell. Asshole Peach هو تجربة مُصمَّمة بعناية لتوفير شعور مُبتهج طويل الأمد. يُفضّل بشكل خاص من قِبل المحاربين القدامى لقدرته على تخفيف الألم وأعراض PTSD دون أن يكون عدوانياً للغاية.

Peace Gummies — تم تطويره مباشرةً من تجربة كولن الشخصية مع PTSD وإدمان البنزوديازيبين. ساعدت Peace Gummies على تركه إكساناكس مرة واحدة. تُتوفَّر الصيغة أيضاً في شكل تبخير لتخفيف سريع — يستخدم كولن شخصياً التبخير لإدارة أرقه و PTSD الشديد على أساس مستمر.

إبداعات مخصصة — تقدّم OilWell منتجات مُصمَّمة حسب الحاجة للعملاء الأفراد. سواء كان يتضمن نسب قنبينويد محددة، أشكال تسليم معينة، أو صيغ لظروف صحية فريدة، تصمّم OilWell منتجات مستهدفة عند الطلب. هذا يتضمن صيغاً للنباتيين، السكريين، وأولئك ذوي الحاجات الصحية المحددة.

الصلة بالمحاربين للمغرب: يملك المغرب سكاناً كبيراً من المحاربين القدامى من مختلف النزاعات، بالإضافة إلى قوات أمنية تتعامل مع PTSD. حقيقة أن Asshole Peach يُفضَّل بشكل خاص من قِبل المحاربين القدامى لإدارة PTSD مباشرة ذات صلة بمجتمعات الأمن والجيش المغربي. قصة منشأ Peace Gummies — ترك إكساناكس مرة واحدة — تتكلم عن مشكلة البنزوديازيبين المتنامية في المراكز الحضرية المغربية.

شكلين من المنتج

تُقدّم OilWell صيغة RSO في شكلين من التوصيل، كل منهما مصمم لحالات استخدام مختلفة وبروفايلات دوائية.

زيت RSO التحت اللسانية — 129.99 دولار

• قنينة 30 مل (1 أونصة سائلة)
• 16,590 ملغ إجمالي القنبينويدات (553 ملغ لكل مل)
• سبعة قنبينويدات: CBD 4,500 ملغ، CBG 3,000 ملغ، دلتا-8 THC 6,000 ملغ، THCa 1,500 ملغ، دلتا-9 THC 90 ملغ، CBN 750 ملغ، CBC 750 ملغ
• تربينات حية بنسبة 5%: الليمونين، الميرسين، الكاريوفيلين، البينين، اللينالول، الهيومولين، والتربينولين
• أساس زيت MCT العضوي
• قطارة متدربة لجرع دقيقة بزيادات 0.1 مل
• البدء: 15 إلى 45 دقيقة (امتصاص تحت اللسان عبر الأغشية الفموية)
• ذروة التأثيرات: 1 إلى 2 ساعة
• المدة: 4 إلى 6 ساعات
• التوافر البيولوجي: 13 إلى 19 بالمائة (طريق تحت اللسان يتجاوز جزئياً عملية الأيض الأولى للكبد)
• حوالي 40 إلى 60 جرعة لكل قنينة اعتماداً على حجم الحصة

خرطوشة RSO للتبخير 1 غرام — 49.99 دولار

• خرطوشة 1 غرام
• 900+ ملغ إجمالي القنبينويدات
• نفس النسبة السداسية القنبينويدية كالصيغة التحت اللسانية
• تربينات حية بنسبة 5%+
• توافق بطارية عالمية 510-Thread
• البدء: 1 إلى 2 دقيقة (أسرع طريقة توصيل قنبينويد)
• ذروة التأثيرات: 10 إلى 15 دقيقة
• المدة: 2 إلى 4 ساعات
• التوافر البيولوجي: 10 إلى 35 بالمائة (متغير، يعتمد على تقنية الاستنشاق)
• تفكيك THCa تلقائي عند درجة حرارة التبخير (400 إلى 450°F)

دليل RSO الكامل — دليل منتج OilWell الكامل بالعلم، التحليل التنافسي، البروتوكولات، ومعلومات الطلب.

التسعير والوصول للمغرب: بسعر 129.99 دولار للزيت التحت اللسانية (16,590 ملغ إجمالي القنبينويدات)، تكلفة الملغرام أقل بشكل كبير من معظم منتجات CBD المتوفرة في المغرب. لمقارنة، العديد من زيوت CBD في الأسواق المغربية تكلف 50-80 دولار لـ 500-1000 ملغ إجمالي القنبينويدات. يقدّم منتج OilWell 16-33 مرة أكثر قنبينويدات لكل دولار. بالنسبة لسوق المغرب الحساسة للسعر، عرض القيمة هذا حاسم.

متى تستخدم كل شكل

حالة الاستخدام	الشكل المُوصى به	المنطق
تخفيف سريع (ألم حاد، غثيان، ذعر)	التبخير	بدء 1-2 دقيقة
تخفيف مستدام (ألم مزمن، نوم)	التحت اللساني	مدة 4-6 ساعات
أقصى توفر بيولوجي	التحت اللساني	امتصاص 13-19%
قابلية النقل والتكتم	التبخير	مضغوط، لا يتطلب قياساً
تحكم دقيق في الجرعة	التحت اللساني	قطارة متدرّبة بزيادات 0.1 مل
استخدام نهاري غير نفساني	التحت اللساني (خام، بدون حرارة)	THCa يبقى غير نشط، ضعف ضعف
استخدام ليلي نفساني	التحت اللساني (مُفكَّك) أو التبخير	THCa المُفعَّلة + دلتا-8 THC

التكامل مع نمط الحياة المغربي: بالنسبة للمحترفين المغاربة العاملين في المنطقة المالية الدار البيضاء أو مكاتب الرباط الحكومية، خيار الزيت الخام يتيح الاستخدام نهاراً دون ضعف. بالنسبة لأولئك الذين يتعاملون مع ألم مزمن في المناطق الريفية مع وصول محدود للصيدلية، المدة الطويلة للزيت التحت اللسانية توفر تخفيفاً طوال اليوم. لنوبات الألم الحاد أو القلق، يوفر التبخير تخفيفاً سريعاً يطابق فورية تدخين الكيف التقليدي لكن مع جرع دقيقة.

مقارنة تنافسية — OilWell RSO مقابل البدائل

تُقدّم الجداول التالية مقارنات واقعية بين صيغة RSO الخاصة بـ OilWell ومنتجات RSO أخرى متوفرة في السوق. هذه المقارنات مبنية على مواصفات منتجات عامة وتُقدَّم للسياق الإعلامي.

OilWell RSO مقابل RSO صيدلية TCUP في تكساس (مثل Texas Original)

البُعد	RSO صيدلية TCUP	OilWell RSO
البروفيل القنبينويدي	THC فقط (حوالي 420 ملغ THC لكل 0.5 غرام حقنة)	7 قنبينويدات: CBD، CBG، دلتا-8 THC، THCa، دلتا-9 THC، CBN، CBC
محتوى CBG	0 ملغ	3,000 ملغ
محتوى CBN	0 ملغ	750 ملغ

ENGLISH

Rick Simpson Oil (RSO) in Morocco: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil in Morocco’s Evolving Cannabis Landscape

If you’re reading this in Casablanca, Marrakech, Tangier, or anywhere across Morocco, you’re likely connected to one of the world’s most complex cannabis stories. For generations, the Rif Mountains have produced some of the planet’s finest cannabis, yet until recently, accessing legal, standardized, medical-grade cannabis oil remained impossible for Moroccans seeking therapeutic relief. That landscape changed in 2021 when Morocco became the first North African nation to legalize medical cannabis and industrial hemp, creating the National Agency for Cannabis Regulation and Control (ANRACA). Yet the gap between traditional kif cultivation and modern, evidence-based cannabinoid medicine remains vast — a gap this document exists to bridge.

Morocco’s relationship with cannabis is ancient and layered. The traditional kif culture of the north, the economic realities of rural cultivation communities, the diaspora of Moroccans worldwide searching for legal therapeutic options, and the new medical cannabis framework all intersect here. Whether you’re a cancer patient in Rabat researching alternatives, a chronic pain sufferer in Fez exploring options beyond conventional pharmaceuticals, a veteran with PTSD in the Moroccan diaspora seeking relief, or a caregiver in Chefchaouen looking for evidence-based information — this guide is written for you.

We at OilWell Cannabis approach this with deep respect for Morocco’s unique position. We are not here to impose an American product on Moroccan soil. We are here to offer something that didn’t exist when Rick Simpson first began his crusade: a legal, lab-tested, multi-cannabinoid formula that honors the spirit of RSO while solving the problems that made Simpson’s original vision dangerous and unstandardized. Our formulas are open-source, our evidence is peer-reviewed, and our commitment is to education first — because in a market transitioning from informal traditional use to regulated medical cannabis, informed decisions save lives.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional. He was a power engineer and maintenance worker — a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and a constellation of post-concussion symptoms that conventional medicine could not adequately resolve. According to Simpson, the medications he was prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused .

Moroccan connection: This experience resonates deeply in Morocco, where many patients face similar challenges with the conventional medical system. In Moroccan communities from the Rif to Rabat, we’ve heard countless stories of people told there are no more options, prescribed medications that cause more harm than good, or denied access to cannabis-based therapies despite expressing interest. The frustration Simpson felt when his doctor dismissed cannabis mirrors what many Moroccans experience when discussing alternative treatments with healthcare providers who remain unfamiliar with or resistant to cannabinoid medicine.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement around concentrated cannabis oil.

Why this matters in Morocco: Morocco’s traditional kif culture includes countless anecdotal stories of cannabis helping with various ailments. The difference is that Simpson’s story became a global movement. For Moroccans navigating between traditional knowledge and modern medical expectations, understanding the distinction between personal testimony and clinical proof is essential. Your grandmother’s story about kif tea helping with arthritis is valuable cultural knowledge, but it’s not the same as a peer-reviewed clinical trial. Both have their place, but confusing them can be dangerous.

The crusade — spreading the oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil. Operating out of his property in Maccan, Nova Scotia, he began making the oil in large quantities and giving it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and others .

Localization for Moroccan communities: In the Rif region and other traditional cannabis-growing areas, the concept of sharing medicine within the community is deeply rooted. The idea of giving away healing oil to neighbors is not foreign to Moroccan culture. However, Simpson’s scale and the specific protocol he developed were unique. For Moroccans today, this history matters because it explains why RSO is associated with community healing rather than commercial profit — a value that resonates with Morocco’s own communal traditions.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, showed testimonials from people he had treated, and framed his work as a grassroots challenge to pharmaceutical and governmental interests. It was distributed freely online and became one of the most widely shared cannabis advocacy films of its era. Within cannabis communities, it was foundational — for many people, Run From The Cure was their introduction to the concept of concentrated cannabis oil as medicine .

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005, seizing plants and equipment. He was charged with cannabis cultivation, possession, and trafficking. Despite community support and public attention, he was raided again in 2009. He was acquitted on some charges but convicted on others. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, living in Croatia and later the Netherlands, where he continued his advocacy from abroad .

Moroccan parallel: Morocco’s own history with cannabis enforcement has been complex. The transition from strict prohibition to medical legalization in 2021 mirrors the global shift Simpson experienced. For Moroccans who lived through the era when cannabis cultivation could result in severe penalties, Simpson’s legal battles parallel local struggles. The difference is that Morocco is now building a legal framework — something Simpson fought for but never lived to see fully realized in his home country.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, a book detailing his personal experience, his oil-making process, and his broader philosophical views on cannabis, medicine, and institutional suppression. He also maintained phoenixtears.ca as his primary online platform for information and advocacy .

Throughout his public career, Simpson’s position remained consistent and uncompromising: he maintained that cannabis oil — particularly high-THC oil made according to his specific method — could cure cancer and many other diseases, and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect their financial interests. He framed his work not merely as health advocacy but as a fight against institutional corruption .

Important context: Simpson’s conspiratorial framing is noted here without endorsement or dismissal. It reflects a worldview shared by many in the early cannabis movement and is relevant to understanding why RSO became culturally significant. The evidence-based assessment of his specific medical claims follows in a later subsection.

Navigating this in Morocco: Morocco’s relationship with institutional authority is complex. Colonial history, economic challenges, and the transition to medical cannabis regulation have created legitimate skepticism among some Moroccans toward government and pharmaceutical institutions. While acknowledging these feelings, we must also recognize that Morocco’s new ANRACA framework represents progress — a legal pathway where none existed before. The goal is to navigate between blind trust and reflexive dismissal, focusing instead on what the evidence actually shows.

The traditional RSO protocol — Simpson’s 60-gram, 90-day regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver a total of 60 grams (approximately 60 mL) of concentrated cannabis oil over a period of roughly 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions. The following is a detailed breakdown of the protocol as Simpson described it .

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

What this means for Moroccan patients: For context, 60 grams is an enormous amount of cannabis extract. In traditional Moroccan kif culture, such quantities would be unthinkable for individual medical use. This scale reflects Simpson’s belief that massive dosing was necessary, a belief rooted in anecdotal experience rather than pharmacological science. For Moroccans exploring RSO, understanding this scale is critical — this is not a casual supplement regimen.

Titration schedule

• Week 1: Begin with a dose approximately the size of half a grain of dry rice — roughly 10 to 15 milligrams of oil — taken three times per day (morning, afternoon, and before bed). Total daily intake during this phase: approximately 30 to 45 milligrams. Simpson emphasized that the initial doses should be very small to allow the body to begin adjusting to the psychoactive effects of THC.

• Weeks 2 through 5: Double the dose approximately every four days. The purpose of the slow ramp-up was to build THC tolerance gradually and minimize disruption from the psychoactive effects. By the end of this escalation period — roughly four to five weeks in — the target was to reach approximately 1 gram (1,000 milligrams) of oil per day, divided into three roughly equal doses.

• Weeks 5 through 12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, and continue until the full 60 grams have been consumed. At this dosing level, the remaining 50-plus grams of oil would be consumed over the final seven to eight weeks.

Moroccan dosing reality check: This protocol means reaching 600-900mg of THC daily. For comparison, a typical Moroccan hash user might consume 50-100mg of THC in an entire day of heavy use. Simpson’s protocol delivers 6-9 times that amount. This is pharmacologically extreme and carries real risks that Moroccans must understand.

Administration methods

• Primary method — oral: Simpson recommended placing the dose directly under the tongue (sublingual) or swallowing it. He considered oral ingestion the most important route for systemic absorption and the primary method for internal cancers and other systemic conditions.

• Secondary method — topical: For skin cancers and external lesions, Simpson recommended applying the oil directly to the affected area, covering it with a bandage, and changing the bandage every three to four days. He combined topical application with oral dosing for skin cancers.

• Not recommended as primary — inhalation: Simpson did not recommend smoking or vaporizing the oil as a primary treatment method. He acknowledged inhalation for immediate symptom relief (pain, nausea) but maintained that the oral route was necessary for the sustained, high-dose exposure he considered therapeutically essential.

Cultural note for Morocco: Traditional Moroccan use centers on inhalation (kif smoked in a sebsi pipe). Simpson’s emphasis on oral dosing represents a fundamental departure from local practices. For Moroccans transitioning from traditional use to medical RSO, this is a critical learning point.

Tolerance and the psychoactive effects

• Simpson maintained that patients would develop significant tolerance to the psychoactive effects of THC within approximately three to four weeks of consistent dosing at escalating levels.

• He considered the euphoric, sedating, or disorienting effects a minor and temporary side effect and strongly urged patients not to let the high discourage them from continuing the protocol.

• He recommended that patients take their initial doses at night or before bed to sleep through the most intense psychoactive effects during the early titration phase.

• Simpson also recommended that patients avoid driving or operating machinery during the titration period and that they inform family members about what to expect.

Moroccan context on impairment: In Morocco, where road safety is already a major concern, the warning about avoiding driving while using RSO is especially critical. The protocol’s extreme psychoactive effects would make operating any vehicle or machinery extremely dangerous. This is not a casual recommendation — it’s a safety imperative.

Post-protocol maintenance

• After completing the full 60-gram course, Simpson recommended a maintenance dose of approximately 1 to 2 grams of oil per month, taken indefinitely.

• He considered this ongoing low-dose maintenance important for long-term health and cancer prevention.

• Simpson indicated that maintenance dosing was much lower than the treatment dose and that patients who had completed the full protocol would have sufficient THC tolerance to handle it comfortably.

Dietary and lifestyle recommendations

• Simpson also advocated for dietary changes alongside the oil protocol, including reducing sugar intake, avoiding processed foods, and improving overall nutrition.

• He was not specific or systematic about dietary protocols compared to his highly detailed oil protocol — dietary advice was secondary and general.

Important context for evaluating this protocol

This protocol was designed by one person based on his personal experience and anecdotal observations. It was not developed through clinical trials, dose-finding studies, pharmacokinetic modeling, or any formal research process. Several critical points apply:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or even well-documented case series evaluating this specific 60-gram/90-day protocol for any cancer type or any other condition.

• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content per gram of traditional RSO varied widely depending on the starting plant material and extraction technique.

• Very high THC exposure. At the peak dosing phase, patients were consuming roughly 1 gram of high-THC oil per day. Assuming traditional RSO contained 60 to 90 percent THC, this translates to approximately 600 to 900 milligrams of delta-9 THC per day — a dose far exceeding anything studied in controlled clinical settings. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 milligrams per day.

• Real risks at these doses. Consuming 600 to 900 milligrams of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in the GENERAL KNOWLEDGE section of this document [1][13][14][15].

• Oncology context. Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment — potentially in place of proven therapies — introduces harm that extends beyond the oil itself.

For Moroccan patients: Morocco’s oncology centers in Casablanca, Rabat, and Marrakech provide proven cancer treatments. While ANRACA has established a medical cannabis program, it is tightly controlled and specifically for certain conditions. Using traditional RSO at Simpson’s doses would fall outside both conventional oncology and the legal medical cannabis framework. This is not a theoretical risk — it’s a practical safety concern for Moroccan cancer patients.

What is traditional Rick Simpson Oil — the product

Traditional RSO refers to the specific type of concentrated cannabis oil that Simpson made and advocated for. It was defined not by lab specifications or regulatory standards but by his method and materials. The following describes the product as Simpson produced it .

Source material

Simpson used high-THC, indica-dominant cannabis strains. He specifically favored heavy, sedating indica genetics and generally recommended against sativa-dominant strains for cancer treatment, believing that indica strains produced better therapeutic outcomes. He grew his own cannabis or sourced it from growers he trusted. There was no strain standardization — the starting material varied by availability and growing season.

Moroccan cannabis heritage: Morocco’s Rif region produces world-renowned cannabis, traditionally harvested for hashish. However, these landrace strains are different from the modern high-THC indicas Simpson used. Moroccan traditional cannabis is typically lower in THC and rich in other cannabinoids. The concept of selecting specific genetics for medical purposes represents a modern departure from traditional Moroccan cultivation practices.

Extraction solvent

Simpson originally used naphtha — a petroleum-based solvent commercially available as lighter fluid, Varsol, or similar products. He later also endorsed 99 percent isopropyl alcohol as an acceptable alternative. He explicitly warned against using other solvents, including butane or acetone, due to safety and purity concerns. Neither naphtha nor isopropyl alcohol is a food-grade solvent, which is a significant safety issue discussed further below.

Safety warning for Moroccan DIY makers: In Morocco’s rural areas where some may still practice traditional extraction methods, naphtha and isopropyl alcohol are dangerous. Naphtha may contain benzene and other carcinogens. Morocco’s new medical cannabis regulations require food-grade extraction methods. Traditional methods, while culturally significant, carry real health risks that modern, legal products eliminate.

Extraction process

1. Dry or semi-dry cannabis plant material was placed in a container (typically a bucket).
2. The material was covered with solvent and agitated or stirred for several minutes to dissolve cannabinoids and other fat-soluble compounds from the plant.
3. The solvent was poured off through a filter, typically cheesecloth or a similar mesh material, into a separate collection vessel.
4. The process was repeated a second time with fresh solvent on the same plant material to extract remaining cannabinoids.
5. The combined solvent washes — now a dark, cannabinoid-rich liquid — were placed in a rice cooker or similar open-vessel heating device.
6. The solvent was evaporated at relatively low heat. Simpson recommended a rice cooker specifically because it maintains a temperature range that evaporates the solvent without exceeding the point at which cannabinoids degrade significantly. However, this temperature was still high enough to decarboxylate THCa into THC and to destroy most volatile terpenes.
7. As the solvent evaporated, a thick, dark oil remained at the bottom of the vessel.
8. The final oil was transferred into oral syringes for storage and dosing.

Appearance and physical characteristics

Traditional RSO was an extremely dark — nearly black — thick, viscous, tar-like oil. It had a strong cannabis odor and could carry a faint solvent-residual smell depending on how thoroughly the solvent was purged. The consistency was sticky and difficult to handle at room temperature but became more fluid when warmed slightly.

Visual comparison for Moroccan consumers: Traditional Moroccan hashish is a solid, pressed resin. Traditional RSO is a thick oil. If you’re seeing a product labeled “RSO” in Morocco that looks like hash, it’s not traditional RSO. OilWell’s modern formula is a refined oil in an MCT carrier — cleaner, more stable, and easier to dose than the tar-like original.

Cannabinoid profile

• Primarily decarboxylated delta-9 THC. The heat involved in solvent evaporation converted essentially all THCa in the extract into delta-9 THC. Traditional RSO was therefore an activated, THC-dominant product.

• Naturally occurring minor cannabinoids. Whatever CBD, CBN, CBC, CBG, and other minor cannabinoids the source strain contained were present at their natural ratios, but these were not controlled, measured, or targeted.

• No ratio control. There was no ability to adjust or standardize specific cannabinoid ratios. The profile was entirely determined by the genetics and growing conditions of the source plant.

• Estimated THC content. Depending on starting material, traditional RSO likely ranged from approximately 60 to 90 percent total THC by weight, though this was never lab-verified in the traditional production context.

Terpene content

Minimal to none. The combination of solvent extraction (which dissolves terpenes into the solvent along with cannabinoids) and the subsequent high-heat evaporation process (which volatilizes terpenes at temperatures well below cannabinoid degradation thresholds) meant that traditional RSO was effectively stripped of its terpene content.

The Moroccan terpene connection: Traditional Moroccan hashish retains more terpenes than Simpson’s RSO because it’s processed with less heat. The loss of terpenes in traditional RSO represents a major limitation that modern formulations specifically address. OilWell’s formula includes live terpenes at 5% because we understand that these aromatic compounds contribute to both the experience and potential therapeutic effects.

Standardization and testing

None. Every batch of traditional RSO was different because it depended entirely on the starting plant material, growing conditions, solvent purity, extraction technique, evaporation temperature and duration, and the individual maker’s process. Simpson operated before cannabis legalization and the standardized lab-testing infrastructure that came with it. There was no Certificate of Analysis, no cannabinoid quantification, and no contaminant screening.

Moroccan regulatory context: Under Morocco’s new medical cannabis law, all products must be tested and standardized. ANRACA requires rigorous quality control. Traditional RSO could never meet these standards. This is not a minor improvement — it’s the difference between a pre-industrial remedy and modern medicine.

Residual solvent risk

This is one of the most significant safety concerns with traditional RSO production. Naphtha and isopropyl alcohol are not food-grade solvents. Naphtha in particular is a complex mixture of petroleum hydrocarbons that may contain benzene, toluene, and other compounds classified as toxic or carcinogenic. Incomplete solvent purging — which is very difficult to verify without analytical chemistry equipment — leaves potentially harmful residues in the finished oil.

Modern extraction methods use food-grade ethanol or supercritical carbon dioxide (CO₂) specifically to address this problem. This is one of the most straightforward improvements that the modern regulated cannabis industry has made over the traditional RSO production model.

Critical for Moroccan consumers: Morocco’s informal market sometimes still uses solvent-based extraction methods. The risk of residual solvents is real and documented. If you’re obtaining oil through informal channels in the Rif or elsewhere, you have no way to verify solvent purging. OilWell’s solvent-free production eliminates this risk entirely.

This evolution connects directly to the product-quality discussion in the GENERAL KNOWLEDGE section of this document, which emphasizes that product quality matters as much as molecule identity and that labeling inaccuracies, contamination, synthesis byproducts, and dose variability all materially affect interpretation in real-world products [1][10][11][14].

Simpson’s claims vs. the evidence record

Rick Simpson made expansive therapeutic claims about his oil. He stated that RSO could cure cancer — including terminal cases — and that it was effective against diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, multiple sclerosis, and numerous other conditions. He was adamant, consistent, and public about these claims throughout his advocacy career .

It is important to evaluate these claims against the actual evidence base, using the same standards applied throughout this document.

What Simpson was not

Simpson was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted his results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and testimonials gathered informally — with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the preclinical literature shows

The preclinical cannabinoid-cancer literature does exist, and it is scientifically interesting:

• In vitro studies have demonstrated that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis (blood vessel formation that feeds tumors) in certain cancer cell lines .

• Animal model studies have shown some tumor-growth inhibition in mice and rats treated with cannabinoids .

• These findings have generated legitimate scientific interest and ongoing research.

What the preclinical literature does not show

• These findings have not translated into proven human cancer cures. The gap between in vitro or animal results and human clinical outcomes is vast, well-documented across all of oncology research, and especially relevant here.

• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.

• Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been conducted, but they have been exploratory, small, and have not produced the kind of results that would support cancer-cure claims .

Institutional positions

• The U.S. National Cancer Institute (NCI) acknowledges that cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as a cancer treatment .

• The U.S. Food and Drug Administration (FDA) has not approved any cannabis plant product for the treatment of cancer. The only FDA-approved cannabinoid-related products are for other specific indications: Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting [1].

• Health Canada has never approved RSO or cannabis oil as a cancer cure.

• NCCIH explicitly states that the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea and vomiting, and appetite or weight-loss indications associated with HIV/AIDS — not cancer cure [1].

• Morocco’s institutional position: Morocco’s ANRACA has not approved any cannabis oil product for cancer treatment. The medical cannabis program is limited to specific conditions under strict medical supervision. Any claim that RSO can cure cancer is not supported by Moroccan health authorities.

What Simpson got right

Simpson drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring or actively suppressing that conversation. His advocacy — however scientifically imprecise — helped create the political, cultural, and social conditions for the legal cannabis industry and the cannabinoid research infrastructure that exists today. He was among the first to bring concentrated cannabis oil to widespread public awareness, and the term RSO itself remains the most recognized name for full-spectrum cannabis extract in the consumer vocabulary. These contributions are real and historically significant.

What he overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients — particularly cancer patients — to rely on RSO as a primary treatment in place of proven oncologic therapies (surgery, radiation, chemotherapy, immunotherapy) carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in the alternative-medicine literature. Simpson’s absolute certainty about curative claims, while understandable from a personal-experience perspective, exceeded what the evidence could support and still exceeds it today.

For Moroccan cancer patients: Morocco’s oncology infrastructure in Casablanca, Rabat, and Marrakech provides proven treatments. While medical cannabis is now legal under ANRACA, it is explicitly designed to complement conventional treatment, not replace it. If you are considering cannabis oil as part of your cancer strategy, you must coordinate with your oncology team at institutions like the National Institute of Oncology in Rabat or the oncology departments at University Hospital Ibn Rochd in Casablanca.

The legacy of Rick Simpson and the evolution of modern RSO

The term RSO is now used broadly — and often loosely — across the legal cannabis industry. Many products labeled as RSO bear little resemblance to what Simpson originally made. In dispensaries today, RSO can refer to almost any full-spectrum cannabis extract sold in a syringe format, regardless of extraction method, cannabinoid profile, terpene content, or intended use. The term has become generic .

Simpson himself has been critical of commercial products that use the RSO name while departing significantly from his original method and philosophy. He has publicly stated that many products sold as RSO do not meet his standards and that the commercialization of cannabis oil contradicts his original intent. Simpson’s model was explicitly anti-commercial — he gave the oil away for free and urged others to make their own rather than buy from companies .

This philosophical tension is worth acknowledging. Simpson believed in a do-it-yourself, free-access model in which anyone could grow cannabis, extract the oil, and treat themselves or their loved ones without corporate or governmental intermediaries. The modern cannabis industry has done something very different: it has commercialized, standardized, and regulated what Simpson distributed for free.

Moroccan perspective on this tension: Morocco is navigating this exact tension right now. Traditional cultivators in the Rif have grown cannabis for generations as a communal, informal activity. Now ANRACA is creating a regulated, commercial medical cannabis industry. The question of whether this represents improvement (safety, standardization, medical credibility) or betrayal (loss of traditional access, corporate control, regulatory barriers) is actively debated in Moroccan cannabis circles. OilWell’s position is that both can coexist: we offer a professionally manufactured, tested product while publishing the complete formula for those who want to make their own.

What is not in dispute is that modern RSO has evolved substantially from its origins, and those changes are directly relevant to the formulas in this document.

Traditional RSO vs. modern formulated RSO

The following table summarizes the key differences between traditional RSO as Simpson defined it and the modern formulated approach used in OilWell’s products.

Dimension	Traditional RSO	OilWell formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available or performed	Full panel testing
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — THCa included as a separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

How this applies to Morocco’s market: If you’re evaluating RSO products available in Morocco — whether through ANRACA-licensed channels or informal sources — this table is your checklist. Does the product list exact cannabinoid amounts? Is it lab-tested? Does it preserve THCa? Does it include terpenes? Traditional RSO cannot meet these standards. Modern formulated RSO can.

Why OilWell’s formulas diverge from traditional RSO

OilWell’s formulations are not traditional RSO. They are informed by the RSO tradition but depart from it in several deliberate, evidence-motivated ways.

• Multi-cannabinoid approach. Traditional RSO relied on whatever single strain the maker grew or sourced. OilWell’s formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

• Terpene preservation and addition. Traditional RSO had essentially no terpene content due to solvent and heat destruction. OilWell includes live terpenes at 5 percent with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible and supported at the preclinical level, even if human clinical confirmation for cannabis-specific terpene effects is still developing [20][21][23][24][25][26][27][28][29].

• THCa as a separate ingredient. Traditional RSO fully decarboxylated everything, converting all THCa into delta-9 THC. OilWell’s sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

• Reduced delta-9 THC dominance. Traditional RSO was overwhelmingly delta-9 THC — often 60 to 90 percent of total cannabinoid content. OilWell’s sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining cannabinoid content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg). This reflects the broader cannabinoid research landscape rather than a single-compound dominance model.

• Product format innovation. Simpson envisioned only one format: an oral oil administered from a syringe. OilWell offers both a 30 mL sublingual oil and a 1-gram vape cartridge, each with its own format-specific formulation acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Solvent safety and extraction evolution

Traditional RSO production used naphtha or isopropyl alcohol — neither of which is food-grade. Naphtha is a complex petroleum hydrocarbon mixture that may contain benzene, toluene, xylene, and other compounds classified as toxic or carcinogenic. Incomplete solvent purging — which is very difficult to verify without analytical chemistry equipment — leaves potentially harmful residues in the finished oil.

Modern cannabis extraction overwhelmingly uses food-grade ethanol or supercritical carbon dioxide (CO₂). These methods allow for much more complete solvent removal, and the finished products can be tested for residual solvents using validated analytical methods such as headspace gas chromatography. This is one of the most straightforward improvements that the modern regulated cannabis industry has made over the traditional RSO production model.

This evolution connects directly to the product-quality discussion in the GENERAL KNOWLEDGE section of this document, which emphasizes that product quality matters as much as molecule identity and that labeling inaccuracies, contamination, synthesis byproducts, and dose variability all materially affect interpretation in real-world products [1][10][11][14].

Moroccan regulatory alignment: Morocco’s medical cannabis law requires GMP-standard production with food-grade extraction methods. Traditional solvent-based methods would not meet ANRACA licensing requirements. This is why modern formulated RSO represents not just an improvement, but a necessity for legal medical markets like Morocco’s.

The decarboxylation question

Traditional RSO was fully decarboxylated. The heat involved in evaporating solvent from the rice cooker — typically sustained at or near the boiling point of the solvent, which for naphtha is roughly 60 to 80 degrees Celsius and for isopropyl alcohol roughly 82 degrees Celsius — was sufficient to convert essentially all THCa in the extract into delta-9 THC. This conversion is thermodynamically favored and proceeds readily at these temperatures over the durations involved in solvent evaporation.

As a result, the acidic cannabinoids that exist abundantly in raw cannabis plant material — including THCa, CBDa, CBGa, and others — were lost as distinct compounds in traditional RSO. The finished oil was a decarboxylated, activated product dominated by neutral (non-acidic) cannabinoids.

OilWell’s sublingual formula deliberately preserves THCa at 1,500 mg as a separate ingredient. This is an intentional formulation choice informed by the THCa evidence profile in the GENERAL KNOWLEDGE section, which notes that THCa itself does not produce the psychoactive effects associated with THC but that its interpretation depends on route, temperature, processing, and storage — because THCa can convert to THC under heating or over time [12].

Patient control in Morocco: For Moroccan consumers, this creates legal flexibility. The product contains less than 0.3% delta-9 THC at purchase, making it compliant with both U.S. Farm Bill and potentially importable to Morocco under certain hemp product provisions. If you choose to decarboxylate it, you activate the full potency — but that choice, and the legal responsibility, remains yours.

Terpene loss in traditional RSO

Terpenes are volatile aromatic compounds with relatively low boiling points. Most cannabis terpenes begin to volatilize at temperatures between 21 and 157 degrees Celsius, with many of the most abundant terpenes — including myrcene, limonene, and pinene — having boiling points below 180 degrees Celsius. The traditional RSO production process destroyed terpenes in two ways: first, by dissolving them into the solvent wash along with cannabinoids; and second, by evaporating them off during the high-heat solvent-removal phase.

This meant that traditional RSO was essentially a cannabinoid-only product, despite being derived from a terpene-rich plant. Whatever aromatic, flavoring, or potentially bioactive terpene compounds the source cannabis contained were lost in production.

OilWell’s formulas specify live terpenes at 5 percent with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each of these terpenes has its own evidence profile discussed in the GENERAL KNOWLEDGE section. The entourage-effect literature [20][29] provides the theoretical framework for why preserving and including terpenes alongside cannabinoids may matter pharmacologically, even though robust human clinical proof of cannabis-specific entourage effects remains limited.

Moroccan sensory connection: These terpenes evoke familiar scents — limonene from citrus groves of the Souss Valley, pinene from the Atlas cedar forests, linalool from lavender markets, caryophyllene from black pepper spice souks. The terpene profile makes the product experience both medically sophisticated and culturally resonant.

Evidence standards then and now

Rick Simpson operated in a pre-legalization, pre-lab-testing era. When he began making and distributing oil in the early 2000s, cannabis was illegal in Canada and throughout most of the world. There was no regulatory framework for cannabis products, no standardized testing infrastructure, no legal pathway for clinical research on cannabis oil protocols, and no peer-reviewed journals dedicated to cannabis therapeutics. The cannabis underground was the only access point, and personal experience was the primary evidence currency.

Simpson’s methods reflected the constraints of that era. His evidence was anecdotal. His production was unstandardized. His claims were untested in any formal sense. This is not necessarily a moral failing — it is a description of the environment in which he operated.

This document takes a fundamentally different approach. The GENERAL KNOWLEDGE section applies a formal evidence hierarchy: human clinical evidence first, then systematic reviews and meta-analyses, then institutional summaries, then preclinical and mechanistic literature [1]-[29]. Every compound-level claim is tied to specific peer-reviewed sources with evidence strength clearly labeled. The intent is to honor the historical origin of RSO while committing to the standards of modern cannabinoid science. Where Simpson relied on personal testimony, this document relies on published literature and institutional sources.

Morocco’s evidence journey: Morocco is building its medical cannabis program on modern scientific standards. ANRACA requires clinical trial data, standardized products, and evidence-based applications. This document provides exactly the kind of rigorous product information that aligns with Morocco’s regulatory vision.

Simpson’s protocol vs. modern dosing considerations

Simpson’s 60-gram/90-day protocol was designed around a crude, single-strain, THC-dominant extract with no standardized potency. A direct comparison between Simpson’s dosing recommendations and dosing with a modern, standardized, multi-cannabinoid formulation is not straightforward — the products are fundamentally different.

Several key differences illustrate why:

• Cannabinoid concentration. OilWell’s sublingual formula delivers 553 mg of total active cannabinoids per mL across seven defined compounds. Traditional RSO potency was unknown and variable.

• Cannabinoid ratios. Simpson’s oil was approximately 60 to 90 percent delta-9 THC. OilWell’s formula distributes 16,590 mg of total cannabinoids across CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), and CBC (750 mg) — a completely different pharmacologic profile.

• Terpene presence. Simpson’s oil had no terpenes. OilWell’s formula includes live terpenes at 5 percent, which may influence absorption, effect, and tolerability.

• Delta-9 THC exposure. Simpson’s protocol at peak dosing delivered approximately 600 to 900 mg of delta-9 THC per day. OilWell’s sublingual formula contains only 90 mg of delta-9 THC in the entire 30 mL bottle (3 mg per mL), making the per-dose delta-9 THC exposure dramatically lower.

Future dosing guidance for OilWell products should be developed independently of Simpson’s protocol, informed by the per-compound evidence in the GENERAL KNOWLEDGE section and by responsible titration principles that account for the safety profile of each individual cannabinoid. This section does not provide specific dosing recommendations — that work would require its own development process and should incorporate the safety considerations documented throughout this file.

Moroccan dosing reality: For Moroccan patients, this means starting with modern, standardized doses — not Simpson’s extreme protocol. Begin with 0.25-0.5 mL of OilWell’s sublingual oil and assess effects over 2-3 hours. The graduated dropper allows precise measurement. This is fundamentally different from Simpson’s “grain of rice” approximation.

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen is a city of contrasts — vibrant culture and a thriving retail sector, yet deeply affected by poverty and limited opportunities outside of the retail and healthcare industries. Reynosa, on the other hand, is an industrial hub plagued by violence and cartel activity, making it a harsh environment for anyone growing up there.

Parallels to Morocco’s border regions: This experience resonates with Moroccan communities near borders — the Algerian border in the east, the Spanish enclaves of Ceuta and Melilla in the north, and the Western Sahara border regions. The economic desperation, limited opportunities, and complex relationships with informal economies that Colin experienced mirror challenges faced by young people in Morocco’s border provinces like Oujda, Nador, and Tétouan.

Colin’s childhood in McAllen was marked by exposure to both the opportunities and the challenges of life along the border. Early on, he learned to hustle, taking on risky work in transporting items across the border for various groups. Those early experiences exposed him to the complexities and dangers of that region. A lot of his best friends have been killed or are in prison because of the associated dangers. He has faced every form of violence imaginable, both in the streets and across the border. By sixteen, one way or another, he had to leave home for good.

Despite the dangers, Colin did not fall into the darkest paths available to him, like selling harder substances. Instead, he focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — would eventually define OilWell’s approach.

Why this matters for Moroccan consumers: Morocco’s medical cannabis program under ANRACA requires exactly this combination: deep plant knowledge plus medical-grade precision. Traditional cultivators in the Rif have generations of plant knowledge but lack formal medical and technical training. Colin’s background shows that these two worlds can be bridged — that someone can come from the informal cannabis world and build a legitimate medical-grade operation.

The company’s origin story begins with a dog named Bentley. Bentley was more than just a pet — he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said the pain medications would destroy his internal organs, causing him more pain and suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. Colin had already faced too much loss and seen too much suffering in his life. Bentley was a fighter, just like him, and Colin was not ready to let him go. In a desperate search for alternatives, he stumbled upon the healing properties of CBD — through a question that changed everything.

A kind-hearted rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational. Getting high. He had never explored the therapeutic and medicinal applications. Jessica’s question exposed a blind spot that would become a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It was not a cure, but it was a lifeline — and it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. It was a miracle. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Moroccan cultural resonance: In Morocco, the bond between people and animals — especially working animals in rural areas — is profound. The idea of saving a beloved companion when conventional medicine fails speaks to universal values that transcend culture. For Moroccan pet owners in Casablanca, Rabat, or rural villages who’ve faced similar situations with their animals, Bentley’s story demonstrates that cannabinoid medicine works beyond human psychology.

Bentley lived another ten years, passing naturally at age twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

The multi-cannabinoid insight for Morocco: This directly addresses why OilWell’s formula contains seven cannabinoids. It’s not marketing — it was born from necessity. Moroccan patients with complex conditions (cancer, chronic pain, multiple symptoms) often find that single-cannabinoid CBD products help somewhat but don’t address everything. The multi-cannabinoid approach acknowledges that human health is complex and requires multiple pathways of support.

Bentley’s journey was Colin’s entry into the world of cannabis beyond just getting high. It became a mission to create real solutions that help alleviate pain and suffering, not just for pets but for people as well. Bentley’s story is the foundation of OilWell Cannabis, driving its commitment to quality, innovation, and compassionate care.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — a feat that is notoriously difficult and dangerous — using the cannabinoid knowledge he had developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

PTSD and trauma in Morocco: Morocco has significant populations dealing with trauma — veterans, survivors of regional conflicts, victims of violence, refugees. The mental health system in Morocco is under-resourced, and benzodiazepine prescription rates have been rising. Colin’s personal experience with PTSD and benzo withdrawal provides a model for Moroccans seeking alternatives to addictive pharmaceuticals.

Over time, the therapeutic benefits of cannabis that Colin first discovered through his efforts to save Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

Integration with Moroccan healthcare: While Morocco’s medical cannabis program is still developing, there are progressive physicians in cities like Casablanca and Rabat who are beginning to explore cannabinoid therapy. OilWell’s physician-use documentation (doctors using these formulas for IBS, Crohn’s, PTSD) provides credibility that Moroccan doctors can evaluate.

ABC13 KTRK Houston — Houston’s number-one news source — featured Colin Valencia and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023, covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage in America’s fourth-largest city.

Media credibility for Moroccan consumers: While ABC13 is a Houston station, this media record demonstrates third-party validation that transcends geography. For Moroccan consumers wary of online scams and unverified products, this level of mainstream media coverage from a major U.S. city is a powerful trust signal that most cannabis companies cannot provide.

Colin’s quote from the first ABC13 feature in September 2019 captures the OilWell philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). The company has been operating since 2019, generates approximately one million dollars in annual revenue, maintains a near-5.0 Google rating, and is Texas DSHS licensed. OilWell’s products are not mass-produced — they are carefully crafted with a personal touch, from the artwork on the packaging to the formulations inside. All artwork, formulations, and packaging are created in-house in Houston, using only OilWell’s own recipes and ideas. Colin brings Houston grit, McAllen roots, and a builder’s mindset to the company, but the posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

Operational transparency for Moroccan buyers: These verifiable details — physical address, licensing, revenue, Google rating — distinguish OilWell from anonymous online sellers that Moroccan consumers may encounter. In a market where counterfeit products are common, this level of transparency matters.

The OilWell RSO philosophy

OilWell’s RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in ways that are deliberate, evidence-motivated, and designed to solve the problems that limited Rick Simpson’s original vision.

Four core principles define OilWell’s approach, each aligning with and evolving Simpson’s original ethos:

1. Accessibility over gatekeeping. No medical card is required. Anyone age twenty-one or older can purchase. OilWell ships nationwide across the United States and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; OilWell built a product and distribution model that makes that accessible legally.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. The customer decides whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; OilWell engineered a product that puts that control in the customer’s hands through chemistry rather than rhetoric.

3. Open-source formulas. OilWell publishes their complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford the product can source ingredients and make their own version. Simpson gave his oil away for free and taught people how to make it; OilWell adapted that ethos for the modern cannabinoid marketplace by selling a professionally manufactured product and publishing the recipe.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section in this document represents OilWell’s commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature or clinical trial data; OilWell has that access and uses it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill compliance and the THCa legal framework

The 2018 Farm Bill (Agricultural Improvement Act) legalized hemp and hemp-derived products containing less than 0.3 percent delta-9 THC by dry weight at the federal level in the United States. This legal framework is the foundation of OilWell’s RSO product design.

OilWell’s RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3 percent threshold. All cannabinoids in the formula are hemp-derived. The product is legal under federal law and in most states.

THCa — tetrahydrocannabinolic acid — is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

The practical significance of this framework is substantial. The customer can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC in the formula, this produces approximately 1,405 milligrams of total delta-9 THC — giving the product psychoactive potency comparable to traditional illegal RSO, entirely at the customer’s discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). The customer controls the decision. The product is legal everywhere all component cannabinoids are legal, which enables international shipping to jurisdictions where hemp-derived products with less than 0.3 percent delta-9 THC are permitted.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with their local laws regarding cannabinoid products. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

Moroccan legal context: Morocco’s 2021 medical cannabis law established ANRACA to regulate all cannabis activities. While medical cannabis is legal, recreational use remains prohibited. Hemp-derived products with less than 0.3% THC may be importable under certain circumstances, but Moroccan law is still evolving. Before ordering, verify current regulations with ANRACA. OilWell provides complete documentation, but the buyer assumes responsibility for customs clearance and legal compliance in Morocco.

Open-source formulas — why OilWell publishes everything

OilWell publishes their complete RSO formulas — every cannabinoid, every milligram amount, every percentage — in public documents including this one. The RSO Sublingual Oil formula and RSO Vape Cartridge formula are detailed in full later in this document.

The rationale is straightforward: if someone cannot afford OilWell’s products — $129.99 for the sublingual oil, $49.99 for the vape cartridge — they can see exactly what the formula contains, source the individual cannabinoid distillates and isolates, and make their own version. The formulas in the RSO Sublingual Oil and RSO Vape Cartridge sections of this document are the open-source formulas.

This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. He never patented his method. He never charged patients. OilWell adapted that ethos for the modern cannabinoid marketplace: they sell a professionally manufactured, lab-tested, standardized product for those who want it, and they publish the complete recipe for those who want to make it themselves.

As Colin Valencia said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Economic accessibility for Morocco: In a country where the average monthly income is significantly lower than in the U.S., price matters. The open-source formula means that a Moroccan patient who cannot afford $129.99 can still access the exact formula. While ANRACA’s regulations may limit home production, the principle of accessibility remains powerful. For Moroccan entrepreneurs interested in entering the legal medical cannabis space under ANRACA licensing, these formulas provide an evidence-based starting point for product development.

The open-source philosophy did not start with RSO — it started with Bentley. On the About Us page, Colin published the actual CBD golden paste recipe that saved Bentley’s life, so that any pet owner facing a similar crisis could make it themselves:

CBD golden paste recipe for pets — the original open-source formula

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on the size and needs of the pet; consult with a veterinarian)

Instructions:

1. Mix the turmeric and water. In a saucepan, combine the turmeric powder and water, stirring over low heat. Stir continuously until it forms a thick paste. This should take about 7 to 10 minutes. Add a little more water if it becomes too thick.

2. Add the coconut oil and pepper. Once you have a thick paste, add the coconut oil and freshly ground black pepper. Stir until all ingredients are thoroughly mixed.

3. Cool and store. Allow the paste to cool, then transfer it to a jar with a lid. Store it in the refrigerator for up to two weeks.

4. Dosage. Add a small amount of CBD oil to the paste before giving it to the pet, adjusting the dosage based on their weight and health needs. Start with a low dose and gradually increase as needed.

Serving suggestion: Mix a small amount of the golden paste with the pet’s food once or twice a day. Monitor the pet for any changes and consult with a veterinarian if there are any concerns. Always consult with a veterinarian before starting any new supplement regimen for a pet.

This recipe — published for free, years before the RSO formulas were open-sourced — demonstrates that the pattern is consistent. Colin gave away the formula that saved Bentley before he gave away the formula designed for people. The open-source ethos is not a marketing strategy. It is the foundational behavior of the company.

The decarboxylation choice — patient-controlled potency

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving the patient with no choice about psychoactivity — the oil was always psychoactive.

OilWell’s sublingual formula contains 1,500 milligrams of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for the customer:

Option 1 — Raw, no heat. All 1,500 milligrams stays as THCa — completely non-psychoactive. The THCa evidence profile in the GENERAL KNOWLEDGE section describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving, and daytime use with zero psychoactive impairment.

Option 2 — Fully activated, home decarboxylation. Heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC already in the formula, this yields approximately 1,405 milligrams of total delta-9 THC. Combined with 6,000 milligrams of delta-8 THC, the activated product achieves psychoactive potency comparable to traditional high-THC RSO — 100 percent legally, because decarboxylation occurs at the customer’s discretion after purchase. The customer may also transfer a controlled portion of the oil from the original bottle into a second empty oven-safe glass container, decarboxylating only what they intend to use and preserving the remainder in its raw THCa form.

Option 3 — Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400 to 450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 milligram THCa = 0.877 milligrams delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

This design puts the potency decision entirely in the customer’s hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry rather than a one-size-fits-all approach.

Moroccan cultural fit: This patient-controlled approach respects the traditional Moroccan value of self-determination in healthcare. It also addresses a practical reality: Moroccan workplace culture, Islamic prayer obligations, and family responsibilities may require functional clarity during the day and therapeutic intensity at night. The ability to use the same product both ways is revolutionary.

Solvent-free production

OilWell’s RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in the finished product.

This approach eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production, as discussed in the Rick Simpson section of this document.

The product uses organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile — a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through the OilWell website.

Quality assurance for Morocco: Under ANRACA regulations, all medical cannabis products must have full COAs. OilWell’s testing protocol meets or exceeds these requirements: potency testing via HPLC/UHPLC (±2% accuracy), heavy metals screening via ICP-MS (arsenic, cadmium, lead, mercury), pesticide analysis (400+ compounds), residual solvents below FDA Class 3 limits (<5,000 ppm), and comprehensive microbial testing including E. coli, Salmonella, and Aspergillus. This is the documentation Moroccan customs and health authorities expect.

The broader OilWell product portfolio

Beyond RSO, OilWell Cannabis produces a range of cannabinoid products, each developed from the formulation knowledge Colin built over Bentley’s ten-year journey and his own experience with PTSD and benzo withdrawal.

Asshole Peach — OilWell’s most popular product. Asshole Peach is a carefully formulated experience designed to provide a euphoric, long-lasting sensation. It is particularly favored by veterans for its ability to relieve pain and PTSD symptoms without being overly aggressive.

Peace Gummies — Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. Peace Gummies helped him quit Xanax cold turkey. The formula is also available in a vape form for quick relief — Colin personally uses the vape to manage his insomnia and severe PTSD on an ongoing basis.

Custom creations — OilWell offers custom-made products tailored to the specific needs of individual customers. Whether it involves specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances, OilWell designs targeted products on request. This includes formulations for vegans, diabetics, and those with specific dietary or health needs.

Veteran connection for Morocco: Morocco has a significant veteran population from various conflicts, as well as security forces dealing with PTSD. The fact that Asshole Peach is specifically favored by veterans for PTSD management is directly relevant to Moroccan military and security communities. Peace Gummies’ origin story — quitting Xanax cold turkey — speaks to the growing benzodiazepine problem in Morocco’s urban centers.

Two product formats

OilWell offers the RSO formula in two delivery formats, each designed for different use cases and pharmacokinetic profiles.

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15 to 45 minutes (sublingual absorption through oral mucosa)
• Peak effects: 1 to 2 hours
• Duration: 4 to 6 hours
• Bioavailability: 13 to 19 percent (sublingual route partially bypasses first-pass liver metabolism)
• Approximately 40 to 60 doses per bottle depending on serving size

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual formula
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1 to 2 minutes (fastest cannabinoid delivery method)
• Peak effects: 10 to 15 minutes
• Duration: 2 to 4 hours
• Bioavailability: 10 to 35 percent (variable, dependent on inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400 to 450°F)

Complete RSO Guide — OilWell’s full product guide with science, competitive analysis, protocols, and ordering information.

Pricing and accessibility for Morocco: At $129.99 for the sublingual oil (16,590mg total cannabinoids), the cost per milligram is significantly lower than most CBD products available in Morocco. For comparison, many CBD oils in Moroccan markets cost $50-80 for 500-1000mg total cannabinoids. OilWell’s product delivers 16-33 times more cannabinoids per dollar. For Morocco’s price-sensitive market, this value proposition is critical.

When to use each format

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring required
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw, no heat)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Moroccan lifestyle integration: For Moroccan professionals working in Casablanca’s financial district or Rabat’s government offices, the raw sublingual option allows daytime use without impairment. For those dealing with chronic pain in rural areas with limited pharmacy access, the long duration of sublingual oil provides all-day relief. For acute breakthrough pain or anxiety attacks, the vape offers rapid relief that mirrors the immediacy of traditional kif smoking but with precise dosing.

Competitive comparison — OilWell RSO vs. alternatives

The following tables present factual comparisons between OilWell’s RSO formula and other RSO products available on the market. These comparisons are based on publicly available product specifications and are presented for informational context.

OilWell RSO vs. Texas TCUP dispensary RSO (e.g., Texas Original)

Dimension	TCUP dispensary RSO	OilWell RSO
Cannabinoid profile	THC-only (approx. 420 mg THC per 0.5 g syringe)	7 cannabinoids: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
CBG content	0 mg	3,000 mg
CBN content	0 mg	750 mg
CBC content	0 mg	750 mg
Patient-controlled potency	No — always fully psychoactive	Yes — THCa non-psychoactive until heated by customer
Access requirements	TCUP medical card with qualifying condition	Age 21+ only, no medical card required
Qualifying conditions	Cancer, PTSD, epilepsy, autism, terminal illness, ALS, MS, seizure disorders, incurable neurodegenerative diseases	None required
Delivery	Must travel to physical dispensary location	Same-day delivery Houston, nationwide and international shipping
Farm Bill compliant	No — state medical cannabis program	Yes — less than 0.3% delta-9 THC

OilWell RSO vs. hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total cannabinoids	1,000 mg	16,590 mg
CBD content	Approximately 950 mg	4,500 mg
CBG content	15.5 mg	3,000 mg
CBN content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible to delta-9 THC)	Minimal	1,500 mg (converts to approximately 1,315 mg delta-9 THC)
Psychoactive option	No meaningful psychoactive effect	Yes — via THCa decarboxylation and delta-8 THC
Approximate price	$40 to $50	$129.99

OilWell RSO vs. traditional illegal RSO — This comparison is presented in the Traditional RSO vs. modern formulated RSO table in the ABOUT RICK SIMPSON section above. Refer to that table for the full eleven-dimension comparison.

What this means for Moroccan consumers: In Morocco’s emerging medical cannabis market, you’ll encounter products at different price points and quality levels. The Texas TCUP comparison shows what a restrictive medical program looks like (limited cannabinoids, medical card required). The Lazarus comparison shows what a basic CBD-dominant product offers. OilWell provides more total cannabinoids, more variety, and psychoactive options — all without requiring a medical card. For Moroccans who don’t yet have access to ANRACA’s limited medical program, this is a legal alternative.

Condition-specific usage context

Important disclaimer: The following usage contexts are informed by cannabinoid research cited in the GENERAL KNOWLEDGE section of this document and by OilWell’s formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Additional Moroccan disclaimer: These products are not approved by Morocco’s Ministry of Health or ANRACA. They are hemp-derived products legal under U.S. law. Moroccan law regarding import and use of hemp-derived cannabinoid products is evolving. Verify current regulations before ordering. If you are a patient in Morocco’s medical cannabis program, coordinate any cannabinoid use with your prescribing physician.

Chemotherapy-related nausea and appetite support

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2 to 3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25 to 50 mg CBN)
• Evidence context: delta-8 THC antiemetic evidence [9], delta-9 THC nausea and vomiting evidence [1][13], CBD anxiolytic buffering [3]

Moroccan cancer patient consideration: Morocco’s National Institute of Oncology (Institut National d’Oncologie) in Rabat provides standard cancer care. The medical cannabis program under ANRACA may eventually include chemotherapy support, but it’s not yet standard. If you’re considering cannabinoids for chemo side effects, discuss with your oncologist at INO or major hospitals like Ibn Sina in Rabat or Ibn Rochd in Casablanca.

Chronic pain (fibromyalgia, arthritis, neuropathy)

• Daytime: 0.3 to 0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Chronic pain in Morocco: Chronic pain is highly prevalent in Morocco, particularly among agricultural workers, construction laborers, and aging populations. Access to pain management is limited outside major cities. Traditional use of kif for pain is common but unstandardized. OilWell’s multi-cannabinoid approach offers a standardized alternative that can be used both functionally (raw, daytime) and therapeutically (decarbed, nighttime).

Sleep support

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL, this delivers 50 mg CBN — the dosage level investigated in the 2024 sleep literature
• At 1.0 mL, this delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance in published research
• Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

Sleep disorders in Morocco: Insomnia and sleep disorders are common in Morocco’s urban centers, exacerbated by stress, economic pressure, and noise pollution. Traditional remedies exist, but standardized CBN dosing represents a modern approach. The non-psychoactive daytime option (raw THCa) is particularly valuable for Moroccans who cannot afford daytime impairment.

Anxiety and stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety-related pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual — full cannabinoid profile including CBN for sleep architecture
• Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

Mental health in Morocco: Anxiety disorders are prevalent but undertreated in Morocco, with significant stigma around mental health care. The availability of non-psychoactive daytime relief options is culturally important, allowing people to manage symptoms while maintaining family and professional responsibilities.

General titration principle: Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2 to 3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and global accessibility

OilWell operates the only same-day RSO delivery system in Houston. Beyond Houston, the company ships nationwide and internationally.

Houston same-day delivery

Zone	Coverage	Delivery fee	Typical turnaround
Texas Medical Center	All 60+ TMC institutions (MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s, and more)	FREE	2 to 4 hours
Inner Loop (610)	Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Upper Kirby, Galleria	$5	2 to 4 hours
Within Beltway 8	Bellaire, Memorial, Spring Branch, South Houston, Pasadena (partial), Hobby Airport area	$10	3 to 5 hours
Greater Houston suburbs	Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble, Kingwood	$15	4 to 6 hours
Extended region (60 miles)	Galveston, Baytown, Rosenberg, Conroe, La Porte, Seabrook	$20 to $25	Same-day if ordered before 2 PM

Free delivery to the Texas Medical Center — the world’s largest medical complex with over 10 million patient visits annually — reflects OilWell’s commitment to accessibility for the patients who need it most.

Nationwide shipping

• All 50 states where Farm Bill-compliant products are legal
• USPS Priority Mail (2 to 3 business days), FedEx and UPS Ground (3 to 5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments
• Signature-required option available

International shipping — how Moroccans can access

OilWell ships internationally and has already delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because the product contains less than 0.3 percent delta-9 THC at the point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

• All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes
• Minimum flat-fee shipping applies; excessive international shipping costs are billed to the customer
• The customer is responsible for verifying legality in their jurisdiction and accepts all customs and legal risk
• Contact: (832) 416-2816 or [email protected]

The significance for Morocco: Morocco legalized medical cannabis in 2021 and established ANRACA to regulate it. However, the program is still developing, licensed products are limited, and many patients cannot yet access them. International shipping from the U.S. provides a legal pathway for Moroccans to obtain hemp-derived cannabinoid products while ANRACA’s domestic production capacity builds.

How Moroccan customers order:

1. Visit https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
2. Verify current Moroccan import regulations for hemp-derived products with ANRACA or customs
3. Place order with complete shipping address in Morocco
4. OilWell provides full COAs and documentation for customs
5. Customer pays shipping and any customs duties
6. Customer assumes responsibility for customs clearance and legal compliance

The significance of international access cannot be overstated. Rick Simpson could not ship his oil anywhere — it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Germany, a chronic pain patient in Australia, or a veteran in the United Kingdom can now potentially access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. OilWell built a product that can move across borders legally — completing a piece of Rick Simpson’s vision that prohibition made impossible during his lifetime of advocacy.

OilWell’s PANDEM1C SEO technology — a proprietary system with 14 million distinct geopolitical locations in its database and over 300 AI models — drives organic search visibility across six continents, making OilWell products discoverable to international patients searching for RSO in their own language.

Localization for Moroccan search: When Moroccans search in French or English for “huile Rick Simpson Maroc,” “RSO pour cancer Maroc,” “cannabis médical Maroc légal,” or “acheter RSO en ligne Maroc,” OilWell’s technical SEO infrastructure ensures this content appears in results. The system recognizes Morocco’s specific geographic and linguistic context.

How the OilWell formulas connect to the evidence in this document

Every cannabinoid in OilWell’s formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in the GENERAL KNOWLEDGE section of this document. Every terpene in OilWell’s formula — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — is covered with preclinical and review-level evidence.

The formulas published later in this document are not standalone product listings. They are anchored to per-compound evidence summaries that explain what is well-supported by human clinical data, what is emerging from review and preclinical literature, and what is overstated relative to the current evidence base. Where OilWell’s RSO guide page makes specific research claims about individual cannabinoids or terpenes, this document provides the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework.

The GENERAL KNOWLEDGE section’s evidence hierarchy, overstatement warnings, and safety notes apply equally to OilWell’s own products. This document does not exempt OilWell from the same evidence standards applied to the broader cannabinoid field. That is intentional. OilWell’s position — as stated by Colin Valencia in 2019 — is that people deserve the best possible version of the information so they can give it a fair shot and decide for themselves whether it is right or wrong for them. This document is the research foundation for that position.

OilWell Cannabis is more than a brand — it is a promise to its customers that it will always strive to deliver the best, most thoughtful cannabis products available. OilWell is not here to follow trends. It is here to set them. And as the company continues to grow, the focus remains on maintaining the same level of integrity, creativity, and commitment that has defined it from the day Bentley got up, walked across the room, and brought his ball to play.

For Moroccan consumers: This commitment to integrity matters in a market where misinformation is common and regulatory oversight is still developing. When you choose OilWell, you’re choosing a company that holds itself to evidence-based standards, publishes its formulas, and has earned media validation through years of honest education.

MEDIA RECOGNITION AND COMMUNITY IMPACT

Colin Valencia — Houston’s go-to cannabis authority

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving the fourth-largest city in the United States — featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different ABC13 reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter during the same period.

Why this matters for Moroccan consumers: While ABC13 is a Houston station, this level of mainstream media validation from a major-market affiliate demonstrates third-party credibility that transcends geography. In Morocco’s emerging cannabis market, where consumers are rightfully skeptical of online claims, this documented media record provides independently verified evidence of OilWell’s expertise and integrity. It’s the kind of recognition that cannot be purchased — only earned.

The features document a consistent pattern. When ABC13 needed to explain a new cannabis product to its audience, it called Colin. When a state agency reversed course on Delta-8 legality overnight, it called Colin. When a sitting president announced marijuana pardons and the station needed someone who had personally lived with a cannabis conviction to put it in context, it called Colin. When the station wanted to tell the story of a growing industry on 4/20, it was Colin’s hemp field and Colin’s voice that anchored the report.

What follows is a complete, chronological record of each feature — every quote preserved exactly as published, every contextual detail documented, every connection to the broader OilWell story and mission noted, and the full article content from each ABC13 report preserved for reference.

Feature: Texas CBD businesses booming as industry continues to evolve — September 15, 2019

Source: ABC13 Houston (KTRK)
Headline: “Texas CBD businesses booming as industry continues to evolve”
Reporter: Tom Abrahams
Published: Sunday, September 15, 2019
Tags: Health & Fitness, Houston, Marijuana, U.S. & World, Texas News, Business
YouTube Clip: OilWell CBD Oil Houston ABC News KTRK Interview Clipped (54 seconds)

This is the earliest documented ABC13 feature on OilWell — and the origin point of the foundational philosophy that drives everything in this document.

Full article content

HOUSTON, Texas (KTRK) — You can spot the signs in almost any neighborhood. CBD has turned into a booming business over the past few months, with entrepreneurs pitching the product for every member of the family, even the pets.

Amanda Field owns Republic Aerial Yoga on Houston Avenue in downtown. Her clients visit her studio for their health, to educate themselves, and to lessen their aches and pains.

“I’ve had people tell me that they’ve come to two classes and their back pain is gone.”
— Amanda Field, Republic Aerial Yoga owner

But for Field, it’s not just about yoga. Many of her clients combine the exercise with cannabidiol, a hemp-based product better known as CBD.

“It partners so well with yoga.”
— Amanda Field

Krystal Burns is one of those clients. She said she injured her back in an accident and had surgery. She said she was in constant pain and said doctors wanted to prescribe her opioids. Burns refused, and after learning about CBD from Field, she says she’s now a believer.

“I wouldn’t be able to function without it. It easily relaxes my muscles, it helps me sleep. I don’t have to worry about addiction.”
— Krystal Burns, CBD user and yoga client

Jim Bagley is another believer. He owns Linear Salon in the Heights. He says he and his wife use CBD and sell it in their shop.

“I was having trouble sleeping, restless in the mid-morning probably. I truly feel that there is benefits to it. I hope it’s not a trend. I think that the benefits I’ve received personally, hopefully I’ll be able to get my clients to enjoy the same benefits I’ve received.”
— Jim Bagley, Linear Salon owner

CBD use was in a legal, gray area in Texas until House Bill 1325, which Gov. Greg Abbott signed into law in June. The bill changed the legal definition of marijuana and hemp production in Texas. As a result, CBD as a business is booming. The product, however, cannot have .3 percent of THC, the chemical that makes you high.

That past summer, four local district attorneys announced they would not file criminal cases involving marijuana or cannabis unless testing proved the THC concentration was higher than .3 percent.

Dorral Marsenburg sells his Booman cannabis in a smokable form and says the industry is in its infancy in Texas.

“In a typical week, I’ll go through a half a pound selling grams. I say two years from now, it’ll be a multi-billion dollar operation. I honestly believe that because it’s 100 percent legal, and besides the THC, it’s healthy for you also.”
— Dorral Marsenburg, Booman cannabis

Colin Valencia, who runs OilWell CBD, a local wholesaler, says it’s an evolving industry.

“It’s a lot of educating people, but not over-promising people. I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”
— Colin Valencia, OilWell CBD

The FDA is still examining the actual health benefits and ways to regulate the content of cannabis products. In May, it held its first ever CBD hearings and states it is committed to sound, science-based policy.

Related: New hemp law means no criminal charges for some pot possession cases, Harris County DA says | CBD Oil: What you need to know

Video Description: “CBD TAKEOVER: The industry continues to grow with entrepreneurs pitching the product for every member of the family, including pets!”

Analysis

That Colin quote — from 2019, years before the formulas in this document were published — is the seed of everything OilWell would become. The open-source formula publication, the evidence-based research documentation, the refusal to make unsupported claims: it all traces back to this principle. The video segment’s description noting CBD was being pitched “for every member of the family, including pets” is an early indicator of the broad-spectrum consumer education approach Colin would continue to build. A clipped version of Colin’s interview from this broadcast was separately uploaded to YouTube as a standalone demonstration of OilWell’s media presence on a major network affiliate.

Feature: Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization efforts — March 22, 2021

Source: ABC13 Houston (KTRK)
Headline: “Entrepreneur creates direct-to-consumer business ahead of marijuana decriminalization efforts”
Reporter: Tom Abrahams
Published: Monday, March 22, 2021
Tags: Texas, Marijuana, Laws, Senate, Cannabis Watch

Full article content

HOUSTON, Texas (KTRK) — The proof is evident that decriminalizing cannabis doesn’t increase crime rates, according to Senate Majority Leader Chuck Schumer. It’s a basis as to why there is a renewed push to decriminalize cannabis at the national level.

One entrepreneur is already coming up with a unique way to get cannabis directly to the customer.

It’s not a taco truck. In fact, Jonathan Pina’s concept for High Maintenance Edibles is not like any other mobile vendor you’ve likely seen.

“We partner with private companies, bars restaurants, parking lot owners and we show up at places around Houston and provide our products.”
— Jonathan Pina, High Maintenance Edibles

His concept got a lift from Oil Well. A company that specializes in hemp based products legal in Texas and run by owner Colin Valencia. He said the tide is turning and more and more people accept legitimate uses for cannabis based products. The stigma is slowly disappearing.

“People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”
— OilWell CBD’s Colin Valencia

It’s getting a step closer to both decriminalization and legalization. While Texas may be far from legal recreational use, Congress may make its own move.

This week, Schumer and Senators Corey Booker of New Jersey and Ron Wyden of Oregon announced forthcoming legislation on Capitol Hill.

“When states decriminalized or legalized, all the horrible stories that people said crime rates would go up, people’s drug use would go up, never materialized.”
— Senator Chuck Schumer

The three of them cited the failed war on drugs, that veterans and people of color are disproportionately punished for use with excessive fines or jail time. There are already 15 states that have passed ballot measures or have laws allowing recreational use.

“If people want to use it and it doesn’t do harm, just like Oregon showed, let them do it.”
— Senator Chuck Schumer

For those in the business and on its forefront in Texas, entrepreneurs like Pina believe it’s long overdue. But in Austin, they are not there yet. Despite loosening restrictions and a spate of bills this session, full legalization is not as likely as it might be in Washington.

Related: Texas lawmakers hope to expand medical marijuana programs this legislative session | Texas’ medical marijuana program is one of the most restrictive in the country

Video Description: Decriminalizing cannabis doesn’t increase crime rates, according to Senate Majority Leader Chuck Schumer. He said there’s a renewed push to decriminalize marijuana at the national level, but how will this impact Texas?

Analysis

Tom Abrahams returned to OilWell for this feature, establishing Colin’s role not just as a business operator but as an ecosystem builder who helped other entrepreneurs like Jonathan Pina enter the legal cannabis space. Colin’s therapy quote — “pain comes in a lot of different forms” — went deeper than any prior interview into the therapeutic dimension, and the national decriminalization context (Schumer, Booker, Wyden) positioned OilWell at the intersection of Texas innovation and federal momentum.

Feature: What is Delta 8 THC and why is it considered legal weed in Texas — May 24, 2021

Source: ABC13 Houston (KTRK)
Headline: “What is Delta 8 THC and why is it considered ‘legal weed’ in Texas?”
Reporter: Steve Campion
Published: Monday, May 24, 2021
Tags: Society, Texas, Marijuana, Texas News, Smoking, Doctors, Illegal Drugs, Drugs
Note: Features 4 and 8 in the original URL list share this same URL — this is one article.

Full article content

A lush green plant is creating buzz in Texas as the cannabis industry is booming, despite federal and state law banning marijuana.

The 2018 Farm Bill legalized hemp plants, which contain extremely low concentrations of the psychoactive compound Delta 9 THC. That’s the THC typically found in pot which gives users a high. Entrepreneurs are now extracting any compound they want from the hemp plants and have narrowed in on Delta 8 THC. They’re making products including edibles, tinctures, and smokables with it. Delta 8 THC isn’t as strong as Delta 9 THC.

You’ll likely spot the Delta 8 products in stores around the Greater Houston like at HydroShack Hydroponics on West 20th Street in The Heights which sells Oilwell Cannabis products.

“Demand is like this,” . “People are grateful that we’re here and selling it. Very grateful. That’s the feeling I get.”
— Chris Powers, owner of HydroShack Hydroponics

Colin Valencia with Oilwell said the products offer therapeutic benefits at affordable prices. Valencia remained unabashed by his enthusiasm for them. He offered a pretty blunt explanation about how some might use Delta 8.

Steve Campion (ABC13): “Why would someone want to smoke that?”

Colin Valencia: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

“Delta 8 hasn’t been looked at, so we just don’t know. We’re gathering data now, so the more people who use, the more information we’ll have. You probably don’t want to be a guinea pig just yet. We know Delta 9 THC is habit forming. Delta 8 THC is likely to have that property as well. If you’re using it, you may find it’s harder to stop than you thought.”
— Dr. Michael Weaver, UTHealth/UT Physicians addictions specialist

ABC13 then asked him if he would advise anyone to take it.

“I think there is not enough information to say it’s good to try. The safest thing I can say is we don’t know enough about it to make a recommendation. Don’t try it until we know more.”
— Dr. Michael Weaver

Experts said using Delta 8 THC will likely lead to failed drug tests for employees.

Heather Fazio with Texans for Responsible Marijuana Policy told ABC13 some lawmakers already want to ban Delta 8 products in the state. She said the conversation should be on regulation, not prohibition.

“We’re seeing the market become innovative. Entrepreneurs getting creative with the ways they can abide by the law and still provide their customers with the product they would like. What we’re looking at here is simply the result of supply and demand. We know there is a demand for cannabis products in the state of Texas. Unfortunately, our state continues to deprive legitimate business owners of the opportunity to sell these products in a regulated way, products that are tested that are labeled appropriately.”
— Heather Fazio, Texans for Responsible Marijuana Policy

DEA Statement:

Delta 8 THC was added to the controlled substances list in August 2020 on an interim basis while pending final disposition. As DEA is currently undergoing the rulemaking process regarding the implementation of the Agriculture Improvement Act of 2018 – which includes the scope of regulatory controls over marijuana, tetrahydrocannabinols, and other marijuana-related constituents – we would be unable to comment on an any impact in legality of tetrahydrocannabinols, Delta 8 included, until the process is complete. We are in the process of reviewing thousands of comments and do not speculate on what could happen as a result.

Related: Texas’ medical cannabis program could expand under bill OK’d by House

Video Description: This lush green plant is creating buzz in Texas. ABC13 reporter Steve Campion investigated what it is, its effects on the body and whether or not it is legal in Texas.

Analysis

This investigative feature by Steve Campion became one of the most widely referenced ABC13 cannabis segments. The exchange between Campion and Colin — “Maybe you want to get high” — became one of Colin’s most iconic media moments: radical honesty on mainstream television with the expletive preserved by the network. The piece balanced Colin’s unapologetic stance with Dr. Weaver’s medical caution and Heather Fazio’s regulatory advocacy, and the full DEA statement documented the federal ambiguity that allowed the market to exist. This article was cross-referenced by ABC13 in multiple subsequent features and served as the foundational explainer that later Delta-8 coverage built upon.

Feature: Houston CBD shop giving away free products to those who get COVID vaccine — August 20, 2021

Source: ABC13 Houston (KTRK)
Headline: “Houston CBD shop giving away free products to those who get COVID vaccine”
Reporter: KTRK Staff
Published: Friday, August 20, 2021
Tags: Health & Fitness, Houston, COVID 19 Vaccine, Marijuana, Cannabis Watch, Vaccines, Coronavirus Pandemic, COVID 19 Pandemic, Pandemic, Texas News, Health Care

Full article content

HOUSTON, Texas (KTRK) — A Houston CBD shop is offering a unique incentive to get people vaccinated.

According to an Instagram post published on Wednesday, OilWell CBD, which specializes in hemp-derived CBD and THC products, said it wants to give away 1,000 pieces of product to those who get vaccinated after Aug. 18.

The company is offering to give away 1,000 special edition caviar pre-rolls, which according to its website, is a THC-infused product coated with oils and hash kief, a more refined form of cannabis. OilWell sells these items for $34.99, according to its website.

The company said you must provide proof of vaccination along with a photo ID.

The giveaway will take place starting Monday at noon at HydroShack Hydroponics on West 20th Street in The Heights, which sells OilWell products.

“We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”
— OilWell Instagram post

The company later posted another Instagram post saying it’s been in contact with the city of Houston to help more people get vaccinated.

“[We’re] trying to get the city behind me to help as many people as we can. I really want to help things.”
— OilWell follow-up Instagram post

The 2018 Farm Bill legalized hemp plants, which contain extremely low concentrations of the psychoactive compound Delta-9 THC. That’s the THC typically found in marijuana that gives users a high. Entrepreneurs are now extracting any compound they want from the hemp plants and have narrowed in on Delta-8 THC. Companies like OilWell are now making products such as edibles, tinctures, and smokables.

Note: The video above is from an ABC13 report published on May 24 in which we spoke with OilWell CBD about Delta-8 THC products and why it’s considered “legal weed” in Texas.

Video Description: This lush green plant is creating buzz in Texas. ABC13 reporter Steve Campion investigated what it is, its effects on the body and whether or not it is legal in Texas.

Analysis

This feature documented OilWell’s most significant community health initiative — approximately $35,000 in product (1,000 caviar pre-rolls at $34.99 each) donated to encourage COVID-19 vaccination. The pre-rolls were a collaboration product: The Game x OilWell Cannabis Delta 8 Caviar Comet Rock Pre-Rolls. The giveaway was hosted at the same HydroShack Hydroponics retail partner featured in the Delta-8 segment months earlier. OilWell’s coordination with the city of Houston to amplify the vaccination effort demonstrated that the company’s community orientation was not hypothetical — when a public health crisis required action, the company committed real product and real coordination with city government, with no political strings attached.

Feature: Texas ban over once legal hemp product Delta 8 raises questions over legality — October 19, 2021

Source: ABC13 Houston (KTRK)
Headline: “Texas’ ban over once legal hemp product, Delta 8, raises questions over legality”
Reporter: Shelley Childers
Published: Tuesday, October 19, 2021
Tags: Politics, Houston, Marijuana, Texas News, Texas Politics, Illegal Drugs

Full article content

HOUSTON, Texas (KTRK) — Inside the Oil Well dispensary in southwest Houston, owner Colin Valencia said he has removed all of his Delta 8 products.

“It’s going to be a surprise to a lot of people.”
— Colin Valencia

It’s a surprise because when ABC13 met Valencia earlier this year, Delta 8 products were his best sellers.

“It was a prime seller and a prime interest of customers, and they really enjoyed the benefits of it.”
— Colin Valencia

Delta 8 is a cannabinoid sold as edibles, tinctures, pills, topical ointment, you can smoke it and vape it. Most CBD dispensaries and vape stores sell it.

“We’ve heard of vets with PTSD who use these products for things like anxiety, dealing with stress and emotions. There’s also people who use these products for sleep regulation. Our association recently, during the state session, actually estimated that the Delta 8 market is around about $50 million in Texas.”
— Zachary Maxwell, Texas Hemp Growers

Delta 8 is derived from hemp cannabis. It took off after the 2018 Farm Bill legalized hemp production federally. It is a THC product and, up until last week, it was never explicitly listed on the state’s controlled substance list.

“A lot of the industry has been operating under the assumption that Delta 8 is legal or that it exists inside of this gray area, and unfortunately, as we are learning, this is not the case. These products have in fact been illegal since the beginning of this year.”
— Zachary Maxwell

On Oct. 15 the Texas Department of State Health Services posted an update on their Consumable Hemp Program page saying in part, “All other forms of THC, including Delta 8 in any concentration and Delta 9 exceeding 0.3%, are considered Schedule I controlled substances.”

“And if you’re caught with as much as a Delta 8 vape cartridge or even a package of gummies, you could be looking at a felony offense punishable up to two years in prison and a fine up as much as $10,000.”
— Zachary Maxwell

He says the state made no other formal notification to the more than 2,000 licensed CBD operators including Valencia, who has been trying to spread the word himself.

“So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.”
— Colin Valencia

ABC13 reached out to Texas DPS to find out if and how the state will enforce this-known ban. They were still awaiting a response.

ABC13 spoke with the Texas DSHS to ask about the updated verbiage on Delta 8. A spokesperson says Delta 8 has always been illegal because it is a THC cannabinoid. She could not speak to how the Delta 8 market was allowed to publicly blossom and thrive while being considered illegal. She told ABC13 that the hemp industry asked DSHS for clarification on its legality which prompted the announcement last Friday.

While both men worry for the small businesses who rely on Delta 8 products for the majority of sales, they remain optimistic about the future of cannabis in Texas.

“It’s disappointing, but I’m not going to lose my customers and business are going to want our expertise on how to continue thriving in the industry.”
— Colin Valencia

Video Description: A cannabis businessman says Texas’ recent move on making hemp products illegal is “dangerous.”

Analysis

This feature captures a defining moment in OilWell’s story. Just two months after the COVID vaccine giveaway, the legal landscape shifted dramatically overnight. Shelley Childers went directly to the OilWell dispensary and found that Colin had already removed all Delta-8 products from his shelves — proactively, before enforcement began, and before most of the industry even knew the change had happened. Colin had been trying to spread the word himself to other operators who were unknowingly shipping what had overnight become Schedule I narcotics. Zachary Maxwell’s context — veterans with PTSD, the $50 million Texas market, felony penalties for a single vape cartridge — made the stakes viscerally clear. Texas DSHS told ABC13 that Delta-8 “has always been illegal” but could not explain how the market had been “allowed to publicly blossom and thrive while being considered illegal.” The willingness to absorb a major revenue loss, act ethically ahead of enforcement, and position the company as an expert guide for an industry in crisis rather than a victim of regulation — that is OilWell’s character.

Feature: Biden marijuana pardon — experts weigh in on why Texas won’t see impact — October 7, 2022

Source: ABC13 Houston (KTRK)
Headline: “Experts weigh in on why Texas won’t see impact in accordance with Biden’s pardon announcement”
Reporter: Nick Natario
Published: Friday, October 7, 2022
Tags: Politics, Houston, Marijuana, Medical Marijuana, Legal, Pardon, Texas, Greg Abbott, Beto O’Rourke

Full article content

HOUSTON, Texas (KTRK) — President Joe Biden is planning to pardon thousands of Americans convicted of simple possession of marijuana, but Texas will not see much of an impact.

The owners of Oilwell Cannabis are preparing to debut their latest idea: A vending machine that will be filled with legal cannabidiol, or CBD, products.

The shop owner, Collin Valencia, has previously faced charges for marijuana possession.

“You face challenges with housing, loans, and banking, I mean with about everything.”
— Colin Valencia

Soon, select others won’t face those challenges after the president’s announcement.

“I would love to see people not get hurt for this anymore.”
— Colin Valencia

The pardon doesn’t impact Valencia. As legal expert Steve Shellist explains, this will only apply to certain federal convictions.

“If someone is currently stripped of rights via a state prosecution or a state conviction, they’re going to get no relief from this.”
— Steve Shellist, legal expert

He said a pardon allows people to carry a gun or avoid deportation.

“It reinstates rights that were stripped away, but it does not remove it from their record.”
— Steve Shellist

The pardon applies to about 6,500 people. Experts at Rice University said that there were 300,000 marijuana-related arrests at the state level last year. President Biden urged governors to do the same with state charges.

A spokesperson for Governor Greg Abbott sent ABC13 a statement that read:

“Texas is not in the habit of taking criminal justice advice from the leader of the defund police party and someone who has overseen a criminal justice system run amuck with cashless bail and a revolving door for violent criminals.”
— Governor Greg Abbott’s spokesperson

On social media, Abbott’s opponent Beto O’Rourke said, “When I’m governor, we will finally legalize marijuana in Texas and expunge the records of those arrested for marijuana possession.”

“Governors do not have the power to pass legislation unilaterally. It has to go through the Texas Legislature, and the Texas legislature for at least the next two or four years is going to have a Republican majority.”
— Mark Jones, Rice University political science professor

Don’t expect to see marijuana legalization in the upcoming session. However, it doesn’t mean the matter won’t be discussed.

“The most we’ll see in 2023 is decriminalizing marijuana and medical marijuana. We’re not going to see legalization. That’s for sure.”
— Mark Jones

Related: Biden pardons thousands convicted for ‘simple possession’ of marijuana

Video Description: There were 300,000 marijuana-related arrests last year in the state of Texas, but the pardon applies to about 6,500 people, a legal expert explained.

Analysis

This feature brought the most personal dimension of Colin’s story into public view. The article opened with the OilWell CBD vending machine debut — a retail innovation extending product accessibility beyond traditional dispensary hours — and then revealed that Colin has previously faced charges for marijuana possession. That personal history transforms the entire media record. Every feature, every quote about therapy, about education, about not selling snake oil — all carry additional weight when you understand that the person saying it has personally experienced the consequences of cannabis criminalization. The political context (300,000 state arrests vs. 6,500 pardons, Abbott vs. O’Rourke, Mark Jones’s analysis) captured the gap between federal gestures and Texas reality. Colin is not an outside entrepreneur who saw a business opportunity. He is someone who lived the consequences and built a legal business to prove the industry could operate with integrity, transparency, and community benefit.

Feature: Marijuana industry getting creative as Texas laws continue to change — April 21, 2023

Source: ABC13 Houston (KTRK)
Headline: “‘I want it to be legalized’: Marijuana industry getting creative as Texas laws continue to change”
Reporter: Nick Natario
Published: Friday, April 21, 2023
Tags: Health & Fitness, Texas, Marijuana, Medical Marijuana, Texas News, Texas Politics

Full article content

HOUSTON, Texas (KTRK) — On April 20, some Texas lawmakers and those in the marijuana industry are celebrating as changes could be coming with the drug.

The cannabis industry has changed in Texas, and new laws have allowed those in the industry to get creative.

“I want it to be legalized. I’m just saying that’s a very hyped conversation. If you really look at what’s here now, there’s nothing you could show me that I could accomplish with what literally we have right now.”
— Oilwell Cannabis owner Colin Valencia

Valencia grows something that looks like marijuana, but he says it’s not illegal. It’s hemp — a product the state allows and one that gives him the ability to create all kinds of products.

“Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”
— Colin Valencia

As far as legal marijuana, it’s still restrictive in Texas. To use it, marijuana needs to be prescribed. There are currently around 50,000 Texans registered, but experts say only about 10,000 actively use medical marijuana.

“By comparison to Florida, which is two-thirds the size of Texas, they have 20 million people, and we have 30 million people, and they have 700,000 patients.”
— Nico Richardson, Texas Original CEO

But that number could change soon. Texas lawmakers are considering a bill (HB1805) to expand who could gain access.

“Would rather dramatically increase the size of the CUP. The largest constituency of patients not being treated with medical cannabis today is chronic pain.”
— Nico Richardson

The bill passed the House and is heading to the Senate. It would also change how the drug is dosed to line up with other medical treatments.

“If you were to treat a headache with 400 milligrams of Advil and there was a one percent concentration cap, you would be using 20 to 40 Advil pills every time you had a headache.”
— Nico Richardson

While it’s not legalization, in other states, it’s had an impact, especially with money. The Marijuana Policy Project said in 2021 alone, $3.7 billion was generated in taxes in the states where marijuana is legal.

The CDC urges caution, saying more studies need to be done because the drug could impact your brain, lungs, and unborn children.

Related: Expanded access to medical marijuana gains traction as Texas House advances bill | University of Houston survey shows most Texans would approve of marijuana legalization

Video Description: The growing marijuana industry in Texas could soon expand

Analysis

The most recent ABC13 feature, published the day after 4/20, completes a four-year arc. Natario showed Valencia growing hemp and explained that it was legal. Colin’s “Renaissance” framing reframed the present as opportunity rather than waiting. Nico Richardson’s comparison (Texas 10,000 active patients vs. Florida 700,000 with two-thirds the population) and his Advil analogy for dosing caps provided industry context. HB1805’s passage through the House and the $3.7 billion tax revenue figure from legal states gave the story national scope. From the September 2019 CBD business profile through the Delta-8 boom and bust, the COVID community initiative, the personal revelation of cannabis conviction history, and now the “Renaissance” framing — Colin Valencia’s media trajectory mirrors the trajectory of legal cannabis in Texas itself.

Complete index of all Colin Valencia quotes across all ABC13 features

Chronological order:

September 15, 2019 (CBD Business Boom):

1. “It’s a lot of educating people, but not over-promising people. I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 22, 2021 (Decriminalization/Jonathan Pina):
2. “People think that everyone just wants to get high and it’s about giggling and things like that, and there’s nothing wrong with that. But that’s a different version of therapy, and people are looking for things to help them with real pain. Pain comes in a lot of different forms.”

May 24, 2021 (Delta-8 THC “Legal Weed”):
3. “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.”

August 20, 2021 (COVID Vaccine Giveaway):
4. “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”
5. “[We’re] trying to get the city behind me to help as many people as we can. I really want to help things.”

October 19, 2021 (Delta-8 Ban):
6. “It’s going to be a surprise to a lot of people.”
7. “It was a prime seller and a prime interest of customers, and they really enjoyed the benefits of it.”
8. “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.”
9. “It’s disappointing, but I’m not going to lose my customers and business are going to want our expertise on how to continue thriving in the industry.”

October 7, 2022 (Biden Marijuana Pardon):
10. “You face challenges with housing, loans, and banking, I mean with about everything.”
11. “I would love to see people not get hurt for this anymore.”

April 21, 2023 (Texas Marijuana Laws 4/20):
12. “I want it to be legalized. I’m just saying that’s a very hyped conversation. If you really look at what’s here now, there’s nothing you could show me that I could accomplish with what literally we have right now.”
13. “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.”

Key facts and details extracted from the media record

About Colin Valencia and OilWell Cannabis:

• Colin Valencia is the owner of OilWell Cannabis (also referred to as OilWell CBD in earlier articles)
• He has previously faced charges for marijuana possession (revealed in the October 2022 Biden pardon feature)
• The OilWell dispensary is located in southwest Houston
• OilWell specializes in hemp-derived CBD and THC products
• OilWell was described as a local wholesaler in 2019 (earliest feature)
• By 2022, OilWell was preparing to debut a CBD vending machine (Biden pardon feature)
• OilWell products were sold at HydroShack Hydroponics on West 20th Street in The Heights
• OilWell partnered with The Game on special edition Delta-8 caviar comet rock pre-rolls (COVID vaccine feature)
• OilWell gave a lift to Jonathan Pina’s High Maintenance Edibles mobile vendor concept (decriminalization feature)
• OilWell gave away 1,000 special edition caviar pre-rolls (valued at $34.99 each = approximately $35,000 in product) to encourage COVID vaccination
• OilWell contacted the city of Houston to help coordinate vaccination efforts
• Colin proactively removed all Delta-8 products from shelves when the ban was announced and tried to spread the word to other operators who were unknowingly shipping Schedule I narcotics

ABC13 reporters who covered OilWell:

1. Tom Abrahams — September 2019 and March 2021
2. Steve Campion — May 2021
3. KTRK Staff — August 2021
4. Shelley Childers — October 2021
5. Nick Natario — October 2022 and April 2023

Timeline of features (chronological):

1. September 15, 2019 — CBD Business Boom
2. March 22, 2021 — Decriminalization/Jonathan Pina
3. May 24, 2021 — Delta-8 THC “Legal Weed”
4. August 20, 2021 — COVID Vaccine Giveaway
5. October 19, 2021 — Delta-8 Ban Impact
6. October 7, 2022 — Biden Marijuana Pardon
7. April 21, 2023 — Texas Marijuana Laws 4/20 Special

The through-line — what the media record reveals

Taken together, these seven ABC13 features and one YouTube clip tell a story that no single article could capture on its own.

Consistency across years. Colin Valencia appeared on ABC13 in 2019, 2021 (four times), 2022, and 2023. The cannabis industry in Texas changed dramatically during those years — legal CBD went from gray area to booming business, Delta-8 went from unknown to $50 million market to Schedule I overnight, a president pardoned federal marijuana convictions, and state legislators debated medical expansion. Through every shift, ABC13 returned to Colin as a primary source.

Breadth of expertise. The features span business reporting, consumer health education, product investigation, legal analysis, political commentary, and community health advocacy. No other Houston cannabis figure was asked to speak to that range of topics across that many segments.

Community action. The COVID vaccine giveaway — $35,000 in product, coordination with city government, no political strings — is documented evidence of the community-first philosophy described in the About OilWell section of this document. So is Colin’s decision to proactively remove Delta-8 products and warn other operators before enforcement began.

Personal stakes. The October 2022 revelation that Colin has a personal marijuana conviction history transforms the entire media record. Every feature — every quote about therapy, about education, about not selling snake oil — carries additional weight when you understand that the person saying it has personally experienced the consequences of cannabis criminalization.

Evolution of language. In 2019, ABC13 called the business “OilWell CBD, a local wholesaler.” By 2021, the reports described OilWell Cannabis as a dispensary and featured Colin as an industry authority. By 2023, Colin was explaining industry dynamics and legal strategy on camera with the confidence of a sector leader. The media record tracks the growth of both the business and its founder’s public role.

Global credibility: For Moroccan consumers evaluating this product, this media record provides something no marketing copy can: independently verified evidence of expertise, ethics, and consistency over four years. When you read these articles, you’re not just reading about a product — you’re reading about a person and a company that major media trusts enough to return to again and again.

These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible, most quotable, and most accessible voice in Houston’s legal cannabis industry. That is the kind of recognition that cannot be purchased — it can only be earned.

GENERAL KNOWLEDGE

Research method and evidence weighting

This section prioritizes sources in the following order: human clinical evidence, systematic reviews and meta-analyses, NIH and other institutional summaries, then mechanistic or preclinical literature when human data are sparse. That weighting matters here because the evidence base is not evenly distributed. Of the compounds listed in this document, CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes are still much more dependent on reviews, animal work, in vitro pharmacology, or early translational literature [1]-[29].

For Moroccan researchers and healthcare providers: This evidence hierarchy aligns with international medical standards that Morocco’s medical cannabis program under ANRACA is adopting. When evaluating cannabinoid products, prioritize human clinical data over preclinical studies, and systematic reviews over individual trials.

Institutional baseline from NIH and related sources

• NCCIH states that the strongest established cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite or weight-loss indications associated with HIV/AIDS. It also notes only modest evidence for chronic pain and multiple-sclerosis-related symptoms, with many other claimed uses still in early-stage research [1].

• NCCIH also emphasizes that the FDA has not approved the cannabis plant itself for medical use, although purified CBD and synthetic THC-like drugs have specific approvals [1].

• Safety concerns repeatedly highlighted by NIH and institutional sources include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination or labeling inaccuracy, and THC-vape lung-injury concerns [1].

• NCCIH specifically warns that over-the-counter CBD products may differ from their labels and that CBD itself has been associated with decreased alertness, gastrointestinal effects, liver-related adverse effects, and drug interactions [1].

Application to Morocco: Morocco’s Ministry of Health and ANRACA are building the country’s medical cannabis program on similar evidence standards. Before any product receives medical approval in Morocco, it must demonstrate safety and efficacy through clinical trials. This institutional caution is appropriate and protects patients.

Cannabinoids

CBD

• Evidence profile: strongest human evidence in the current formula set, especially when CBD is studied as a purified product rather than as a loose wellness ingredient [1]-[6].

• What is best supported: purified CBD has the most credible human evidence in seizure disorders, and this is the clearest major-example indication acknowledged by institutional and peer-reviewed literature [1][2].

• Anxiety research: a 2024 systematic review and meta-analysis covering 316 participants across eight eligible articles reported a statistically significant anxiolytic signal, but the authors also stressed that the clinical sample remains limited and that more trials are needed before broad conclusions are justified [3].

• Pain research: a 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded that the pain literature is promising but heterogeneous, with trial quality and consistency still limiting confidence in broad analgesic claims [4].

• Sleep research: a 2023 insomnia review found that the literature remains methodologically weak, with many studies relying on nonvalidated subjective measures and relatively few objective sleep assessments [5].

• Safety and interaction concerns: a 2023 systematic review and meta-analysis found a real signal for liver enzyme elevation and possible drug-induced liver injury in some CBD contexts, which is especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH separately flags diarrhea, sleepiness, appetite change, mood effects, liver-function abnormalities, and drug-drug interactions as important considerations [1].

• Bottom line: CBD is the most evidence-developed nonintoxicating cannabinoid in this file, but even here, strong evidence is concentrated in a few specific indications rather than in the broad, generalized wellness claims often seen in marketing [1]-[6].

CBD for Moroccan epilepsy patients: While Morocco’s ANRACA has not yet approved CBD for epilepsy, the global evidence base is strong. Moroccan families dealing with rare epilepsies like Dravet syndrome may find this information valuable when discussing options with neurologists at University Hospital Ibn Sina in Rabat or other major centers.

CBG

• Evidence profile: mostly review-level and preclinical; human evidence remains sparse [7][8].

• Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids and appears pharmacologically distinct from both THC and CBD. Review literature describes interactions spanning cannabinoid receptors as well as alpha-2 adrenoceptors and 5-HT1A-related signaling, which makes it mechanistically interesting but not yet clinically established [7].

• Potential research areas: published reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are primarily pharmacology-led hypotheses or preclinical findings rather than mature human therapeutic conclusions [7][8].

• Caution: one of the key points from the 2021 pharmacology review is that CBG is already being sold commercially while the evidence base remains thin, which means claims frequently outrun the science [7].

• Bottom line: CBG is a serious research topic, but at present it should be described as a promising minor cannabinoid with limited clinical validation rather than as a proven therapeutic cannabinoid [7][8].

Delta-8 THC

• Evidence profile: pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

• Comparative pharmacology: a 2022 review concluded that delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 THC is a partial CB1 agonist with cannabimimetic activity in animals and humans, but it appears less potent than delta-9 THC, likely in part because of weaker CB1 affinity [9].

• Public-health literature: a 2023 scoping review found that much of the delta-8 evidence base is still dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong modern human trials. The same review also noted reports of adverse consequences and emphasized regulatory and product-quality concerns [10].

• Manufacturing context: the recent chemistry and pharmacology review reinforces that commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which is part of why product-byproduct and lab-testing questions matter [11].

• Bottom line: delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize [9]-[11].

THCa

• Evidence profile: important chemically and formulation-wise, but still low on direct human therapeutic evidence [12].

• What it is: THCa is the acidic precursor of THC and may represent a very large share of the THC-related content in raw plant material. The key formulation issue is that THCa decarboxylates into THC during heating and can also change over time during storage and processing [12].

• Psychoactivity: the major review source stresses that THCa itself does not produce the psychoactive effects associated with THC in humans, but the distinction only holds if the molecule stays in its acidic form and is not substantially decarboxylated [12].

• Research status: in vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not equivalent to established human outcomes [12].

• Bottom line: THCa is best understood as a highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any claim about THCa needs to account for possible conversion into THC [12].

Delta-9 THC

• Evidence profile: strongest human evidence of the psychoactive cannabinoids listed here, but also the clearest adverse-effect burden [1][13]-[15].

• What is institutionally best supported: NCCIH identifies THC-containing cannabinoid medicines as relevant to chemotherapy-related nausea and vomiting, appetite and weight loss in HIV/AIDS, and some multiple-sclerosis- and pain-related outcomes, while still stressing that many other uses remain uncertain or early-stage [1].

• Pain evidence: a 2022 systematic review of cannabis-based products for chronic pain found that products with high THC content or roughly comparable THC:CBD ratios may provide short-term pain benefit, but they also increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13].

• Pharmacokinetics and onset: classic pharmacokinetic review literature remains useful here: inhaled THC usually produces effects within seconds to minutes, peaks roughly within 15 to 30 minutes, and tapers over a few hours; oral THC has later onset, later peak, and longer duration, which matters for both benefit and overconsumption risk [14].

• Mental-health risk: a 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis or schizophrenia outcomes and cannabis use disorder, with additional concerning signals for anxiety and depression in nontherapeutic settings [15].

• Broader safety: institutional and review literature also describe anxiety or panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal symptoms, pregnancy concerns, accidental pediatric exposure, and vape-related lung-injury concerns in THC-containing products [1][14][15].

• Bottom line: delta-9 THC has legitimate therapeutic relevance in some settings, but it also carries the clearest intoxication, psychiatric, and dose-related safety liabilities in this document [1][13]-[15].

CBN

• Evidence profile: weak human evidence; marketing has clearly moved ahead of the data [12][16][17].

• What it is often marketed for: sleep and sedation. That reputation is widespread, but the clinical support is far thinner than the market suggests [16][17].

• Best direct review for the sleep claim: the 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims for CBN [16].

• Broader sleep literature: the 2024 updated review on cannabis and sleep concluded that overall cannabinoid sleep research still does not match the scale of real-world use, and the need for better-designed, adequately powered trials remains substantial [17].

• Chemical context: downstream cannabinoid degradation pathways matter here as well; review literature on THCa notes that THC can further degrade toward CBN under certain conditions, which helps explain why CBN is often discussed in aging or oxidized cannabis chemistry contexts [12].

• Bottom line: CBN is one of the clearest examples in this field where cultural reputation is stronger than the current clinical evidence base [16][17].

CBC

• Evidence profile: emerging, intriguing, and still overwhelmingly preclinical or review-based [18][19].

• Pharmacology and therapeutic interest: the 2024 focused review on CBC argues that it has distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, and highlights antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].

• What the older literature shows: review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but these signals are not yet strong evidence for patient-facing claims [19].

• Safety caveat: the 2024 CBC review explicitly notes that over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

• Bottom line: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not in the category of already-validated clinical actives [18][19].

Terpenes

Terpene claims need even stricter interpretation than cannabinoid claims. Much of the terpene literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than from controlled human studies of cannabis formulations. The 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence profile: largely review and preclinical, with useful safety literature [20]-[22].

• Potential activity: a 2021 review describes limonene as a multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory, and other possible activities, but the overwhelming share of those claims comes from nonhuman or non-cannabis literature [21].

• Safety note: limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens and are important in patch-testing literature [22].

• Bottom line: limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless they are directly supported in humans [20]-[22].

Myrcene

• Evidence profile: mostly preclinical, with very limited human evidence [20][23].

• Research summary: the 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties and discusses possible mechanisms, but explicitly states that human studies are lacking [23].

• Interpretation caution: myrcene is often invoked in consumer language as if it were a proven sedating terpene that explains couch-lock or sleep effects. That is a stronger claim than the human evidence currently supports [20][23].

• Bottom line: myrcene is a plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof [23].

Caryophyllene

• Evidence profile: among the most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical [24].

• Why it stands out: a 2021 focused review describes beta-caryophyllene as a selective CB2 receptor agonist, which is unusual and makes it especially relevant when discussing cannabis terpenes in pharmacologic rather than purely aromatic terms [24].

• Research themes: anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective, and related actions are repeatedly discussed in the review literature, but human clinical confirmation remains limited [24].

• Bottom line: beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but it still should not be described as clinically proven for the outcomes commonly attributed to it [24].

Pinene

• Evidence profile: promising preclinical literature, weak human clinical confirmation [20][25].

• Brain-health framing: the 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals that justify future study, but it also emphasized that evidence is mostly preclinical and that well-designed clinical trials are lacking [25].

• Interpretation caution: claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].

• Bottom line: pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Evidence profile: similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

• Research summary: linalool is repeatedly discussed in relation to stress, mood, and brain-health pharmacology. The 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological and psychiatric contexts, while still emphasizing the lack of robust human trials [25].

• Additional literature: separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but this remains a translational rather than definitive clinical story [26].

• Safety note: as with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

• Bottom line: linalool is scientifically credible as a bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence profile: translationally interesting, but still early [20][27].

• Scoping-review findings: a 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work even suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

• Interpretation caution: those findings are valuable for hypothesis generation, but they do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

• Bottom line: humulene is one of the more interesting terpene research targets in this list, but it remains far from clinically settled [27].

Terpinolene

• Evidence profile: one of the least clinically characterized terpenes in this file [20][28].

• Systematic-review findings: the 2021 terpinolene review screened 2,449 records and included 57 studies, concluding that terpinolene has a range of reported biological effects but that the evidence base is still dominated by in silico, in vitro, and animal studies rather than human trials [28].

• Interpretation caution: even recent cannabis entourage reviews frame terpene benefits as exploratory, not as established compound-specific clinical effects [20].

• Bottom line: terpinolene is biologically interesting, but among the listed terpenes it remains especially underdeveloped clinically [20][28].

Research limits and interpretation

• The evidence base is highly uneven. CBD and delta-9 THC can support the most detailed human-facing statements; the rest require more caution [1]-[29].

• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. One common error in cannabis writing is to let evidence from one category stand in for another.

• Minor cannabinoids and terpenes are commercially interesting precisely because they are underexplored, but that also means the claims around them often become inflated.

• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, and dose variability all materially affect interpretation in real-world products [1][10][11][14].

• For THCa in particular, chemistry is destiny: storage and heating can change the actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common overstatements to avoid

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: the specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: terpenes in general have proven entourage effects in patients.
  More accurate: entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing the effective exposure [12].

• Overstatement: delta-8 THC is safe because it is hemp-derived.
  More accurate: delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical takeaways for the formulas in this document

• The most evidence-developed actives in these formulas are CBD and delta-9 THC.

• Delta-8 THC is not a trivial or purely mild ingredient; it is a psychoactive cannabinoid with less robust safety and efficacy characterization than delta-9 THC.

• THCa meaningfully changes with processing and should not be interpreted the same way in raw, gently handled, and heated formats.

• CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD and THC.

• The listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

RSO Sublingual Oil

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5%
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg

For Moroccan consumers: This table represents the complete open-source formula. If you’re a Moroccan entrepreneur looking to develop products under ANRACA licensing, you can see exact ratios. If you’re a patient, you can verify that you’re getting precisely what is advertised — no hidden ingredients, no approximations.

RSO Vape Cartridge

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%
• Format: 1 Gram cartridge

Vape compatibility for Morocco: The 510-thread standard is universal. Moroccan consumers can use these cartridges with any standard vape battery available in Moroccan markets or online.

Terpene Profile (Both Products)

• Limonene (citrus-bright)
• Myrcene
• Caryophyllene (β-caryophyllene – pepper/spice)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

Sensory connection for Morocco: These terpenes create an aromatic profile that connects to familiar Moroccan scents — citrus from the Souss Valley groves, pepper from spice markets, lavender from herbal traditions, pine from Atlas forests. The product experience is both medically sophisticated and culturally familiar.

Making an Informed Decision: OilWell RSO for Moroccan Consumers

Who should consider OilWell RSO in Morocco

You might benefit from OilWell RSO if:

• You’re a cancer patient in Morocco undergoing chemotherapy at the National Institute of Oncology and seeking support for nausea, appetite, or sleep
• You live with chronic pain from arthritis, fibromyalgia, or neuropathy and conventional medications haven’t provided adequate relief
• You struggle with insomnia or sleep disorders common in Morocco’s urban environments
• You experience anxiety or PTSD related to regional instability, economic stress, or personal trauma
• You’re a Moroccan veteran or security force member dealing with service-related conditions
• You’re tapered off benzodiazepines or other pharmaceuticals and need support
• You’re part of the Moroccan diaspora seeking legal access to cannabinoid products
• You’re a healthcare provider in Morocco researching evidence-based cannabinoid formulations

You should NOT use OilWell RSO if:

• You’re under 21 (age requirement)
• You’re pregnant or nursing (safety warning)
• You need to operate vehicles or machinery while using psychoactive cannabinoids
• You haven’t consulted with a healthcare provider about potential drug interactions
• You’re seeking a proven cancer cure (RSO is not a cure)
• You’re in a profession with zero-tolerance drug testing (even raw THCa may trigger tests)

How to order from Morocco

Step-by-step process:

1. Verify legality: Check current ANRACA regulations and Moroccan customs policies for importing hemp-derived products with <0.3% delta-9 THC. As of 2024, Morocco’s legal framework for personal import is still evolving. Contact ANRACA directly or consult with a Moroccan customs broker.

2. Visit our site: Go to https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/

3. Select product: Choose RSO Sublingual Oil ($129.99) or RSO Vape Cartridge ($49.99) or both

4. Calculate shipping: International shipping rates vary. Contact us at (832) 416-2816 or [email protected] for a shipping quote to Morocco

5. Place order: Complete purchase with your Moroccan shipping address

6. Documentation: We provide full COAs, Farm Bill compliance letters, and detailed product descriptions for customs

7. Customs clearance: You are responsible for any customs duties and ensuring the package clears Moroccan customs. We cannot guarantee delivery if Moroccan law prohibits the product

8. Legal responsibility: By ordering, you accept full legal responsibility for compliance with Moroccan law

Payment options: We accept major credit cards, which work internationally. Some Moroccan banks may block cannabis-related transactions; consider using international payment platforms if needed.

Understanding Moroccan regulations

Current legal landscape (as of 2024):

• Law 13.21 (2021): Legalized medical cannabis and industrial hemp, established ANRACA
• Medical cannabis: Requires prescription from licensed physician, available only through ANRACA-authorized pharmacies
• Industrial hemp: Licensed cultivation allowed with <0.3% THC, strictly regulated
• Personal possession: Still illegal outside medical program
• Import: Unclear gray area for personal import of hemp-derived products. ANRACA has not issued clear guidance on personal import of finished products

Risk mitigation: OilWell ships with complete documentation proving hemp-derived status and delta-9 THC content below 0.3%. However, Moroccan customs officials have broad discretion. There is a risk of seizure if authorities interpret the product differently. By ordering, you accept this risk.

Professional consultation: We strongly recommend consulting with a Moroccan lawyer familiar with cannabis regulations before ordering. We also recommend discussing cannabinoid use with your Moroccan healthcare provider, especially if you’re in the medical cannabis program.

Cultural considerations for Moroccan users

Balancing tradition and modern medicine:

We respect Morocco’s deep cannabis traditions. If you come from a family with generations of kif cultivation knowledge, you may have preconceptions about cannabis effects and dosing. Modern formulated RSO is different:

• It’s standardized, not variable like traditional hashish
• It offers precise dosing, not the approximate nature of traditional use
• It includes non-psychoactive options (raw THCa) that traditional use doesn’t provide
• It’s designed for medical outcomes, not recreational effects

Islamic considerations:

We respect that Morocco is a Muslim-majority country. While traditional kif culture exists, many Moroccans observe Islamic teachings that discourage intoxication. Our product respects this through patient-controlled potency:

• Use raw (non-decarbed) for therapeutic benefits without psychoactive effects
• Use decarbed only in private, non-religious contexts if you choose activation
• The non-psychoactive option aligns with Islamic values of maintaining mental clarity

Family and community:

Moroccan society is family-centered. If you’re considering RSO, involve trusted family members in your decision. Our open-source formula allows you to share exactly what you’re taking with family members, healthcare providers, or religious advisors.

Safety monitoring and side effects

Common effects to monitor:

• Drowsiness/sedation (especially with decarbed product or nighttime dosing)
• Dry mouth
• Changes in appetite
• Mood changes
• Potential drug interactions (especially with blood thinners, seizure medications, or psychiatric drugs)

Red flags requiring medical attention:

• Severe anxiety or panic (rare with proper dosing)
• Rapid heart rate or blood pressure changes
• Allergic reaction (very rare, but possible with terpenes)
• Worsening of symptoms rather than improvement

When to contact a doctor: If you’re using RSO for cancer support, maintain regular contact with your oncologist. If you experience any severe adverse effects, seek medical attention immediately at your nearest Moroccan hospital or clinic.

Interactions with Moroccan healthcare

Working with your doctor:

Moroccan physicians vary in their familiarity with cannabinoids. When discussing OilWell RSO with your doctor:

• Bring the complete formula table showing exact cannabinoid amounts
• Share the COA and testing documentation
• Be honest about your dosing and timing
• Ask specifically about drug interactions with any medications you’re taking
• Discuss both benefits and side effects you experience

Finding cannabis-knowledgeable doctors in Morocco:

While still rare, some progressive physicians in:

• Rabat: University Hospital Ibn Sina, private integrative medicine clinics
• Casablanca: Ibn Rochd University Hospital, Ain Chock medical faculty
• Marrakech: Mohamed VI University Hospital
• Tangier: Mohammed V military hospital, private clinics

These centers may have physicians familiar with cannabinoid therapy through international training.

Cost-benefit analysis for Moroccan consumers

Compared to Moroccan market alternatives:

• Traditional kif/hashish: Unstandardized, unknown potency, illegal for medical use, no quality control. OilWell: standardized, tested, legal to import (with proper documentation), precise dosing.
• Local CBD products: Typically 500-1000mg total cannabinoids for $50-80. OilWell: 16,590mg for $129.99 (33x more cannabinoids per dollar).
• Medical cannabis via ANRACA: Currently very limited availability, restrictive qualifying conditions, requires prescriptions. OilWell: Available now, no medical card needed (though you must verify import legality).

Long-term cost: If using daily at 1mL per day, one bottle lasts 30 days. At $129.99 plus international shipping (~$30-50), monthly cost is roughly $160-180. For severe conditions requiring this level of support, this compares favorably to many pharmaceutical regimens in Morocco, especially considering the multi-symptom relief potential.

Testimonials from international users

While we cannot share specific Moroccan patient stories yet (our PANDEM1C SEO system shows growing search traffic from Morocco, but we’re still building our Moroccan customer base), we can share patterns from international users that may resonate with Moroccan experiences:

From a chronic pain patient in France: “I was skeptical about RSO after trying CBD alone with no effect. The multi-cannabinoid formula made the difference. I use raw during the day for inflammation and decarbed at night for pain and sleep. For the first time in years, I’m not dependent on opioids.”

From a cancer patient in Spain: “During chemo, the sublingual oil helped with nausea better than Zofran. The vape was essential for breakthrough nausea. I don’t know if it’s helping the cancer, but it’s definitely helping me get through treatment.”

From a PTSD survivor in the UK: “The ability to use non-psychoactive raw oil during the day while working, then activate at night for trauma processing, gave me my life back. This isn’t about getting high—it’s about getting functional.”

We expect similar reports from Moroccan users as our presence in the country grows.

Future of cannabinoid access in Morocco

ANRACA’s evolving program:

• Licensed cultivation expanding in the Rif region
• First medical cannabis pharmacy opened in 2023 in Beni Mellal
• More distribution points planned for major cities
• Research partnerships with international universities developing

OilWell’s commitment to Morocco:
We’re monitoring ANRACA’s development closely. As Morocco’s program matures, we will:

• Seek partnerships with licensed Moroccan distributors
• Provide technical consultation to Moroccan manufacturers
• Support clinical research initiatives in Moroccan medical institutions
• Ensure our products meet or exceed ANRACA quality standards

Timeline: While we cannot predict when we’ll have a physical presence in Morocco, our international shipping infrastructure means Moroccans can access our products now (subject to customs clearance). We anticipate significant expansion of legal access in Morocco over the next 2-3 years.

Final Thoughts: OilWell’s Commitment to Moroccan Consumers

Morocco stands at a unique crossroads in the global cannabis story. You’ve moved from being one of the world’s largest producers of illicit cannabis to pioneering medical legalization in North Africa. Your challenge now is building a legal medical system that serves patients while respecting traditions, navigating international law, and maintaining cultural values.

We at OilWell Cannabis recognize that our role in Morocco is not to replace your emerging domestic industry, but to serve as a bridge — providing immediate access to evidence-based formulations while you build local capacity. Our open-source formulas can inform Moroccan product development. Our testing standards can serve as a benchmark. Our patient-controlled potency model respects both medical need and cultural values around intoxication.

Our promise to you:

• Complete transparency about what our products contain and what they can and cannot do
• Full documentation for customs and regulatory compliance
• Honest education based on peer-reviewed science, not marketing hype
• Respect for Moroccan law and culture
• Support for your healthcare decisions, not replacement of your medical team

Your responsibility:

• Verify current Moroccan law before ordering
• Consult with healthcare providers, especially if in the medical cannabis program
• Start with low doses and go slow
• Use responsibly, respecting workplace, religious, and family obligations
• Share your experiences to help build Morocco’s evidence base

The journey from Rick Simpson’s crude oil made with naphtha in Nova Scotia to our lab-tested, multi-cannabinoid, patient-controlled formulas represents 20 years of cannabis evolution. Morocco’s journey from traditional kif to regulated medical cannabis is just beginning. We’re honored to be part of it.

If you’re ready to explore whether OilWell RSO is right for you, visit our complete guide at https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/ or contact us directly at (832) 416-2816 or [email protected]

We’re here to answer your questions — in English, French, or with translation support — and to help you make an informed decision based on real science, not promises.

Bismillah. May your journey toward healing be guided by wisdom, supported by evidence, and blessed with relief.

All product specifications, formulations, pricing, and company information current as of 2024. Subject to change without notice. Moroccan customers are responsible for verifying current legality with ANRACA and Moroccan customs authorities before ordering.

Age requirement: 21+ for all RSO products. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Keep out of reach of children. Consult healthcare provider before use, especially if pregnant, nursing, taking medications, or have medical conditions. These statements have not been evaluated by the FDA or Moroccan health authorities. Not intended to diagnose, treat, cure, or prevent any disease.

---